{"meta":{"query_hash":"5da7a42e9d2d","filters":{"venue":"JHEP Reports"},"cohort_total":114,"direct_labels_cover":2,"predictions_cover":114,"exported":114,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/5da7a42e9d2d","api":"https://metacan.xera.ac/api/v1/cohort?venue=JHEP+Reports"},"results":[{"id":"W2923998330","doi":"10.1016/j.jhepr.2019.03.001","title":"JHEP Reports: A new EASL open access journal","year":2019,"lang":"en","type":"editorial","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hepatology; Publication; Outreach; Impact factor; Audience measurement; Medicine; Internal medicine; Publishing; Political science; Public relations; Medical education; Family medicine; Law","score_opus":0.03957957871228053,"score_gpt":0.40626750418538915,"score_spread":0.36668792547310863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2923998330","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0016456847,0.032427017,0.007247812,0.1361424,0.732711,0.00069648767,0.008231195,0.008075099,0.07282328],"genre_scores_gemma":[0.010010649,0.038671788,0.009173187,0.078258716,0.7645352,0.0008060962,0.00875897,0.0053251586,0.08446023],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.98056215,0.0025215936,0.0038854205,0.0018167328,0.009721624,0.0014925606],"domain_scores_gemma":[0.80489004,0.057792366,0.021113375,0.013512268,0.07005162,0.03264035],"candidate_categories":["open_science"],"consensus_categories":[],"category_scores_codex":[0.021904608,0.0017614261,0.0029392415,0.013238523,0.0028728135,0.024740482,0.003672582,0.008950745,0.117923185],"category_scores_gemma":[0.11667976,0.0016969645,0.0023019724,0.0052892286,0.0035612145,0.009087892,0.0058482857,0.012848582,0.09703373],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079252146,0.00007640453,0.000602094,0.0010573444,0.00004015269,0.00046684692,0.00007398477,0.000060010996,0.00023051255,0.0029506392,0.92882,0.06554283],"study_design_scores_gemma":[0.000030290468,0.00003766443,0.00066249014,0.0007404422,0.000021780277,0.0006348225,0.00006382524,0.000059713628,0.00015796295,0.0012081532,0.99634933,0.000033547938],"about_ca_topic_score_codex":0.00045362354,"about_ca_topic_score_gemma":0.00052502955,"teacher_disagreement_score":0.9963274,"about_ca_system_score_codex":0.0022302894,"about_ca_system_score_gemma":0.008936084,"threshold_uncertainty_score":0.39449233},"labels":[{"model":"gemma","categories":["scholarly_communication"],"domain":null,"study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"low"},{"model":"gpt","categories":["scholarly_communication","open_science"],"domain":null,"study_design":"not_applicable","genre":"editorial","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W2925188819","doi":"10.1016/j.jhepr.2019.02.005","title":"Acute-on-chronic liver failure: Objective admission and support criteria in the intensive care unit","year":2019,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Decompensation; Hepatorenal syndrome; Intensive care unit; Cirrhosis; Portopulmonary hypertension; Intensive care medicine; Liver transplantation; Hepatic encephalopathy; Intensive care; Transplantation; Internal medicine","score_opus":0.047675907830002695,"score_gpt":0.3648379389039142,"score_spread":0.3171620310739115,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2925188819","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00062944053,0.99131167,0.0005320407,0.001459225,0.0005785929,0.00009550721,0.00023511302,0.000019735568,0.0051387623],"genre_scores_gemma":[0.014955617,0.97666216,0.0019511521,0.0018362909,0.0014688941,0.00020865559,0.001069601,0.000009055439,0.0018385182],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994654,0.00012422873,0.00013914405,0.000047618993,0.00017581724,0.000047681973],"domain_scores_gemma":[0.99896955,0.00031993614,0.00030855314,0.000021628286,0.00028057804,0.0000997627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008719953,0.0007979992,0.0014433119,0.0021262842,0.0003569994,0.0008738597,0.00093879376,0.0007347133,0.0032982063],"category_scores_gemma":[0.0017604219,0.000118614,0.00058170396,0.0027042995,0.0005265499,0.0006880937,0.00060179405,0.001257313,0.0012035382],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017308841,0.00012498077,0.0058635105,0.033099204,0.0003021806,0.0014095681,0.00016317285,0.00036273777,0.00056934374,0.004363804,0.13163638,0.82193214],"study_design_scores_gemma":[0.0002449815,0.00018023056,0.046212453,0.07859092,0.0007518023,0.020940531,0.00059474417,0.00062111474,0.00047719534,0.00560389,0.8456669,0.00011523089],"about_ca_topic_score_codex":0.0021170287,"about_ca_topic_score_gemma":0.0040323343,"teacher_disagreement_score":0.0032982063,"about_ca_system_score_codex":0.00061435456,"about_ca_system_score_gemma":0.0018775038,"threshold_uncertainty_score":0.011033535},"labels":[],"label_agreement":null},{"id":"W2940105550","doi":"10.1016/j.jhepr.2019.02.001","title":"Infliximab for the treatment of refractory immune-related hepatitis secondary to checkpoint inhibitors: A case report","year":2019,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; University of Toronto","funders":"","keywords":"Nivolumab; Ipilimumab; Medicine; Melanoma; Adverse effect; Immune checkpoint; Internal medicine; Immune system; Common Terminology Criteria for Adverse Events; Cancer; Oncology; Immunology; Immunotherapy; Cancer research","score_opus":0.010726329060093267,"score_gpt":0.2735513881588859,"score_spread":0.26282505909879267,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2940105550","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.7625542,0.12028202,0.020529443,0.042368233,0.0051211696,0.0010816472,0.0014239167,0.0012573284,0.04538204],"genre_scores_gemma":[0.9630631,0.013529732,0.0043378356,0.00811691,0.0038713294,0.000108304965,0.00036317203,0.00011809115,0.006491534],"study_design_codex":"case_report","study_design_gemma":"case_report","domain_scores_codex":[0.99881905,0.00015386083,0.00014853885,0.00026572347,0.00019575834,0.0004170371],"domain_scores_gemma":[0.9983821,0.00036822289,0.00040191397,0.00012669232,0.000103998114,0.0006170011],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048055252,0.0032900635,0.00254288,0.0048560896,0.0034881714,0.0026624266,0.0019317624,0.009866528,0.0034967214],"category_scores_gemma":[0.00308116,0.0013925378,0.0034436206,0.003269029,0.001645159,0.0031011163,0.0020544387,0.0062715453,0.0018899946],"study_design_candidate":"case_report","study_design_consensus":"case_report","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013120667,0.000026422958,0.000793124,0.000035562658,0.000013883254,0.997255,0.00007692039,0.000043939872,0.0001604852,0.000104864834,0.0003848542,0.0010918077],"study_design_scores_gemma":[0.000009355097,0.00002252729,0.00065106875,0.000025387895,0.000014963538,0.998456,0.000051786807,0.00013070494,0.00008046203,0.00008755695,0.0004627513,0.0000074818727],"about_ca_topic_score_codex":0.0047927806,"about_ca_topic_score_gemma":0.0064023496,"teacher_disagreement_score":0.009866528,"about_ca_system_score_codex":0.0026593679,"about_ca_system_score_gemma":0.0015778758,"threshold_uncertainty_score":0.019295156},"labels":[],"label_agreement":null},{"id":"W2946374695","doi":"10.1016/j.jhepr.2019.05.004","title":"Radiotherapy for HCC: Ready for prime time?","year":2019,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":66,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Bridging (networking); Radiation therapy; Radiology; Oncology; Medical physics; Internal medicine; Computer science","score_opus":0.24115940712736844,"score_gpt":0.38754633542407724,"score_spread":0.1463869282967088,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946374695","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00004236401,0.9985959,0.00003708954,0.00063819886,0.00021194089,0.0000013042836,0.000006212837,0.0000023632713,0.00046456995],"genre_scores_gemma":[0.00033780502,0.9989542,0.000048595968,0.00026157984,0.0002371691,0.0000016789666,0.000010630985,9.530658e-7,0.00014734635],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980766,0.000051557934,0.00003761225,0.000029534303,0.00005786988,0.000015683934],"domain_scores_gemma":[0.9995179,0.00027812188,0.00007327958,0.000016322218,0.00008943884,0.000024908974],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006459388,0.00043370985,0.0009728173,0.0014887226,0.00018399252,0.0009242865,0.0006500002,0.001020814,0.0038582766],"category_scores_gemma":[0.0016202512,0.00016625867,0.0004984653,0.0016930769,0.00052699045,0.0016841023,0.00046461474,0.0015847108,0.0016476397],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000047972477,0.000019927997,0.00021533137,0.020679863,0.00007688911,0.00017326619,0.00007460106,0.00018347756,0.0002846294,0.0035401157,0.03860852,0.9360955],"study_design_scores_gemma":[0.00001760612,0.00006853674,0.001055597,0.017727789,0.0001594401,0.0025709514,0.00013410937,0.000049640203,0.00018478821,0.002732695,0.97527957,0.00001926042],"about_ca_topic_score_codex":0.0014885241,"about_ca_topic_score_gemma":0.0024687096,"teacher_disagreement_score":0.0038582766,"about_ca_system_score_codex":0.00056276785,"about_ca_system_score_gemma":0.0012065868,"threshold_uncertainty_score":0.012907207},"labels":[],"label_agreement":null},{"id":"W2954121849","doi":"10.1016/j.jhepr.2019.06.001","title":"HBeAg seroconversion is associated with a more effective PD-L1 blockade during chronic hepatitis B infection","year":2019,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital","funders":"AstraZeneca","keywords":"HBeAg; Medicine; Seroconversion; Immunology; Hepatitis B virus; Blockade; Hepatocellular carcinoma; T cell; Virology; Hepatitis B; Antibody; Viral load; HBsAg; Immune system; Virus; Internal medicine; Receptor","score_opus":0.004777561713862955,"score_gpt":0.2349294680056037,"score_spread":0.23015190629174073,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2954121849","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99863774,0.0007309924,0.00009024408,0.000031518783,0.0000079099855,0.0000079549745,0.000038033166,0.000010997733,0.00044469538],"genre_scores_gemma":[0.9994691,0.00010765842,0.000042754968,0.00004221416,0.000012393755,0.0000065829768,0.00008484575,0.0000021435542,0.00023233982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989307,0.000023995939,0.000012691655,0.000019923464,0.000017576629,0.00003285043],"domain_scores_gemma":[0.9994636,0.000094643176,0.0001819633,0.000034734865,0.000038004735,0.00018712295],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020452173,0.00019151309,0.0003636835,0.00028043467,0.00020366898,0.00034042334,0.00008952136,0.00024038441,0.0016152797],"category_scores_gemma":[0.00042894404,0.0000936277,0.0002123649,0.00016238533,0.00017845242,0.00015896797,0.00016557034,0.0006509822,0.00022246833],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.017073737,0.0019157949,0.49348566,0.00027163344,0.00016625256,0.0016500087,0.00055370823,0.00030718386,0.41037446,0.00018777003,0.0007333777,0.07328039],"study_design_scores_gemma":[0.000112529095,0.0031402113,0.9839219,0.00001342896,0.000056025503,0.0016322655,0.00009098626,0.0002217712,0.009656458,0.00007229835,0.0010764363,0.000005666232],"about_ca_topic_score_codex":0.00022139928,"about_ca_topic_score_gemma":0.00020553615,"teacher_disagreement_score":0.0016152797,"about_ca_system_score_codex":0.00016015058,"about_ca_system_score_gemma":0.00013850149,"threshold_uncertainty_score":0.0054036975},"labels":[],"label_agreement":null},{"id":"W2964431599","doi":"10.1016/j.jhepr.2019.07.004","title":"Recent advances in liver transplantation for cancer: The future of transplant oncology","year":2019,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto General Hospital; University of Toronto","funders":"","keywords":"Medicine; Liver transplantation; Hepatocellular carcinoma; Transplantation; Colorectal cancer; Neuroendocrine tumors; Internal medicine; Cancer; Oncology","score_opus":0.047805966528124674,"score_gpt":0.3699732112463504,"score_spread":0.3221672447182257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2964431599","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000692813,0.99864465,0.000049401468,0.00051324075,0.00023626498,9.826697e-7,0.0000053476097,0.0000032116927,0.00047766248],"genre_scores_gemma":[0.0004875018,0.99867517,0.000072428986,0.000258213,0.00035868463,0.0000012492177,0.000007706369,6.98931e-7,0.00013832303],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99980706,0.000045615343,0.000036809543,0.000029708015,0.00006472733,0.000016118038],"domain_scores_gemma":[0.998708,0.00086349517,0.00012691099,0.000026171034,0.00020466998,0.00007079563],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006818651,0.00044056028,0.00081459637,0.0022227059,0.00026868,0.0011045497,0.00050191197,0.000834545,0.0033328321],"category_scores_gemma":[0.0014222723,0.00013717402,0.000387054,0.0024297002,0.0005651477,0.0017851263,0.0005526796,0.0014461393,0.0008047815],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000570492,0.00004094813,0.00036441023,0.023145363,0.00008447937,0.00032303066,0.00014245926,0.00030834973,0.0007491863,0.0068087066,0.038649503,0.9293265],"study_design_scores_gemma":[0.000009984814,0.00006836351,0.0010642955,0.007228604,0.00012611828,0.0019422953,0.0001688549,0.00007918455,0.00019640765,0.004150082,0.9849465,0.000019318262],"about_ca_topic_score_codex":0.0007570876,"about_ca_topic_score_gemma":0.00170538,"teacher_disagreement_score":0.0033328321,"about_ca_system_score_codex":0.00061963167,"about_ca_system_score_gemma":0.0012578082,"threshold_uncertainty_score":0.011149406},"labels":[],"label_agreement":null},{"id":"W2965251010","doi":"10.1016/j.jhepr.2019.04.004","title":"The role of the gut microbiome in chronic liver disease: the clinical evidence revised","year":2019,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":169,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Intestinal permeability; Intestinal Microbiome; Microbiome; Pathogenesis; Liver disease; Gut flora; Disease; Gut microbiome; Fatty liver; Chronic liver disease; Immunology; Biology; Inflammatory bowel disease; Inflammation; Medicine; Gastroenterology; Bioinformatics; Internal medicine; Cirrhosis","score_opus":0.0963577682362618,"score_gpt":0.4091114852073539,"score_spread":0.3127537169710921,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2965251010","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000054331256,0.99886096,0.00003504031,0.0005256115,0.0002032961,0.0000013797653,0.000010111203,0.0000018081167,0.00030749216],"genre_scores_gemma":[0.0005739877,0.99862623,0.000081413025,0.0002688464,0.00029660636,0.0000018950753,0.000013300735,7.1605626e-7,0.00013700618],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9994924,0.00013115794,0.000112645146,0.000075263815,0.00015678922,0.00003174346],"domain_scores_gemma":[0.9976666,0.0014665634,0.00030491434,0.00005058599,0.00042933167,0.000082011815],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013532696,0.0006812296,0.0014043702,0.0024706656,0.00026700177,0.0016847108,0.0007940147,0.0012104944,0.0051679495],"category_scores_gemma":[0.0031753515,0.000248254,0.0006985369,0.0028339888,0.00080413144,0.0023023558,0.0008203529,0.0018511199,0.0014211485],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015003115,0.000037716116,0.00048270597,0.042783983,0.00022733609,0.0003068772,0.00010995792,0.00018932193,0.0007802537,0.0046165846,0.027226258,0.9230891],"study_design_scores_gemma":[0.00002647633,0.0001494439,0.0032487821,0.048005886,0.0006114246,0.0035839372,0.00027824796,0.00012279634,0.00034697476,0.004851275,0.938732,0.000042759875],"about_ca_topic_score_codex":0.0011932662,"about_ca_topic_score_gemma":0.0018840242,"teacher_disagreement_score":0.0051679495,"about_ca_system_score_codex":0.0006160109,"about_ca_system_score_gemma":0.0017824773,"threshold_uncertainty_score":0.017288566},"labels":[],"label_agreement":null},{"id":"W2985497014","doi":"10.1016/j.jhepr.2019.10.007","title":"How to improve HCC surveillance outcomes","year":2019,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Hepatocellular carcinoma; Medicine; Computer science; Internal medicine","score_opus":0.11992296774698413,"score_gpt":0.3296167892671368,"score_spread":0.20969382152015265,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2985497014","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00010512039,0.9958221,0.00022088492,0.0023698024,0.0005270548,0.000018828794,0.00006548509,0.00002263784,0.00084816484],"genre_scores_gemma":[0.0013896574,0.9960427,0.0006053354,0.0010577755,0.00043558178,0.000037784605,0.00012366843,0.0000054724637,0.00030196292],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991586,0.0002782832,0.00016831775,0.00011030667,0.0002162884,0.00006824353],"domain_scores_gemma":[0.9981871,0.0009639086,0.00023841693,0.000053755582,0.0004624796,0.00009417615],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002781224,0.0009620553,0.0019738504,0.003190147,0.00025346625,0.0014065271,0.0013854522,0.0016208522,0.0066956542],"category_scores_gemma":[0.0078171985,0.00027569226,0.0020726495,0.0013150946,0.0003199037,0.002195908,0.00080190634,0.0020977356,0.0022239676],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006483519,0.000058992424,0.00034141302,0.037632886,0.00032931258,0.000061937775,0.000054046795,0.00023708423,0.00015570235,0.0026166486,0.04428717,0.9141599],"study_design_scores_gemma":[0.00015684299,0.00016737793,0.0048421305,0.13335241,0.0014946857,0.00076264853,0.00021785234,0.00031945936,0.00040102896,0.0059899716,0.85224724,0.000048361817],"about_ca_topic_score_codex":0.0030628373,"about_ca_topic_score_gemma":0.0035486592,"teacher_disagreement_score":0.0066956542,"about_ca_system_score_codex":0.0010195038,"about_ca_system_score_gemma":0.002649432,"threshold_uncertainty_score":0.022399187},"labels":[],"label_agreement":null},{"id":"W2988141874","doi":"10.1016/j.jhepr.2019.10.003","title":"Intrahepatic macrophage populations in the pathophysiology of primary sclerosing cholangitis","year":2019,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":61,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network; Toronto Liver Centre; University of Toronto","funders":"Manchester Biomedical Research Centre; Biotechnology and Biological Sciences Research Council; Department of Health and Social Care; Medical Research Council; University of Birmingham; National Institute for Health and Care Research; Birmingham Biomedical Research Centre; University Hospitals Birmingham NHS Foundation Trust","keywords":"Primary sclerosing cholangitis; CD68; Steatohepatitis; CD14; Fatty liver; Medicine; Internal medicine; Gastroenterology; Pathology; Liver disease; Primary biliary cirrhosis; Liver transplantation; Chronic liver disease; Macrophage; Biology; Immunohistochemistry; Transplantation; Receptor; Disease; Cirrhosis","score_opus":0.030673995109366036,"score_gpt":0.27338421958483305,"score_spread":0.24271022447546703,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988141874","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99024105,0.008252905,0.00035340735,0.00016493983,0.00001537079,0.000015478734,0.00002307944,0.000011298099,0.0009224776],"genre_scores_gemma":[0.99806696,0.001413971,0.00018827245,0.000030937983,0.00003542696,0.000014070642,0.00002126734,0.0000010014772,0.00022802921],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9999087,0.000038632195,0.000007879408,0.0000095332025,0.000018528632,0.0000167555],"domain_scores_gemma":[0.9999219,0.000015102867,0.000029351897,0.000004685026,0.000010626661,0.000018321096],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003470919,0.0001855878,0.00013357811,0.0005819305,0.000099107354,0.00022257611,0.00008680927,0.00018583394,0.0008570147],"category_scores_gemma":[0.00015916712,0.00008375689,0.00009152358,0.00016222638,0.0002673724,0.00013990556,0.00018744677,0.00018501922,0.00017730046],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0043842327,0.00034360372,0.36396438,0.0008121872,0.000075649936,0.006124341,0.0010748707,0.00041218213,0.56379664,0.0019195076,0.0008270333,0.056265436],"study_design_scores_gemma":[0.00023587077,0.0024481977,0.8929616,0.00024608427,0.00024012092,0.022096936,0.0016076901,0.0014989437,0.0676701,0.0022740439,0.008699657,0.000020748841],"about_ca_topic_score_codex":0.00010909668,"about_ca_topic_score_gemma":0.00012702499,"teacher_disagreement_score":0.0008570147,"about_ca_system_score_codex":0.00011663783,"about_ca_system_score_gemma":0.00009731054,"threshold_uncertainty_score":0.002867043},"labels":[],"label_agreement":null},{"id":"W2988581613","doi":"10.1016/j.jhepr.2019.10.009","title":"Pcsk9 knockout exacerbates diet-induced non-alcoholic steatohepatitis, fibrosis and liver injury in mice","year":2019,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences; Thrombosis and Atherosclerosis Research Institute; McMaster University; Université de Montréal; Montreal Clinical Research Institute; St. Joseph’s Healthcare Hamilton","funders":"Canadian Institutes of Health Research; Amgen Canada; Amgen; Fondation Leducq; McMaster University; Canada Research Chairs; Heart and Stroke Foundation of Canada","keywords":"Steatohepatitis; Steatosis; Fatty liver; CD36; Internal medicine; Endocrinology; Liver injury; PCSK9; Hepatocyte; Biology; Alcoholic liver disease; LDL receptor; Chemistry; Lipoprotein; Medicine; Cholesterol; Biochemistry; Receptor; Cirrhosis","score_opus":0.009694823089765093,"score_gpt":0.25286993859812845,"score_spread":0.24317511550836335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988581613","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9885095,0.0014551022,0.0033596111,0.0006368724,0.00013028974,0.00012404774,0.0024248848,0.0006036372,0.0027560028],"genre_scores_gemma":[0.97221,0.0017824392,0.0049620685,0.00039827236,0.000057043162,0.00022140509,0.0021094421,0.00021145005,0.018047877],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99962807,0.00004020538,0.000056198885,0.00009297158,0.00007835565,0.00010405832],"domain_scores_gemma":[0.9994568,0.00003343982,0.00019903429,0.0000365605,0.000025294477,0.00024886357],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027608074,0.00080437673,0.0005544136,0.001199702,0.0003500319,0.0005294782,0.0003320071,0.0009381451,0.004782155],"category_scores_gemma":[0.0001768129,0.0005500651,0.00056815037,0.00035908562,0.00057641306,0.00044900205,0.0004649617,0.0018468607,0.0011380359],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0016746942,0.00044641542,0.000869714,0.00013400403,0.000038302576,0.0004206994,0.0000648058,0.00017431777,0.99257576,0.00035582806,0.00031308897,0.002932382],"study_design_scores_gemma":[0.00046653498,0.002783874,0.0334836,0.0001298796,0.00019799778,0.002502516,0.00028117097,0.0027207735,0.9489391,0.00048182087,0.007970356,0.00004241441],"about_ca_topic_score_codex":0.0010242313,"about_ca_topic_score_gemma":0.0022210449,"teacher_disagreement_score":0.004782155,"about_ca_system_score_codex":0.00048147072,"about_ca_system_score_gemma":0.0003894633,"threshold_uncertainty_score":0.015997946},"labels":[],"label_agreement":null},{"id":"W2988855473","doi":"10.1016/j.jhepr.2019.10.005","title":"Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group","year":2019,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":99,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Toronto; University Health Network; University of Calgary; University of Alberta","funders":"Sir Jules Thorn Charitable Trust; Medical Research Council; National Institute for Health and Care Research","keywords":"Autoimmune hepatitis; Medicine; Rituximab; Prednisolone; Internal medicine; Hepatitis; Retrospective cohort study; Cohort; Adverse effect; Gastroenterology; Immunology; Pediatrics; Lymphoma","score_opus":0.00919909392241031,"score_gpt":0.24088738759176556,"score_spread":0.23168829366935526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2988855473","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9180659,0.07466746,0.00056185276,0.00060994935,0.00009112932,0.00016825789,0.00036046142,0.000029772391,0.0054451907],"genre_scores_gemma":[0.9905551,0.007832591,0.0003458402,0.0003450959,0.00017499922,0.000051928073,0.00046461122,0.000011246953,0.00021855449],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980458,0.0010720418,0.00029299018,0.00016236566,0.0003186119,0.000108106564],"domain_scores_gemma":[0.99534047,0.002033873,0.0012634555,0.00044822253,0.00059494114,0.0003190829],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044382424,0.0004993822,0.00063857215,0.00043458535,0.0001287078,0.0005760317,0.00025830916,0.00039140193,0.00071104063],"category_scores_gemma":[0.006236653,0.000074903845,0.0008657306,0.00048445296,0.00034941128,0.00040593135,0.00027990792,0.0004330724,0.0001696259],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.032434948,0.0017110107,0.61647844,0.0015937836,0.005403674,0.00036213838,0.0005879373,0.001035478,0.006047668,0.0002181137,0.0030912952,0.33103555],"study_design_scores_gemma":[0.0060213557,0.031259,0.9334099,0.00093068404,0.00532192,0.002090903,0.00034280427,0.0008391032,0.0056005865,0.00017462054,0.013951796,0.00005728457],"about_ca_topic_score_codex":0.00049576606,"about_ca_topic_score_gemma":0.00048177483,"teacher_disagreement_score":0.0044382424,"about_ca_system_score_codex":0.000320539,"about_ca_system_score_gemma":0.00023757592,"threshold_uncertainty_score":0.023471892},"labels":[],"label_agreement":null},{"id":"W2991772886","doi":"10.1016/j.jhepr.2019.11.004","title":"Methylation signatures in peripheral blood are associated with marked age acceleration and disease progression in patients with primary sclerosing cholangitis","year":2019,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Target Real-world evidence; Intercept Pharmaceuticals; Gilead Sciences; Novartis; Meso Scale Diagnostics; Merck; Dr. Falk Pharma; GlaxoSmithKline; Allergan; Bristol-Myers Squibb","keywords":"Primary sclerosing cholangitis; Medicine; Internal medicine; Gastroenterology; Cohort; Hazard ratio; Cirrhosis; Liver biopsy; Confidence interval; Biopsy; Disease","score_opus":0.007678889443100779,"score_gpt":0.22518395467060626,"score_spread":0.21750506522750548,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2991772886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99888045,0.00036235244,0.0001559291,0.000031516764,0.000004696063,0.0000036555955,0.00017246812,0.000009200197,0.00037974137],"genre_scores_gemma":[0.99952734,0.000062813626,0.00009669418,0.0000104469955,0.0000072174894,0.0000027917738,0.00011980036,0.0000012070864,0.00017165093],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99988043,0.000032349053,0.000014571186,0.00003169657,0.000021638594,0.000019231564],"domain_scores_gemma":[0.9995191,0.00008880195,0.00024855294,0.00003126715,0.000041824038,0.000070510025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018592982,0.00014708367,0.00019731667,0.00033930148,0.00010818957,0.00024373012,0.00008351563,0.00021085911,0.0020648197],"category_scores_gemma":[0.000826612,0.00009216415,0.00013427628,0.0003769581,0.00011298276,0.00013680616,0.00015416494,0.00024142078,0.00019637297],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056912756,0.000020363854,0.989273,0.000018910949,0.00003665731,0.00016361513,0.000058400838,0.00005315206,0.0042218957,0.000019536566,0.00012638133,0.005438915],"study_design_scores_gemma":[0.000004311553,0.00009511024,0.9985814,0.0000027864755,0.00001990232,0.00049004966,0.000036160593,0.00015531424,0.00044800638,0.000027541055,0.00013752299,0.0000018551187],"about_ca_topic_score_codex":0.0005035818,"about_ca_topic_score_gemma":0.0007154257,"teacher_disagreement_score":0.0020648197,"about_ca_system_score_codex":0.000089711066,"about_ca_system_score_gemma":0.00007722523,"threshold_uncertainty_score":0.0069075227},"labels":[],"label_agreement":null},{"id":"W3002581322","doi":"10.1016/j.jhepr.2020.100067","title":"Limitations of non-invasive tests for assessment of liver fibrosis","year":2020,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":303,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre; Toronto General Hospital; University Health Network","funders":"Fonds de Recherche du Québec - Santé; Faculty of Medicine, McGill University","keywords":"Medicine; Liver biopsy; Steatohepatitis; Context (archaeology); Fibrosis; Fatty liver; Chronic liver disease; Biomarker; Biopsy; Hepatic fibrosis; Pathology; Disease; Gastroenterology; Cirrhosis; Biology","score_opus":0.1903950336497323,"score_gpt":0.40080223329310644,"score_spread":0.21040719964337415,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3002581322","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.055572372,0.52283955,0.20333289,0.11023831,0.015983945,0.0024323917,0.00516592,0.0011526681,0.08328192],"genre_scores_gemma":[0.4830517,0.15868108,0.2729712,0.05569088,0.014670521,0.0038385512,0.0024275896,0.00062396127,0.00804454],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.8564581,0.06489104,0.015400513,0.007106437,0.05519028,0.0009536559],"domain_scores_gemma":[0.60401094,0.31032342,0.018049445,0.013081414,0.052663743,0.0018710276],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.122730814,0.0012530772,0.0019196403,0.0039606257,0.0010457335,0.0042149774,0.0045485357,0.0019731084,0.0030057628],"category_scores_gemma":[0.23739971,0.00071825663,0.0013483745,0.0032517263,0.0039513535,0.0031143704,0.0026433482,0.0040811626,0.0017962509],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008138956,0.0002913126,0.105034545,0.010878899,0.0009987258,0.0007171608,0.0026831436,0.0022131577,0.0044751866,0.021585586,0.04787564,0.80243266],"study_design_scores_gemma":[0.0002116478,0.0017483807,0.15939972,0.02273368,0.0017284309,0.02133905,0.004189302,0.012399438,0.014577288,0.06872363,0.6922463,0.00070308143],"about_ca_topic_score_codex":0.005634557,"about_ca_topic_score_gemma":0.0058480836,"teacher_disagreement_score":0.122730814,"about_ca_system_score_codex":0.001993019,"about_ca_system_score_gemma":0.0028721346,"threshold_uncertainty_score":0.6490704},"labels":[],"label_agreement":null},{"id":"W3003672419","doi":"10.1016/j.jhepr.2020.100081","title":"Assessing physician preferences on future therapeutic options and diagnostic practices in non-alcoholic steatohepatitis","year":2020,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto Liver Centre; University of Toronto; University Health Network","funders":"Novartis Pharma; Gilead Sciences; Novartis","keywords":"Steatohepatitis; Medicine; Intensive care medicine; Fatty liver; Disease; Internal medicine","score_opus":0.05752884116265664,"score_gpt":0.3466541766515822,"score_spread":0.28912533548892555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3003672419","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99920684,0.000065302236,0.00016107985,0.00008522055,0.0000020399,0.000022794338,0.000032743283,0.0000014396961,0.00042262877],"genre_scores_gemma":[0.99898165,0.00007343673,0.00068160484,0.00006980715,0.0000047572867,0.000025917821,0.000043198615,5.43041e-7,0.000119065866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99727005,0.0018707453,0.00019655067,0.000103428836,0.00041725015,0.00014199039],"domain_scores_gemma":[0.9835586,0.011567161,0.002858563,0.00024931712,0.0009913968,0.0007750738],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0051736105,0.0001426477,0.00018652521,0.00034801153,0.00032749845,0.00065670913,0.00014587467,0.00043463192,0.0032461903],"category_scores_gemma":[0.015312529,0.00010105416,0.00036892327,0.0003349322,0.00030056076,0.00044004674,0.00033677282,0.00040526537,0.00022995968],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022178157,0.0009640598,0.9287771,0.00040850832,0.00012065548,0.00027037627,0.0076732216,0.00086280284,0.0022586333,0.0001479179,0.00086077576,0.055438112],"study_design_scores_gemma":[0.00020908914,0.0050164284,0.96829814,0.00012354944,0.000081000355,0.0009733573,0.018073829,0.003365354,0.0015321211,0.00038151038,0.0018941014,0.00005157891],"about_ca_topic_score_codex":0.001844754,"about_ca_topic_score_gemma":0.0038900266,"teacher_disagreement_score":0.0051736105,"about_ca_system_score_codex":0.0005622159,"about_ca_system_score_gemma":0.0007924881,"threshold_uncertainty_score":0.027360976},"labels":[],"label_agreement":null},{"id":"W3009714532","doi":"10.1016/j.jhepr.2020.100095","title":"The second volume","year":2020,"lang":"en","type":"editorial","venue":"JHEP Reports","topic":"Organ Transplantation Techniques and Outcomes","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Publication; Computer science; Political science; Law","score_opus":0.005978280017988083,"score_gpt":0.26743334455638246,"score_spread":0.2614550645383944,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3009714532","genre_codex":"other","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010817063,0.03474324,0.0033628617,0.035377834,0.43206397,0.00039076246,0.006162175,0.0034941528,0.4833234],"genre_scores_gemma":[0.004133517,0.017823119,0.0016834723,0.012497261,0.13405684,0.00019563841,0.005560303,0.0020656374,0.82198423],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99599385,0.00044531847,0.00034306524,0.00066861825,0.0021992975,0.00034986765],"domain_scores_gemma":[0.9872751,0.0017919409,0.0007912656,0.0016498218,0.0053713922,0.003120486],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0029517764,0.0015848487,0.0016355561,0.005550175,0.0016609202,0.0129196085,0.0024537353,0.0027816908,0.5956324],"category_scores_gemma":[0.013659405,0.00080083526,0.0013861622,0.002886891,0.0011755263,0.0048245084,0.0038309146,0.004182605,0.48276168],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000023978893,0.00002029821,0.00012635368,0.00025000094,0.000008262389,0.00006037539,0.000025130597,0.000029864392,0.0003184498,0.0018352305,0.9482147,0.04908746],"study_design_scores_gemma":[0.0000050106014,0.000012631477,0.00016598673,0.00013589367,0.0000036592257,0.00017601233,0.00002341124,0.000021468983,0.00009110158,0.00066414103,0.9986945,0.0000062052486],"about_ca_topic_score_codex":0.0010982883,"about_ca_topic_score_gemma":0.0018859043,"teacher_disagreement_score":0.5956324,"about_ca_system_score_codex":0.0023818372,"about_ca_system_score_gemma":0.0040496136,"threshold_uncertainty_score":0.57678133},"labels":[],"label_agreement":null},{"id":"W3018166881","doi":"10.1016/j.jhepr.2020.100117","title":"Imaging and immunometabolic phenotyping uncover changes in the hepatic immune response in the early phases of NAFLD","year":2020,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Fundação de Amparo à Pesquisa do Estado de Minas Gerais; Conselho Nacional de Desenvolvimento Científico e Tecnológico; Coordenação de Aperfeiçoamento de Pessoal de Nível Superior","keywords":"Immune system; Biology; Medicine; Pathology; Immunology","score_opus":0.018518186571138608,"score_gpt":0.2675152929266799,"score_spread":0.24899710635554131,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3018166881","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9768908,0.003498333,0.01703916,0.00018473092,0.000029648132,0.000044965665,0.00079990394,0.0001980602,0.0013142892],"genre_scores_gemma":[0.97912896,0.0024836145,0.014501656,0.00023470209,0.000037349928,0.00010465241,0.0010548363,0.00004621497,0.0024079927],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.9998362,0.000024646844,0.000011651442,0.00004802548,0.00003553928,0.000043907552],"domain_scores_gemma":[0.99987054,0.0000122320525,0.00004345341,0.000011586023,0.000022818642,0.000039343424],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002898172,0.0003531274,0.00024549023,0.0008643492,0.00014123591,0.00033174132,0.00014585076,0.0004709577,0.0011728358],"category_scores_gemma":[0.00013749367,0.0002850376,0.00029546148,0.0002828198,0.00020183998,0.0003718465,0.0002731122,0.0007164171,0.00030326817],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026798298,0.000024420622,0.006865544,0.000047515972,0.000012862838,0.00006510676,0.000020945037,0.000076391305,0.98901004,0.00006753562,0.00007725347,0.003464404],"study_design_scores_gemma":[0.00003512737,0.0006772887,0.3155142,0.000049989143,0.0001150964,0.0017147491,0.0002681747,0.0031307582,0.67425174,0.0003608274,0.0038529385,0.000029115197],"about_ca_topic_score_codex":0.00030978126,"about_ca_topic_score_gemma":0.0007756844,"teacher_disagreement_score":0.0011728358,"about_ca_system_score_codex":0.00018041137,"about_ca_system_score_gemma":0.00013111354,"threshold_uncertainty_score":0.0039235353},"labels":[],"label_agreement":null},{"id":"W3023556837","doi":"10.1016/j.jhepr.2020.100119","title":"Adding the oxygen carrier M101 to a cold-storage solution could be an alternative to HOPE for liver graft preservation","year":2020,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Organ Transplantation Techniques and Outcomes","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministère de la Santé et des Services sociaux","keywords":"Machine perfusion; Viaspan; Hepatocyte; Cold storage; Medicine; Liver transplantation; Chemistry; Transplantation; Surgery; Biology; Biochemistry","score_opus":0.058892949149424334,"score_gpt":0.3246540398878067,"score_spread":0.2657610907383824,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3023556837","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9807006,0.009264662,0.008062434,0.00026207563,0.00021281315,0.000105525716,0.00013464109,0.00009667288,0.0011607202],"genre_scores_gemma":[0.98586744,0.0032600581,0.008472435,0.00019584596,0.000059459682,0.0000832335,0.0003887668,0.000019864105,0.0016528168],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99989367,0.000017523547,0.000011822836,0.000025356892,0.00003146238,0.000020166326],"domain_scores_gemma":[0.9998821,0.00002585871,0.000044691176,0.000009067336,0.000014171377,0.000024107496],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019560139,0.00035641808,0.00025073742,0.0002743495,0.00013992438,0.00030880023,0.00022933369,0.00043311118,0.0010033776],"category_scores_gemma":[0.0001966291,0.000083338615,0.0003567058,0.000121394674,0.0002130368,0.0003969243,0.00024307544,0.00044771706,0.00016598939],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004443545,0.000065770015,0.0007072255,0.000268999,0.000020080312,0.00011741379,0.000018423934,0.0001027933,0.98987633,0.0001121189,0.00008734451,0.008179035],"study_design_scores_gemma":[0.000052404146,0.002893189,0.004885475,0.00006159738,0.00009160283,0.0004060967,0.000042852636,0.0007029883,0.9843685,0.000073908035,0.0064010015,0.000020315234],"about_ca_topic_score_codex":0.00031645352,"about_ca_topic_score_gemma":0.0007296497,"teacher_disagreement_score":0.0010033776,"about_ca_system_score_codex":0.00019798211,"about_ca_system_score_gemma":0.00022541484,"threshold_uncertainty_score":0.0033566356},"labels":[],"label_agreement":null},{"id":"W3091107552","doi":"10.1016/j.jhepr.2020.100191","title":"Obeticholic acid is associated with improvements in AST-to-platelet ratio index and GLOBE score in patients with primary biliary cholangitis","year":2020,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital","funders":"Dr. Falk Pharma; Gilead Sciences","keywords":"Medicine; Obeticholic acid; Internal medicine; Ursodeoxycholic acid; Gastroenterology; Placebo; Pathology","score_opus":0.008873080547713833,"score_gpt":0.21300129425023084,"score_spread":0.20412821370251702,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3091107552","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9977654,0.0016304792,0.00005788682,0.00007065195,0.000014028879,0.000026927908,0.000053751683,0.0000077289305,0.00037313998],"genre_scores_gemma":[0.9993193,0.0002980765,0.00008704354,0.000051373812,0.000016649823,0.00001134443,0.00008415713,0.0000010999116,0.00013090007],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996835,0.00014932787,0.00004139265,0.00003095522,0.000054159824,0.000040754996],"domain_scores_gemma":[0.999019,0.00027763625,0.00042225083,0.00006369291,0.000056146113,0.00016120171],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006162675,0.00027155588,0.0008501424,0.00018580117,0.00015835903,0.00033846774,0.00012728797,0.00030157284,0.0010436171],"category_scores_gemma":[0.0014032298,0.00015310681,0.00079492165,0.00027346058,0.00019749512,0.00021286056,0.00022103902,0.00061232987,0.00010159069],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.30144572,0.004085072,0.495443,0.0008038113,0.0031762973,0.00045043332,0.00021788804,0.0012234605,0.04211393,0.000090164875,0.0011054878,0.1498447],"study_design_scores_gemma":[0.0069007385,0.048827223,0.93824327,0.00004802975,0.0011490827,0.0004176357,0.000082676255,0.0007972405,0.00256171,0.00009161888,0.00086314615,0.000017624257],"about_ca_topic_score_codex":0.0003639882,"about_ca_topic_score_gemma":0.0009577907,"teacher_disagreement_score":0.0010436171,"about_ca_system_score_codex":0.00016210206,"about_ca_system_score_gemma":0.0002252726,"threshold_uncertainty_score":0.0034912229},"labels":[],"label_agreement":null},{"id":"W3110042762","doi":"10.1016/j.jhepr.2020.100217","title":"Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis","year":2020,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Diet, Metabolism, and Disease","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto","funders":"European Commission; National Institute for Health and Care Research; Takeda Pharmaceutical Company","keywords":"Steatosis; Fatty liver; Fructose; Endocrinology; Internal medicine; Glycolysis; Medicine; Biology; Biochemistry; Metabolism; Disease","score_opus":0.015840538796458567,"score_gpt":0.24540463565255863,"score_spread":0.22956409685610007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3110042762","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98369724,0.0074790134,0.003682985,0.00038247235,0.0002167187,0.000072168674,0.00094353757,0.0005256345,0.0030002869],"genre_scores_gemma":[0.98709583,0.0041697784,0.0029017888,0.00017117175,0.000039429357,0.00005681803,0.0010262349,0.00006985638,0.004469176],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99993205,0.00000911513,0.000008863532,0.000013962257,0.000014266004,0.000021747644],"domain_scores_gemma":[0.99991846,0.0000055447194,0.000024363564,0.00000725879,0.0000103506145,0.00003400938],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00008041071,0.00044690885,0.00042879765,0.00029738038,0.00012245755,0.0002914648,0.00022064192,0.00026421694,0.003384835],"category_scores_gemma":[0.00009208746,0.0001107657,0.00029919928,0.00013187651,0.00018343268,0.000285905,0.00017053033,0.00063764135,0.00036579816],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0049776654,0.0007163464,0.0009543888,0.00043128643,0.00009286222,0.000066888446,0.000021851383,0.00028644336,0.96016455,0.00020990806,0.00052175985,0.031556148],"study_design_scores_gemma":[0.00046240183,0.0049773627,0.020865174,0.000060455146,0.00021037988,0.0004198056,0.00009591322,0.0009997009,0.9608518,0.0002915634,0.010739846,0.000025563679],"about_ca_topic_score_codex":0.00055648625,"about_ca_topic_score_gemma":0.0012315905,"teacher_disagreement_score":0.003384835,"about_ca_system_score_codex":0.00017854535,"about_ca_system_score_gemma":0.00020428571,"threshold_uncertainty_score":0.011323392},"labels":[],"label_agreement":null},{"id":"W3122013602","doi":"10.1016/j.jhepr.2021.100234","title":"European ‘NAFLD Preparedness Index’ — Is Europe ready to meet the challenge of fatty liver disease?","year":2021,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Allergan; European Association for the Study of the Liver; National Institute for Health and Care Research; Generalitat de Catalunya; European Social Fund; Gilead Sciences; Centres de Recerca de Catalunya; NIHR Newcastle Biomedical Research Centre; Ministerio de Ciencia, Innovación y Universidades; Instituto de Salud Carlos III; European Commission; Pfizer","keywords":"Preparedness; Epidemiology; Medicine; Fatty liver; Environmental health; Disease; Index (typography); Metabolic syndrome; Obesity; Family medicine; Political science; Pathology; Computer science","score_opus":0.029273893850933482,"score_gpt":0.27670722367827205,"score_spread":0.24743332982733857,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3122013602","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8557872,0.018510967,0.0138751,0.0108148055,0.00089384336,0.00040115343,0.05798211,0.0003237027,0.04141093],"genre_scores_gemma":[0.9181815,0.005274842,0.019477483,0.0017521157,0.00032153353,0.0005583913,0.051515277,0.000089047426,0.0028297422],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99774325,0.00081348926,0.00052619225,0.00027749094,0.0004051583,0.00023454959],"domain_scores_gemma":[0.9944084,0.0014045741,0.0022388017,0.00033368132,0.0009758718,0.0006385868],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0048587634,0.00048278572,0.0005758557,0.0031157592,0.00029883068,0.0015679409,0.0005036982,0.000502752,0.004332008],"category_scores_gemma":[0.011706695,0.00013756212,0.00094308314,0.0041846256,0.00044782567,0.0014345079,0.002259082,0.00059865456,0.0006933223],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006315718,0.00012352859,0.71700853,0.0023084814,0.00073269656,0.00040155466,0.0021452194,0.002263022,0.0008541195,0.006737546,0.03612819,0.23066562],"study_design_scores_gemma":[0.000062761595,0.00019634774,0.89961207,0.0015880374,0.00019421686,0.00062670483,0.0022719225,0.0010345206,0.00077437394,0.003231897,0.09034609,0.000061018585],"about_ca_topic_score_codex":0.002321173,"about_ca_topic_score_gemma":0.0017661109,"teacher_disagreement_score":0.0048587634,"about_ca_system_score_codex":0.000777725,"about_ca_system_score_gemma":0.0011131967,"threshold_uncertainty_score":0.02569592},"labels":[],"label_agreement":null},{"id":"W3130529097","doi":"10.1016/j.jhepr.2021.100260","title":"Assessing the impact of COVID-19 on liver cancer management (CERO-19)","year":2021,"lang":"en","type":"article","venue":"JHEP Reports","topic":"COVID-19 and healthcare impacts","field":"Medicine","cited_by":67,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; Toronto General Hospital; McMaster University; University of Toronto; University Health Network","funders":"UCLH Biomedical Research Centre; Sanofi Genzyme; EMD Serono; Imperial Experimental Cancer Medicine Centre; Cancer Treatment and Research Trust; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas; Ipsen; University College London Hospitals NHS Foundation Trust; Basilea Pharmaceutica; Eisai; Daiichi-Sankyo; National Institute for Health and Care Research; Incyte; BTG; AbbVie; Worldwide Cancer Research; Societat Catalana de Digestologia; Association for International Cancer Research; Sirtex Medical; Wellcome Trust; Cancer Research UK; European Cooperation in Science and Technology; Boston Scientific Corporation; Albert Einstein Cancer Center; Exelixis; Meso Scale Diagnostics; Bayer; Gilead Sciences; Roche; Celgene; Novartis; NIHR Imperial Biomedical Research Centre; Merck; Imperial College London; GlaxoSmithKline; Agència de Gestió d'Ajuts Universitaris i de Recerca; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb; Instituto de Salud Carlos III; Amgen","keywords":"Coronavirus disease 2019 (COVID-19); 2019-20 coronavirus outbreak; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Medicine; Liver cancer; Virology; Cancer; Internal medicine; Infectious disease (medical specialty)","score_opus":0.1496123350925475,"score_gpt":0.5073078806710404,"score_spread":0.35769554557849287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3130529097","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9794134,0.0039965254,0.0010765966,0.0042382698,0.00013307626,0.00072275725,0.006040329,0.000028473885,0.0043505263],"genre_scores_gemma":[0.9924273,0.0013682942,0.0012920307,0.0011377577,0.0000964572,0.00063711946,0.0027629733,0.000011436985,0.00026663078],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98393655,0.008393338,0.0025192867,0.00088581175,0.0024079331,0.0018570758],"domain_scores_gemma":[0.92517287,0.018330734,0.03715269,0.002304221,0.008922876,0.008116712],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.028958483,0.0003730434,0.00043524476,0.0011799819,0.00051479565,0.0016692788,0.0008655178,0.0007040026,0.0022893145],"category_scores_gemma":[0.0561786,0.00029420163,0.001433685,0.0022173158,0.0006366009,0.0014298258,0.0030464416,0.0010835216,0.00032686893],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007037568,0.0002109433,0.9741571,0.0006391779,0.00027778366,0.00003661606,0.00034562708,0.00045454534,0.00006616295,0.00020472016,0.00234152,0.020562058],"study_design_scores_gemma":[0.00010733326,0.0014908635,0.9908641,0.00048911583,0.00018682425,0.00008711116,0.000918109,0.00087652326,0.00017771118,0.00010774862,0.0046726735,0.000021819722],"about_ca_topic_score_codex":0.01076371,"about_ca_topic_score_gemma":0.014465122,"teacher_disagreement_score":0.028958483,"about_ca_system_score_codex":0.003313747,"about_ca_system_score_gemma":0.006479607,"threshold_uncertainty_score":0.15314895},"labels":[],"label_agreement":null},{"id":"W3132063234","doi":"10.1016/j.jhepr.2021.100255","title":"Potent suppression of hydrophobic bile acids by aldafermin, an FGF19 analogue, across metabolic and cholestatic liver diseases","year":2021,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":76,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Bile acid; Internal medicine; Ursodeoxycholic acid; FGF19; Taurine; Deoxycholic acid; Endocrinology; Lithocholic acid; Glycocholic acid; Cirrhosis; Cholic acid; Chemistry; Medicine; Gastroenterology; Biochemistry; Amino acid; Receptor; Fibroblast growth factor","score_opus":0.010647121669061873,"score_gpt":0.2859448023548816,"score_spread":0.2752976806858197,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3132063234","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989794,0.00061303977,0.00012046427,0.000019979583,0.0000074085447,0.000034191977,0.00004796305,0.000008495947,0.00016904535],"genre_scores_gemma":[0.9989266,0.00029953607,0.00033335102,0.000030391098,0.000013195332,0.0000331216,0.00012692036,0.0000019889774,0.00023499668],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9999056,0.000031641313,0.000009324477,0.0000144008545,0.000016210306,0.000022895472],"domain_scores_gemma":[0.99989057,0.000020334008,0.000032026455,0.000008975443,0.0000071871095,0.00004090956],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00025448785,0.00031625776,0.00040602504,0.0001712703,0.00012428104,0.00017256827,0.00013018728,0.00018017397,0.0009610224],"category_scores_gemma":[0.00018455107,0.000115539275,0.00024511485,0.00010673183,0.0001962167,0.000119524695,0.00013425374,0.00043255108,0.0001090401],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.04200732,0.0046797013,0.018010499,0.00023449045,0.000315508,0.0002356342,0.00011288635,0.00065369543,0.8639762,0.00006842269,0.00030832968,0.06939739],"study_design_scores_gemma":[0.02665446,0.3734294,0.20749648,0.00003776164,0.0006339809,0.002275342,0.00015445169,0.001501135,0.3821745,0.00010919776,0.0054963985,0.00003684969],"about_ca_topic_score_codex":0.00021788382,"about_ca_topic_score_gemma":0.0007482344,"teacher_disagreement_score":0.0009610224,"about_ca_system_score_codex":0.00011257806,"about_ca_system_score_gemma":0.00012738998,"threshold_uncertainty_score":0.0032149553},"labels":[],"label_agreement":null},{"id":"W3135464417","doi":"10.1016/j.jhepr.2021.100259","title":"The third year","year":2021,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Macrophage Migration Inhibitory Factor","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University Health Network","funders":"","keywords":"Hepatocellular carcinoma; Cirrhosis; Viral hepatitis; microRNA; Medicine; Liver disease; Scopus; Chronic hepatitis; Disease; Internal medicine; Gastroenterology; Bioinformatics; MEDLINE; Immunology; Political science; Biology; Virus; Gene","score_opus":0.008265417441087861,"score_gpt":0.22760232315784873,"score_spread":0.21933690571676087,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3135464417","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047401697,0.019199923,0.0011774789,0.121724926,0.7230934,0.0001284411,0.0012690016,0.001037092,0.13189569],"genre_scores_gemma":[0.0054858746,0.019205961,0.0014237476,0.09843157,0.18174648,0.00020987322,0.0018664402,0.0011935338,0.69043654],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9928063,0.0008392286,0.00059562514,0.001026378,0.0034567001,0.0012757168],"domain_scores_gemma":[0.97362185,0.0017125254,0.0011482832,0.0020010835,0.0110049425,0.010511414],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.006485998,0.0018546962,0.0020854413,0.0033276964,0.004339268,0.025417432,0.0030219937,0.0074472628,0.4345733],"category_scores_gemma":[0.02604595,0.0006176626,0.0016671197,0.0023945144,0.0022034296,0.011049556,0.00806653,0.010523494,0.36916003],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000014793094,0.0000146106995,0.00007706155,0.00010193927,0.0000040333493,0.00006643457,0.00004712435,0.000011941042,0.00009978775,0.002357779,0.96997696,0.027227558],"study_design_scores_gemma":[0.0000022357228,0.000008182522,0.00006408875,0.00009531582,0.0000014717116,0.00007377098,0.000057862933,0.000005680925,0.00003042676,0.00038801867,0.99926823,0.0000045838324],"about_ca_topic_score_codex":0.0021579033,"about_ca_topic_score_gemma":0.002468664,"teacher_disagreement_score":0.4345733,"about_ca_system_score_codex":0.0037216132,"about_ca_system_score_gemma":0.007246208,"threshold_uncertainty_score":0.8065126},"labels":[],"label_agreement":null},{"id":"W3137209623","doi":"10.1016/j.jhepr.2021.100265","title":"Defatting strategies in the current era of liver steatosis","year":2021,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; Toronto General Hospital","funders":"Deutsche Forschungsgemeinschaft","keywords":"Steatosis; Defatting; Medicine; Fatty liver; Liver transplantation; Liver disease; Internal medicine; Disease; Transplantation; Biology","score_opus":0.07248006118339424,"score_gpt":0.3787049822383436,"score_spread":0.30622492105494936,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3137209623","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001278467,0.99860114,0.00013224153,0.00020535149,0.00016140603,0.000004705602,0.000015490392,0.0000084628,0.00074338075],"genre_scores_gemma":[0.00063073926,0.9984664,0.00017467947,0.00020915212,0.00013971879,0.0000058069495,0.000027842832,0.0000017734823,0.00034394755],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99973565,0.00005184927,0.00004676871,0.000037529786,0.000099447694,0.00002890132],"domain_scores_gemma":[0.99963295,0.00021660479,0.000045513807,0.000012116389,0.000071311944,0.000021565982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007370394,0.0007001915,0.0013519942,0.0022498083,0.0002421908,0.0011049717,0.00071095285,0.0010257214,0.0045669223],"category_scores_gemma":[0.00092738715,0.00024916316,0.0007055747,0.0013777254,0.00046488098,0.001532774,0.0006922161,0.0019851462,0.0018551252],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000107608685,0.00008120832,0.00014378583,0.030729342,0.00012521038,0.00026266315,0.000106648935,0.00036435484,0.0022132196,0.0058583436,0.023999445,0.93600816],"study_design_scores_gemma":[0.000018546589,0.00012976846,0.0005670687,0.0066634747,0.00014366307,0.0012547718,0.000084501655,0.00007827978,0.0008236171,0.0029735619,0.9872399,0.000022882114],"about_ca_topic_score_codex":0.00066510553,"about_ca_topic_score_gemma":0.0012783319,"teacher_disagreement_score":0.0045669223,"about_ca_system_score_codex":0.00047913758,"about_ca_system_score_gemma":0.00066540035,"threshold_uncertainty_score":0.015277803},"labels":[],"label_agreement":null},{"id":"W3154594411","doi":"10.1016/j.jhepr.2021.100290","title":"Predictive performance of newer Asian hepatocellular carcinoma risk scores in treated Caucasians with chronic hepatitis B","year":2021,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Merck Sharp and Dohme; Janssen Pharmaceuticals; Gilead Sciences; Roche; Ipsen; Novartis; AbbVie; Merck; GlaxoSmithKline; Bayer; Siemens; Bristol-Myers Squibb","keywords":"Hepatocellular carcinoma; Medicine; Internal medicine; Cirrhosis; Entecavir; Gastroenterology; Chronic hepatitis; Predictability; Hepatitis B; Hepatitis B virus; Immunology; Virus","score_opus":0.009296919915915636,"score_gpt":0.22336198892904,"score_spread":0.21406506901312436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3154594411","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985172,0.00020671509,0.0002588146,0.000035224086,0.000010483782,0.000010057301,0.00015657592,0.00001135963,0.0007935918],"genre_scores_gemma":[0.9994997,0.000050529186,0.00016822321,0.000009246164,0.000014008491,0.000005158884,0.0001804517,0.0000021802007,0.000070515845],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99930847,0.000300653,0.00007754105,0.000106737374,0.00013836956,0.00006812877],"domain_scores_gemma":[0.99622726,0.0009803851,0.0015785649,0.00022664672,0.00051963935,0.000467532],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016976236,0.00041705367,0.00031627464,0.0007845863,0.00019673242,0.0005560192,0.00023440119,0.0002980522,0.00094103353],"category_scores_gemma":[0.0056057395,0.00013150294,0.000591407,0.000580997,0.0002432971,0.00034470594,0.0004947258,0.00049406115,0.00019570194],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026171666,0.000018241455,0.9959551,0.000005993536,0.000048505648,0.00003412828,0.000035022473,0.00021770777,0.00012521271,0.000022871665,0.000095980664,0.0031794978],"study_design_scores_gemma":[0.000027009823,0.00038420584,0.992965,0.000012067105,0.00009435387,0.0003613978,0.00013052735,0.005331055,0.0003163515,0.00006556453,0.0003025749,0.000009819389],"about_ca_topic_score_codex":0.0039015014,"about_ca_topic_score_gemma":0.0035706735,"teacher_disagreement_score":0.0039015014,"about_ca_system_score_codex":0.00028484553,"about_ca_system_score_gemma":0.00026745247,"threshold_uncertainty_score":0.008978009},"labels":[],"label_agreement":null},{"id":"W3187281785","doi":"10.1016/j.jhepr.2021.100350","title":"Metabolic dysfunction-associated fatty liver disease increases risk of adverse outcomes in patients with chronic hepatitis B","year":2021,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":114,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre; University Health Network","funders":"Stichting voor Lever- en Maag-Darm Onderzoek; Fujirebio Europe; Gilead Sciences","keywords":"Medicine; Fatty liver; Steatosis; Steatohepatitis; Disease; Diabetes mellitus; Internal medicine; Adverse effect; Type 2 diabetes; Overweight; Metabolic syndrome; Gastroenterology; Clinical significance; Obesity; Endocrinology","score_opus":0.005151699342772957,"score_gpt":0.21307036498006576,"score_spread":0.2079186656372928,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187281785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979601,0.0009329857,0.000083116385,0.00020271103,0.000017344059,0.0000062940267,0.00023629943,0.0000040710684,0.0005570161],"genre_scores_gemma":[0.9991805,0.00025397268,0.00008421649,0.00007263973,0.000043020216,0.0000059389504,0.00025454737,0.0000014313156,0.000103712686],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99967575,0.00011561743,0.00003557576,0.000053616863,0.000055815708,0.00006361873],"domain_scores_gemma":[0.9977799,0.0003594548,0.0012036685,0.000099208286,0.00016664216,0.00039112556],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006734318,0.00026298998,0.00027419132,0.0004948378,0.00041237843,0.0005575816,0.00022259817,0.0004887762,0.00291473],"category_scores_gemma":[0.0023287383,0.00017920473,0.0004071355,0.0006794267,0.00021491929,0.00032145862,0.0004664177,0.0006943756,0.00024418902],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009008296,0.000011954528,0.99892277,0.000007895503,0.000024101093,0.00003272173,0.0000075232356,0.000012190298,0.000049837905,0.000004489314,0.000054820808,0.0007816925],"study_design_scores_gemma":[0.000008534084,0.0000685819,0.99927706,0.00001250447,0.00003261406,0.000278022,0.00004814248,0.000112006914,0.000025189145,0.000030652012,0.00010450483,0.0000022063346],"about_ca_topic_score_codex":0.0017478849,"about_ca_topic_score_gemma":0.001956259,"teacher_disagreement_score":0.00291473,"about_ca_system_score_codex":0.00017610841,"about_ca_system_score_gemma":0.00030213228,"threshold_uncertainty_score":0.009750724},"labels":[],"label_agreement":null},{"id":"W3187685128","doi":"10.1016/j.jhepr.2021.100343","title":"External validation of the Toronto hepatocellular carcinoma risk index in a Swedish population","year":2021,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Radiumhemmets Forskningsfonder; Cancerfonden; Swedish Cancer Foundation","keywords":"Hepatocellular carcinoma; Index (typography); Population; Medicine; Oncology; Environmental health; Internal medicine; Computer science; World Wide Web","score_opus":0.027049601423744806,"score_gpt":0.2456920297140943,"score_spread":0.2186424282903495,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3187685128","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99426526,0.00024089974,0.0020984244,0.000085915766,0.00006296615,0.00022005911,0.0011930311,0.00004570734,0.001787694],"genre_scores_gemma":[0.9905573,0.0001784927,0.00203896,0.00009541661,0.000057428806,0.00039727715,0.0057430505,0.000048711543,0.000883236],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9940095,0.0031566604,0.00053012837,0.00089845975,0.0010606112,0.0003446396],"domain_scores_gemma":[0.9815105,0.0063199126,0.0021448066,0.0037867166,0.0056333034,0.00060467166],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.011472825,0.00089211226,0.00057607313,0.0019086855,0.0008500949,0.0010229337,0.0007113212,0.0006872287,0.0016720496],"category_scores_gemma":[0.03189987,0.00031039203,0.0013081752,0.001053053,0.0009125459,0.00037607242,0.0017432501,0.00055506313,0.00078421296],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0014833608,0.00026636012,0.96763366,0.0001769469,0.0005173951,0.0004013997,0.0015420835,0.0028401422,0.001219803,0.00043138876,0.0027637794,0.020723552],"study_design_scores_gemma":[0.0003830483,0.0011965428,0.9707117,0.00029238348,0.000540746,0.0014567333,0.0015584487,0.009640046,0.0023825702,0.00070203195,0.011059496,0.00007613914],"about_ca_topic_score_codex":0.014907498,"about_ca_topic_score_gemma":0.014262606,"teacher_disagreement_score":0.014907498,"about_ca_system_score_codex":0.001145815,"about_ca_system_score_gemma":0.002163698,"threshold_uncertainty_score":0.060674787},"labels":[],"label_agreement":null},{"id":"W3199692770","doi":"10.1016/j.jhepr.2021.100364","title":"Non-invasive imaging criteria for the diagnosis of hepatocellular carcinoma in non-cirrhotic patients with chronic hepatitis B","year":2021,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Horizon 2020 Framework Programme; Ministerio de Ciencia e Innovación; Fundación Científica Asociación Española Contra el Cáncer; European Commission; Samuel Waxman Cancer Research Foundation; National Cancer Institute; Agència de Gestió d'Ajuts Universitaris i de Recerca; Generalitat de Catalunya; Cancer Research UK; U.S. Department of Defense","keywords":"Medicine; Hepatocellular carcinoma; Cirrhosis; Biopsy; Radiology; Gastroenterology; Internal medicine; Liver biopsy","score_opus":0.023563533847907932,"score_gpt":0.24478321405552755,"score_spread":0.22121968020761962,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3199692770","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97653425,0.006063233,0.002260515,0.0004493674,0.00007210777,0.0015693373,0.0035833172,0.000051197105,0.009416693],"genre_scores_gemma":[0.99210465,0.000930775,0.002262917,0.00015523794,0.000066858636,0.0006071074,0.0029326205,0.000008897098,0.0009310227],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99841475,0.00044979865,0.0005099342,0.0001339609,0.00035942427,0.0001321189],"domain_scores_gemma":[0.994802,0.00072180334,0.0032681054,0.00016373704,0.00057848997,0.0004658982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014566109,0.0005437448,0.00057865184,0.0031356718,0.0007482886,0.0005007906,0.0005259935,0.00047100842,0.004197332],"category_scores_gemma":[0.003055871,0.00028230847,0.0004928943,0.0016328682,0.000603215,0.000616266,0.0006651696,0.000409248,0.00083391817],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020794003,0.00008137677,0.9944435,0.00018914405,0.00003970911,0.0003961551,0.00015183969,0.00007417316,0.0006986854,0.00009788429,0.0006247608,0.002994868],"study_design_scores_gemma":[0.000024902149,0.0002645066,0.994649,0.00009652923,0.000025795325,0.0028323722,0.00018111197,0.00023954546,0.00021619698,0.00007419782,0.0013856387,0.00001029058],"about_ca_topic_score_codex":0.001782338,"about_ca_topic_score_gemma":0.0035293235,"teacher_disagreement_score":0.004197332,"about_ca_system_score_codex":0.0004753785,"about_ca_system_score_gemma":0.0008113343,"threshold_uncertainty_score":0.014041483},"labels":[],"label_agreement":null},{"id":"W3202725809","doi":"10.1016/j.jhepr.2021.100368","title":"Serum miR-181b-5p predicts ascites onset in patients with compensated cirrhosis","year":2021,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"European Regional Development Fund; Ministerio de Ciencia e Innovación; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas; Ministerio de Ciencia, Innovación y Universidades; Instituto de Salud Carlos III; Gilead Sciences","keywords":"Ascites; Cirrhosis; Medicine; Internal medicine; Gastroenterology; Portal venous pressure; Biomarker; Portal hypertension; Placebo; Pathology","score_opus":0.0059691491366808454,"score_gpt":0.21047642299185915,"score_spread":0.2045072738551783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3202725809","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9990196,0.0004628459,0.0001656896,0.000031925705,0.0000085881975,0.00000676735,0.000081218,0.0000078071025,0.0002156152],"genre_scores_gemma":[0.999542,0.00006178882,0.00015456202,0.000014993262,0.000010517044,0.0000053953718,0.00013099994,0.0000010104997,0.000078745325],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998029,0.00006990386,0.000022183147,0.000042925996,0.000035767367,0.00002641612],"domain_scores_gemma":[0.99907434,0.0002514601,0.00033441486,0.000045078123,0.00008408171,0.00021059785],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00050629437,0.00031070053,0.00044997124,0.0003536926,0.00022290635,0.0003751467,0.00011594665,0.00034124867,0.0008805362],"category_scores_gemma":[0.0014062223,0.00017919362,0.00030366916,0.00021950025,0.00014709168,0.0002478789,0.00025757187,0.00032228653,0.00018983214],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023429429,0.000059776925,0.9890653,0.000018774572,0.00006237908,0.00006732223,0.000025195446,0.00020930801,0.0033384515,0.000013582413,0.00011659537,0.0046802917],"study_design_scores_gemma":[0.000062694104,0.0006723573,0.9966546,0.000005998232,0.00006437892,0.0002800066,0.000032681266,0.0015052421,0.0005054422,0.000028091454,0.00018235206,0.00000601216],"about_ca_topic_score_codex":0.00035997282,"about_ca_topic_score_gemma":0.0006569533,"teacher_disagreement_score":0.0008805362,"about_ca_system_score_codex":0.0001637655,"about_ca_system_score_gemma":0.00015866692,"threshold_uncertainty_score":0.0029457211},"labels":[],"label_agreement":null},{"id":"W3214836651","doi":"10.1016/j.jhepr.2021.100411","title":"Real-world management of non-alcoholic steatohepatitis differs from clinical practice guideline recommendations and across regions","year":2021,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":52,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Gilead Sciences (Canada)","funders":"NIHR Newcastle Biomedical Research Centre; Horizon 2020 Framework Programme; Innovative Medicines Initiative; European Commission; European Federation of Pharmaceutical Industries and Associations; National Institute for Health and Care Research; Gilead Sciences","keywords":"Steatohepatitis; Guideline; Medicine; Transient elastography; Fatty liver; Disease; Clinical Practice; Family medicine; Internal medicine; Pathology; Fibrosis","score_opus":0.04486728041178561,"score_gpt":0.42644043853230706,"score_spread":0.38157315812052145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3214836651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98119533,0.0032791127,0.002389221,0.0047384435,0.000053190794,0.000083502135,0.0020735513,0.000033873384,0.006153669],"genre_scores_gemma":[0.996977,0.0004276144,0.0010954061,0.00064471184,0.000022150549,0.000030827694,0.0006902857,0.000007413818,0.000104760045],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98992187,0.005051413,0.001780096,0.0009106181,0.0016382248,0.00069770985],"domain_scores_gemma":[0.97557074,0.0060147913,0.011606857,0.0016550894,0.0041861967,0.0009662267],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0058279857,0.00010178743,0.0002505147,0.00066614465,0.00033987468,0.001167494,0.00056418404,0.00033147924,0.0011683722],"category_scores_gemma":[0.019394306,0.00011452575,0.00021422634,0.0013425939,0.0005397363,0.0005090119,0.0006750787,0.00031961134,0.00020557907],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006627267,0.000033358683,0.9776904,0.00022919576,0.00011804334,0.00018941039,0.0014973589,0.00029779685,0.00036644386,0.00030776905,0.0022071633,0.016996678],"study_design_scores_gemma":[0.000009684261,0.000049146234,0.9911618,0.00029830608,0.000045555902,0.0004687539,0.0029621834,0.0005063283,0.0002631262,0.0001814995,0.0040402096,0.000013415193],"about_ca_topic_score_codex":0.022152811,"about_ca_topic_score_gemma":0.03503372,"teacher_disagreement_score":0.022152811,"about_ca_system_score_codex":0.0014782132,"about_ca_system_score_gemma":0.002683515,"threshold_uncertainty_score":0.044047713},"labels":[],"label_agreement":null},{"id":"W3216774526","doi":"10.1016/j.jhepr.2021.100398","title":"Humoral immunity in hepatitis B virus infection: Rehabilitating the B in HBV","year":2021,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"National Institutes of Health; Fonds Wetenschappelijk Onderzoek","keywords":"HBcAg; HBsAg; Hepatitis B virus; Immunology; Humoral immunity; Hepatitis B; Immune system; Virology; B cell; Biology; Antibody; Immunity; Medicine; Virus","score_opus":0.06430622315871269,"score_gpt":0.38134827861304305,"score_spread":0.31704205545433034,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3216774526","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00003914167,0.9992299,0.000032318174,0.00017130391,0.0002092003,0.0000018542215,0.0000035427354,0.0000026708735,0.0003099719],"genre_scores_gemma":[0.00030392865,0.999086,0.00005158247,0.00014800127,0.00019511516,0.0000028581446,0.0000071990107,6.7635506e-7,0.00020468966],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99983084,0.00004201485,0.00003266408,0.000022497636,0.000058090354,0.000013927067],"domain_scores_gemma":[0.9996123,0.00022305732,0.000044989705,0.000011894501,0.00007726761,0.000030586187],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00056077866,0.00063442555,0.0009814958,0.0024320926,0.00023840893,0.0008620737,0.0007073996,0.0011268905,0.003136207],"category_scores_gemma":[0.0010284039,0.00020027338,0.0004109823,0.0017953243,0.00058734755,0.001327937,0.0005964692,0.001517786,0.0016231037],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008372322,0.000049781273,0.00014899678,0.033692397,0.000078727455,0.00023198327,0.000082333536,0.00016992194,0.00096918194,0.0026573753,0.0333833,0.9284524],"study_design_scores_gemma":[0.000024857834,0.00011975912,0.0011317094,0.0108344,0.00012879966,0.0021538003,0.00010077278,0.00005288136,0.000349469,0.0020256077,0.98306125,0.000016738986],"about_ca_topic_score_codex":0.00076228485,"about_ca_topic_score_gemma":0.0010471566,"teacher_disagreement_score":0.003136207,"about_ca_system_score_codex":0.00048572404,"about_ca_system_score_gemma":0.0009068141,"threshold_uncertainty_score":0.010491669},"labels":[],"label_agreement":null},{"id":"W4213412991","doi":"10.1016/j.jhepr.2022.100462","title":"Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals","year":2022,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatitis C virus research","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Centre for Disease Control","funders":"National Health and Medical Research Council; Ministero dell’Istruzione, dell’Università e della Ricerca; Ministero della Salute; Gilead Sciences; University of Sydney; Department of Health and Ageing, Australian Government; Genome British Columbia; Merck","keywords":"NS5A; NS5B; Medicine; Hepatitis C virus; Sofosbuvir; Drug resistance; Virology; NS3; Internal medicine; Ribavirin; Virus; Hepacivirus; Biology; Microbiology","score_opus":0.023632290323086683,"score_gpt":0.33304164089867544,"score_spread":0.30940935057558877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4213412991","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99927217,0.00007923058,0.00002387946,0.000035534922,0.0000037117507,0.0000044145772,0.00023325728,0.0000017915095,0.0003459267],"genre_scores_gemma":[0.99929464,0.00007940059,0.000024589674,0.000039958493,0.000008967587,0.000007143539,0.0003825771,0.0000026167174,0.00016008248],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996543,0.000056289937,0.000033098157,0.000113783324,0.00004391979,0.00009859031],"domain_scores_gemma":[0.9982535,0.00016335817,0.0008494756,0.00012888724,0.00018740256,0.0004173176],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000625226,0.00026240238,0.00023937969,0.0011092182,0.0006387237,0.00082027004,0.00032760523,0.0004995855,0.0018576973],"category_scores_gemma":[0.0020737299,0.0002530046,0.00039019153,0.0012360316,0.00037659748,0.0007098293,0.0005193427,0.00062432326,0.00042813722],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000041260275,0.000014909004,0.99908996,0.000001715799,0.000010511796,0.00005396963,0.0001267518,0.000016212367,0.00009470248,0.000008500218,0.00006779192,0.0004737166],"study_design_scores_gemma":[0.0000029801313,0.00006395837,0.9989887,0.0000032767975,0.000007507226,0.00026023056,0.00041695082,0.000050333096,0.000019677573,0.000008419377,0.00017459644,0.000003435607],"about_ca_topic_score_codex":0.008022981,"about_ca_topic_score_gemma":0.00440409,"teacher_disagreement_score":0.008022981,"about_ca_system_score_codex":0.00030704704,"about_ca_system_score_gemma":0.0003449471,"threshold_uncertainty_score":0.015952587},"labels":[],"label_agreement":null},{"id":"W4214591600","doi":"10.1016/j.jhepr.2022.100461","title":"Molecular epidemiology and clinical characteristics of hepatitis D virus infection in Canada","year":2022,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"McMaster University; University of British Columbia; University of Ottawa; University of Toronto; University of Alberta; McGill University; University of Calgary; University of Manitoba; Public Health Agency of Canada","funders":"","keywords":"Medicine; Hepatitis D virus; HBsAg; Internal medicine; Cohort; Epidemiology; Cirrhosis; Hepatitis D; Hepatitis B virus; Liver disease; Genotype; Virology; Virus; Biology","score_opus":0.03231127326058857,"score_gpt":0.3279446422088672,"score_spread":0.29563336894827863,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4214591600","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9925175,0.0009469704,0.00009939532,0.00030117124,0.000008307321,0.000037173388,0.004027992,0.000009898936,0.0020516245],"genre_scores_gemma":[0.9979722,0.000436524,0.000102659586,0.000077206045,0.0000035973426,0.000008363562,0.0010927697,0.0000025112972,0.00030417202],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99936336,0.000035332156,0.000044717563,0.0001337163,0.0001946342,0.00022826617],"domain_scores_gemma":[0.9984238,0.00009076509,0.00034528316,0.000033000906,0.00061651954,0.00049064006],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037153895,0.0002759584,0.0002631091,0.001965057,0.0019218414,0.0010365493,0.0007872161,0.0004070173,0.0022500555],"category_scores_gemma":[0.0014880373,0.00026990753,0.0003269949,0.0035545875,0.0007956105,0.00026479797,0.000774895,0.0004749267,0.00021844318],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000035330748,0.000009533786,0.9974954,0.000013141025,0.000011429366,0.0000533827,0.00011193982,0.00005206177,0.00012542335,0.000041569772,0.00030945154,0.0017415009],"study_design_scores_gemma":[0.0000041877574,0.000015983534,0.9987387,0.0000177549,0.0000070404553,0.00013866706,0.0004347409,0.00012935264,0.000037125563,0.000019621646,0.00045179826,0.000005022085],"about_ca_topic_score_codex":0.97816867,"about_ca_topic_score_gemma":0.97545063,"teacher_disagreement_score":0.021831334,"about_ca_system_score_codex":0.018201184,"about_ca_system_score_gemma":0.01963672,"threshold_uncertainty_score":0.13205945},"labels":[],"label_agreement":null},{"id":"W4220972607","doi":"10.1016/j.jhepr.2022.100478","title":"Deprescribing zolpidem reduces falls and fractures in patients with cirrhosis","year":2022,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; National Institutes of Health; Valeant Pharmaceuticals International","keywords":"Zolpidem; Medicine; Deprescribing; Decompensation; Cirrhosis; Benzodiazepine; Internal medicine; Pediatrics; Intensive care medicine; Psychiatry; Polypharmacy","score_opus":0.004356386718543738,"score_gpt":0.21295695695821767,"score_spread":0.20860057023967393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4220972607","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9963548,0.0013771083,0.00026687593,0.0005267937,0.000050832645,0.00019407546,0.00052863156,0.000010255749,0.0006905491],"genre_scores_gemma":[0.9986156,0.0002923021,0.00030070427,0.00022907768,0.00003991516,0.00008044343,0.00025586796,0.0000010469403,0.00018514194],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9977139,0.0015431811,0.00019542819,0.00015021888,0.00017071124,0.00022655782],"domain_scores_gemma":[0.9967384,0.0013488214,0.0009867774,0.00029095626,0.0002019239,0.00043315106],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037564219,0.00030062438,0.0009024045,0.00018347222,0.00027274972,0.000558531,0.0004177287,0.0007957746,0.0028460897],"category_scores_gemma":[0.009193833,0.00029149483,0.0029701046,0.0002816678,0.00028795176,0.0004904089,0.00044909105,0.00077646645,0.00012790131],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.47282305,0.010585937,0.3441555,0.0022987602,0.0113070635,0.00023873604,0.00025688324,0.025762271,0.003214877,0.0010845494,0.004510631,0.12376172],"study_design_scores_gemma":[0.15280008,0.17226683,0.6096377,0.00041565762,0.007283983,0.00029184567,0.0002723621,0.048217393,0.0020439783,0.0025061732,0.004135338,0.00012866259],"about_ca_topic_score_codex":0.003443321,"about_ca_topic_score_gemma":0.005155623,"teacher_disagreement_score":0.0037564219,"about_ca_system_score_codex":0.0007575809,"about_ca_system_score_gemma":0.001090566,"threshold_uncertainty_score":0.01986605},"labels":[],"label_agreement":null},{"id":"W4224944802","doi":"10.1016/j.jhepr.2022.100495","title":"Higher subcutaneous adipose tissue radiodensity is associated with increased mortality in patients with cirrhosis","year":2022,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta; University of Alberta Hospital; Alberta Hospital Edmonton","funders":"","keywords":"Radiodensity; Medicine; Cirrhosis; Adipose tissue; Internal medicine; Gastroenterology; Confounding; Hazard ratio; Radiology; Radiography; Confidence interval","score_opus":0.018521804276233678,"score_gpt":0.2741412992779203,"score_spread":0.2556194950016866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4224944802","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994616,0.00020795074,0.000057880585,0.000021426747,0.000003211927,0.0000018563467,0.000058451104,0.0000022346844,0.00018533377],"genre_scores_gemma":[0.99976975,0.00004752323,0.000041424933,0.000008037569,0.0000076700435,0.0000017034847,0.000065749075,5.2498524e-7,0.000057628447],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99989545,0.000027239847,0.000016421614,0.000020801193,0.000019742634,0.000020210895],"domain_scores_gemma":[0.9992446,0.00014741239,0.00040565652,0.00003518694,0.000052122632,0.000115098344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00020917667,0.00018215233,0.00019803818,0.00042948188,0.0001843678,0.00027844557,0.000115553485,0.00022786202,0.0028375739],"category_scores_gemma":[0.0009305905,0.000115206596,0.00016195081,0.0004329351,0.00021191586,0.00014840766,0.0002675563,0.00027420753,0.00021138514],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000116285235,0.000007428289,0.99850106,0.000006666395,0.000015379843,0.00008054182,0.000015079421,0.000014516363,0.00035846856,0.000004429779,0.000025235224,0.00085480575],"study_design_scores_gemma":[0.0000034399777,0.00006824931,0.99912983,0.0000030325314,0.000011187027,0.0005522151,0.000046499037,0.00005987707,0.00007231437,0.000010625455,0.00004180328,9.883702e-7],"about_ca_topic_score_codex":0.0005040851,"about_ca_topic_score_gemma":0.00061488524,"teacher_disagreement_score":0.0028375739,"about_ca_system_score_codex":0.00007683819,"about_ca_system_score_gemma":0.00008530614,"threshold_uncertainty_score":0.009492636},"labels":[],"label_agreement":null},{"id":"W4251823135","doi":"10.1016/j.jhepr.2019.07.001","title":"Editorial musings","year":2019,"lang":"es","type":"editorial","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Radiation therapy; Medicine; Randomized controlled trial; Hepatocellular carcinoma; Cancer; Oncology; Surgery; Internal medicine","score_opus":0.025328404746769152,"score_gpt":0.25729106091989784,"score_spread":0.2319626561731287,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4251823135","genre_codex":"editorial","genre_gemma":"editorial","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"editorial","genre_consensus":"editorial","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013448302,0.006436006,0.00034857765,0.082985856,0.8821927,0.000081138256,0.00054426474,0.00034041598,0.026936598],"genre_scores_gemma":[0.002949192,0.011330424,0.0007670819,0.1075093,0.6932411,0.00017213635,0.0011167715,0.00052198657,0.1823919],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99637693,0.0005600788,0.00042944393,0.00051638426,0.0017576482,0.000359396],"domain_scores_gemma":[0.9798465,0.004535536,0.0011740815,0.0010256902,0.010546046,0.002872217],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038360716,0.0016424287,0.0013463091,0.0028132228,0.0023075896,0.0058077364,0.002472468,0.005970901,0.2694617],"category_scores_gemma":[0.03558334,0.0005415053,0.0017730995,0.0010920158,0.0010658939,0.004321267,0.0026294247,0.006255637,0.13905741],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000013389814,0.0000050349036,0.00002101461,0.00010585252,0.000002846254,0.0000502967,0.000012936691,0.000008059246,0.000028933779,0.00029537344,0.986865,0.012591175],"study_design_scores_gemma":[0.000009036496,0.000010721058,0.00006664082,0.00023127724,0.000005421434,0.0001593379,0.00004095177,0.000016883185,0.000052525527,0.00048333715,0.9989178,0.000005983574],"about_ca_topic_score_codex":0.0009016736,"about_ca_topic_score_gemma":0.0019317395,"teacher_disagreement_score":0.2694617,"about_ca_system_score_codex":0.0019704772,"about_ca_system_score_gemma":0.0032060016,"threshold_uncertainty_score":0.9014392},"labels":[],"label_agreement":null},{"id":"W4280595648","doi":"10.1016/j.jhepr.2022.100498","title":"Stereotactic body radiation therapy for hepatocellular carcinoma: From infancy to ongoing maturity","year":2022,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":75,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Hepatocellular carcinoma; Radiation therapy; Cirrhosis; Oncology; Radiofrequency ablation; Radiology; Internal medicine; Ablation","score_opus":0.10344352584465884,"score_gpt":0.32238962160097967,"score_spread":0.21894609575632085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4280595648","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000052230273,0.99948114,0.000023390143,0.00015712589,0.00006180939,0.0000016465332,0.000005159556,0.0000018074096,0.00021572673],"genre_scores_gemma":[0.0003533419,0.99933076,0.000048571655,0.00010666424,0.00007819606,0.0000025299282,0.000008747055,7.3903254e-7,0.000070484435],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996749,0.000079745114,0.00006814348,0.00004559027,0.000108842316,0.000022819528],"domain_scores_gemma":[0.9990067,0.0006495073,0.00011816704,0.000023911623,0.00016263935,0.000039144717],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011437088,0.0005330363,0.0014642187,0.001939962,0.00020147234,0.0009041706,0.0008311713,0.00094125856,0.0024269868],"category_scores_gemma":[0.0015476008,0.0002500265,0.00079061225,0.0025938225,0.0005068697,0.001387857,0.0005807744,0.0015140156,0.0007723531],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009667659,0.00003382362,0.00022861436,0.043492157,0.00018466849,0.00011256899,0.00008925966,0.00018694566,0.00057070155,0.001955721,0.014658826,0.93839],"study_design_scores_gemma":[0.000048161754,0.0001755209,0.0022925131,0.025459182,0.00051617145,0.0016660537,0.00014056181,0.00010990177,0.00039458508,0.002265838,0.9669034,0.00002824016],"about_ca_topic_score_codex":0.0013074813,"about_ca_topic_score_gemma":0.0020125017,"teacher_disagreement_score":0.0024269868,"about_ca_system_score_codex":0.0006520573,"about_ca_system_score_gemma":0.0013920573,"threshold_uncertainty_score":0.008119047},"labels":[],"label_agreement":null},{"id":"W4281249735","doi":"10.1016/j.jhepr.2022.100508","title":"A new mouse model of radiation-induced liver disease reveals mitochondrial dysfunction as an underlying fibrotic stimulus","year":2022,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Effects of Radiation Exposure","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Eastern Health; Université de Lausanne; University of Bern","keywords":"Fibrosis; Biology; DNA damage; Pathology; Cancer research; Senescence; Medicine; Cell biology","score_opus":0.029971465619637292,"score_gpt":0.291080551182611,"score_spread":0.2611090855629737,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4281249735","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9162834,0.0075862864,0.06305111,0.0011248855,0.0003856025,0.0004912907,0.0047776075,0.0017346403,0.0045651263],"genre_scores_gemma":[0.9007607,0.007958515,0.051909894,0.00062785635,0.00009725602,0.0017063187,0.008756487,0.00045078073,0.0277321],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9995602,0.00006702708,0.00006737854,0.00014309627,0.000101844475,0.000060528975],"domain_scores_gemma":[0.999443,0.000058303875,0.00025273184,0.00007934583,0.00005060188,0.00011598749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00063325913,0.0014303725,0.00071100297,0.0021332216,0.00039475923,0.00058606756,0.00071040256,0.0014496172,0.003557732],"category_scores_gemma":[0.00020513145,0.0005170785,0.00094604574,0.0005871962,0.00063813047,0.00071058265,0.00048289506,0.002186084,0.0010848014],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00038231257,0.00025218955,0.00044876043,0.00011541962,0.000027844551,0.00026262557,0.000045794783,0.0001514085,0.99546355,0.00055702945,0.00023062195,0.0020623608],"study_design_scores_gemma":[0.00028131425,0.0045700665,0.00817099,0.00014650016,0.0002695239,0.004158354,0.00012207066,0.002926917,0.95909,0.0006224045,0.01958689,0.00005502292],"about_ca_topic_score_codex":0.00036096305,"about_ca_topic_score_gemma":0.0007441155,"teacher_disagreement_score":0.003557732,"about_ca_system_score_codex":0.00045848178,"about_ca_system_score_gemma":0.00031356682,"threshold_uncertainty_score":0.0119018555},"labels":[],"label_agreement":null},{"id":"W4286509886","doi":"10.1016/j.jhepr.2022.100544","title":"Farnesoid X receptor agonist tropifexor attenuates cholestasis in a randomised trial in patients with primary biliary cholangitis","year":2022,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":48,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Liver Centre; University of Alberta","funders":"Novartis Institutes for BioMedical Research; Intercept Pharmaceuticals; Medical Research Council; Merck; Dr. Falk Pharma; GlaxoSmithKline; National Institute for Health and Care Research; Novartis; Pfizer","keywords":"Ursodeoxycholic acid; Tolerability; Placebo; Medicine; Discontinuation; Internal medicine; Obeticholic acid; Adverse effect; Cholestasis; Gastroenterology; Primary biliary cirrhosis; Farnesoid X receptor; Agonist; Receptor; Pathology","score_opus":0.00779975170173277,"score_gpt":0.2178358120458716,"score_spread":0.21003606034413883,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4286509886","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98914903,0.004739552,0.00050610834,0.0005232632,0.00039938613,0.003010879,0.0005412369,0.000091328846,0.0010391951],"genre_scores_gemma":[0.98539877,0.0051909154,0.0011171045,0.00075615157,0.00043748177,0.003421505,0.0008622285,0.00001689246,0.0027988967],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99940073,0.00036157816,0.000047424346,0.00006914958,0.00003722014,0.00008395082],"domain_scores_gemma":[0.9991423,0.00026053205,0.00018720057,0.000072864794,0.00007077016,0.00026628928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017668197,0.0010634004,0.0028253507,0.0003003402,0.00032141508,0.0007105014,0.00057866145,0.0012975482,0.0046414253],"category_scores_gemma":[0.0016176183,0.0006426041,0.0015928737,0.00029113123,0.0007898818,0.00065939524,0.00031656786,0.0017185222,0.00056528026],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.97664523,0.003978443,0.00042395052,0.00076021993,0.0005382555,0.000058826565,0.00004880895,0.00017983133,0.0061406526,0.00004721765,0.0003517423,0.010826912],"study_design_scores_gemma":[0.912094,0.085243866,0.001523469,0.000025862972,0.00022635612,0.000036465823,0.000017271457,0.00013382778,0.00033628425,0.000028424238,0.0003259508,0.000008137858],"about_ca_topic_score_codex":0.0008133925,"about_ca_topic_score_gemma":0.001877327,"teacher_disagreement_score":0.0046414253,"about_ca_system_score_codex":0.00041463916,"about_ca_system_score_gemma":0.0008645131,"threshold_uncertainty_score":0.01552707},"labels":[],"label_agreement":null},{"id":"W4288058386","doi":"10.1016/j.jhepr.2022.100531","title":"Impact of the COVID-19 pandemic on hepatitis B and C elimination: An EASL survey","year":2022,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":79,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Centro Hospitalar Universitário do Porto; European Association for the Study of the Liver; Università degli Studi di Salerno; Roche España; University of Nottingham; Queen Elizabeth Hospital Birmingham Charity; Humanitas Research Hospital; Università degli Studi di Napoli Federico II; Azienda Ospedaliera Ospedali Riuniti Villa Sofia Cervello; Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico; Gilead Sciences; Uniwersytet Medyczny w Bialymstoku; Ankara Universitesi; Faculty of Medicine Siriraj Hospital, Mahidol University; University of Toronto; AbbVie; Università Cattolica del Sacro Cuore; Kocaeli Üniversitesi; Mahidol University; North American Membrane Society","keywords":"Pandemic; Medicine; Hepatitis C; HBsAg; Virology; Viral hepatitis; Hepatitis B; Coronavirus disease 2019 (COVID-19); Family medicine; Hepatitis B virus; Internal medicine; Disease; Virus; Infectious disease (medical specialty)","score_opus":0.08551850487269273,"score_gpt":0.37467653011625196,"score_spread":0.2891580252435592,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4288058386","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99469805,0.00015964166,0.00009208237,0.0003034376,0.0000065406275,0.000049149672,0.0036150364,0.000008831788,0.0010673021],"genre_scores_gemma":[0.99480814,0.00027094083,0.00026044127,0.0005906714,0.000025274114,0.000111307105,0.0034011041,0.000005068918,0.0005269786],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988312,0.00042304603,0.00015536479,0.00012775706,0.00022714185,0.00023546687],"domain_scores_gemma":[0.99567944,0.0008371943,0.0017488244,0.00015904232,0.0007545784,0.0008209749],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025840471,0.00021782069,0.00022241614,0.0011111922,0.0002771066,0.00059154903,0.00033251962,0.00047259982,0.0014861482],"category_scores_gemma":[0.0042526075,0.00022373462,0.00038680664,0.0012071248,0.00023003513,0.00074663636,0.0011179941,0.00048410788,0.00040294323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000082516846,0.000083706465,0.9946203,0.000043894386,0.000023089371,0.00005727605,0.00034000922,0.00008092029,0.00013063864,0.000017377784,0.0010065696,0.00351372],"study_design_scores_gemma":[0.00000488512,0.000120996185,0.99845445,0.000017109516,0.000006100271,0.000072710965,0.00057962304,0.000121663244,0.000049911643,0.00000450393,0.00056346774,0.0000044687354],"about_ca_topic_score_codex":0.017261608,"about_ca_topic_score_gemma":0.015434144,"teacher_disagreement_score":0.017261608,"about_ca_system_score_codex":0.0009777443,"about_ca_system_score_gemma":0.0009056773,"threshold_uncertainty_score":0.03432226},"labels":[],"label_agreement":null},{"id":"W4295007474","doi":"10.1016/j.jhepr.2022.100578","title":"What to do about hepatocellular carcinoma: Recommendations for health authorities from the International Liver Cancer Association","year":2022,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Cancer Research UK","keywords":"Hepatocellular carcinoma; Medicine; Incidence (geometry); Liver cancer; Public health; Cancer; Health care; Family medicine; Environmental health; Political science; Internal medicine; Nursing","score_opus":0.18210931816076126,"score_gpt":0.37645002174293657,"score_spread":0.1943407035821753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4295007474","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001550787,0.8180699,0.0005384574,0.16470239,0.008409788,0.00020067029,0.0003917152,0.00007514687,0.0074568475],"genre_scores_gemma":[0.0012274374,0.9523919,0.0029929506,0.03671372,0.0022522514,0.00027335875,0.00039517332,0.000017786258,0.0037353314],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972211,0.0011028249,0.00064399943,0.00013020361,0.0007359413,0.00016586883],"domain_scores_gemma":[0.9903914,0.0038237735,0.0013676473,0.00020131526,0.003415514,0.0008004344],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0069326474,0.00080192887,0.0021112424,0.0028958528,0.00085146906,0.00270279,0.001974868,0.00451419,0.010274278],"category_scores_gemma":[0.0152282575,0.0005229326,0.0020062611,0.0027961456,0.00091955677,0.004523003,0.0015903292,0.0057937964,0.0062316163],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050551902,0.000069846836,0.00029401958,0.023183571,0.00009649126,0.00017919754,0.00035476,0.00009095907,0.0001683128,0.003828209,0.47631407,0.49537003],"study_design_scores_gemma":[0.000047687772,0.000030916653,0.00064535066,0.040315244,0.0001480385,0.0002024896,0.00030198065,0.000024404544,0.00004211591,0.0020144114,0.956206,0.000021301637],"about_ca_topic_score_codex":0.0070899,"about_ca_topic_score_gemma":0.015010538,"teacher_disagreement_score":0.010274278,"about_ca_system_score_codex":0.0019864154,"about_ca_system_score_gemma":0.011092426,"threshold_uncertainty_score":0.03666377},"labels":[],"label_agreement":null},{"id":"W4296668671","doi":"10.1016/j.jhepr.2022.100590","title":"ABCB4 variant is associated with hepatobiliary MR abnormalities in people with low-phospholipid-associated cholelithiasis syndrome","year":2022,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Pediatric Hepatobiliary Diseases and Treatments","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"","keywords":"Gastroenterology; Internal medicine; Medicine; Pathology; Odds ratio","score_opus":0.00605458934532746,"score_gpt":0.21482490478322422,"score_spread":0.20877031543789676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4296668671","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995461,0.000207675,0.00003648759,0.000011960038,0.0000016858967,0.0000049382934,0.000055176744,0.000002001124,0.00013389709],"genre_scores_gemma":[0.99976355,0.000060991453,0.00005165547,0.000011488153,0.000004796388,0.0000031466795,0.00005991785,6.2111354e-7,0.00004380457],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996402,0.000071060465,0.00006293861,0.00008615226,0.000076651195,0.000063022584],"domain_scores_gemma":[0.99931943,0.0001318616,0.00036872784,0.000041336083,0.000061599865,0.000077102486],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034893776,0.00029695255,0.00036140828,0.0011214964,0.00042045597,0.00042742767,0.00027636834,0.0005250248,0.0019621872],"category_scores_gemma":[0.0015907207,0.0003515631,0.00034283838,0.0009869523,0.00034580744,0.00035240047,0.00036715073,0.00027715176,0.0002626124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000076045326,0.000011485233,0.9976248,0.000011230514,0.00001906702,0.00079635024,0.00008748491,0.000010862941,0.0005061956,0.000010583953,0.000030033358,0.0008157597],"study_design_scores_gemma":[0.000009004362,0.000090254565,0.9945564,0.000007069614,0.000029165372,0.004813159,0.00015574096,0.000077976256,0.00011340989,0.00001794886,0.00012557546,0.0000041433477],"about_ca_topic_score_codex":0.0024156189,"about_ca_topic_score_gemma":0.001977298,"teacher_disagreement_score":0.0024156189,"about_ca_system_score_codex":0.00020972527,"about_ca_system_score_gemma":0.00015363356,"threshold_uncertainty_score":0.0065641403},"labels":[],"label_agreement":null},{"id":"W4298625046","doi":"10.1016/j.jhepr.2022.100599","title":"Inflammatory conditions play a role in recurrence of PSC after liver transplantation: An international multicentre study","year":2022,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Nova Scotia Health Authority; Dalhousie University; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Liver transplantation; Primary sclerosing cholangitis; Hazard ratio; Internal medicine; Retrospective cohort study; Transplantation; Gastroenterology; Inflammatory bowel disease; Colectomy; Risk factor; Proportional hazards model; Disease; Surgery; Confidence interval; Ulcerative colitis","score_opus":0.010368161312670553,"score_gpt":0.2796791013966749,"score_spread":0.26931094008400436,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4298625046","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991597,0.00044262383,0.00006471078,0.000033816912,0.000005303579,0.000013757317,0.00014608454,0.0000016227721,0.00013228989],"genre_scores_gemma":[0.9994816,0.00014660215,0.00007230576,0.00002688193,0.00001668599,0.000011383535,0.00021080913,0.0000014609648,0.000032308533],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986412,0.00055105693,0.00016611801,0.00030194505,0.0001568095,0.0001829998],"domain_scores_gemma":[0.9960592,0.0005463807,0.0021827365,0.00046966234,0.00021837017,0.00052364456],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021727434,0.00065868616,0.0006046546,0.001175013,0.00065815524,0.0010055222,0.0007154547,0.0009258417,0.0011443998],"category_scores_gemma":[0.0034982404,0.0005341397,0.0013525906,0.002425071,0.0004960149,0.0007649401,0.0010773111,0.000852999,0.00018020661],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00028751075,0.00004081473,0.9987056,0.000015617985,0.000095091695,0.00010156311,0.00011462407,0.000025965723,0.00007639113,0.000010477592,0.000044837077,0.00048146804],"study_design_scores_gemma":[0.00001966773,0.0001513102,0.9991416,0.000008465725,0.00008533542,0.00027924083,0.0001375028,0.00008152553,0.000014907387,0.000008726945,0.000067040746,0.0000047117187],"about_ca_topic_score_codex":0.004915583,"about_ca_topic_score_gemma":0.004235682,"teacher_disagreement_score":0.004915583,"about_ca_system_score_codex":0.00043949336,"about_ca_system_score_gemma":0.00044556145,"threshold_uncertainty_score":0.011490703},"labels":[],"label_agreement":null},{"id":"W4309340251","doi":"10.1016/j.jhepr.2022.100626","title":"Genotype-phenotype relationships of truncating mutations, p.E297G and p.D482G in bile salt export pump deficiency","year":2022,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Pediatric Hepatobiliary Diseases and Treatments","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of Toronto; University Health Network; Children's Hospital of Eastern Ontario; Hospital for Sick Children; University of Ottawa","funders":"National Institute of Diabetes and Digestive and Kidney Diseases","keywords":"Bile Salt Export Pump; Genotype; Phenotype; Mutation; Enterohepatic circulation; Internal medicine; Compound heterozygosity; Gastroenterology; Progressive familial intrahepatic cholestasis; Endocrinology; Biology; Medicine; Liver transplantation; Bile acid; Genetics; Transplantation; Gene","score_opus":0.02277527426349955,"score_gpt":0.26818453647062873,"score_spread":0.2454092622071292,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4309340251","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99953365,0.00005937642,0.00005591805,0.000008905931,0.0000013564865,0.0000032911155,0.000186886,0.0000018046178,0.000148824],"genre_scores_gemma":[0.99956316,0.000025340389,0.00007789282,0.000007994021,0.0000028200732,0.000004446255,0.00026379694,0.0000019607892,0.000052474566],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996251,0.00008738312,0.0000660965,0.0001150649,0.00005754087,0.000048759797],"domain_scores_gemma":[0.9989605,0.00049539167,0.0002963174,0.000056184494,0.00004805632,0.0001435414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00039006802,0.00028888448,0.000231644,0.000830737,0.00023981807,0.0003120688,0.00019429262,0.0004264942,0.002192729],"category_scores_gemma":[0.0017277449,0.0001235804,0.000217236,0.00044208593,0.00024171929,0.00019514722,0.00032876286,0.00028257183,0.00035000488],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005550516,0.000040279632,0.99155265,0.0000112996595,0.00004909112,0.0018605018,0.00006570709,0.00013306885,0.0025225158,0.000039150756,0.00014439954,0.0030262251],"study_design_scores_gemma":[0.00004027784,0.00026453537,0.9811802,0.0000086192,0.000057338908,0.016259618,0.0001427701,0.0004578265,0.0011172567,0.00011599404,0.00034635369,0.000009159355],"about_ca_topic_score_codex":0.00053859054,"about_ca_topic_score_gemma":0.0006097717,"teacher_disagreement_score":0.002192729,"about_ca_system_score_codex":0.00014687233,"about_ca_system_score_gemma":0.00009394143,"threshold_uncertainty_score":0.0073354244},"labels":[],"label_agreement":null},{"id":"W4318447285","doi":"10.1016/j.jhepr.2023.100689","title":"TACE and conformal radiotherapy vs. TACE alone for hepatocellular carcinoma: A randomised controlled trial","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"Direction de l’hospitalisation et de l’offre de Soins; Institut National Du Cancer","keywords":"Medicine; Hepatocellular carcinoma; Transcatheter arterial chemoembolization; Hazard ratio; Clinical endpoint; Internal medicine; Adverse effect; Population; Randomized controlled trial; Radiation therapy; Gastroenterology; Surgery; Urology; Confidence interval","score_opus":0.03836181107514302,"score_gpt":0.2677111404418221,"score_spread":0.22934932936667907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4318447285","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8562937,0.08727275,0.0035351869,0.0037847564,0.0062919036,0.032076884,0.0029697714,0.0003808078,0.007394344],"genre_scores_gemma":[0.9260638,0.019637382,0.0041091475,0.0034900014,0.0026725042,0.03694528,0.0012548744,0.000048060272,0.0057791197],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99646914,0.0023294361,0.00035531007,0.0003885175,0.00020390213,0.00025361707],"domain_scores_gemma":[0.99681515,0.0015173204,0.0008437834,0.00020732339,0.00017601669,0.0004404513],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0044416417,0.001957208,0.0056231045,0.0007784012,0.00049169466,0.0017122094,0.0012001455,0.003314251,0.012528108],"category_scores_gemma":[0.007406831,0.0007938902,0.0048686485,0.0010727344,0.001493758,0.0015924324,0.0008135119,0.0032976042,0.0012610573],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98554426,0.0013309275,0.00014395513,0.0030280156,0.0026118017,0.00002665041,0.000027938611,0.00014972549,0.00031119314,0.00013674745,0.00039385425,0.0062948656],"study_design_scores_gemma":[0.98711187,0.01062857,0.00027872637,0.00015824988,0.0011182006,0.000014803068,0.000010760282,0.00013152725,0.00004393732,0.00014904272,0.00034551258,0.000008802284],"about_ca_topic_score_codex":0.0011780597,"about_ca_topic_score_gemma":0.0017702406,"teacher_disagreement_score":0.012528108,"about_ca_system_score_codex":0.0013961729,"about_ca_system_score_gemma":0.0014305285,"threshold_uncertainty_score":0.041910768},"labels":[],"label_agreement":null},{"id":"W4322154777","doi":"10.1016/j.jhepr.2023.100715","title":"A genomic enhancer signature associates with hepatocellular carcinoma prognosis","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Epigenetics and DNA Methylation","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université de Montréal; Montreal Heart Institute","funders":"National Medical Research Council; Medical Research Council","keywords":"Hepatocellular carcinoma; Enhancer; Signature (topology); Cancer research; Computational biology; Biology; Genetics; Gene; Gene expression; Mathematics","score_opus":0.009057418960118191,"score_gpt":0.22936931318703072,"score_spread":0.22031189422691252,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4322154777","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986743,0.00015980056,0.00039846078,0.000033380038,0.00000309218,0.0000034858842,0.00040776472,0.000016842952,0.0003030441],"genre_scores_gemma":[0.9993326,0.00002510543,0.00018412818,0.000008473143,0.00000331431,0.0000025504905,0.00034903837,0.0000026570676,0.00009192192],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998971,0.000021197704,0.000010591592,0.00002994697,0.000020441663,0.000020727408],"domain_scores_gemma":[0.99930227,0.00015640666,0.00030867243,0.000056881963,0.000078840334,0.00009692885],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018684864,0.00012165876,0.00018514523,0.00039531224,0.00010146705,0.00020992072,0.00010935759,0.0001648168,0.0019017599],"category_scores_gemma":[0.00073257386,0.000054751938,0.00016107851,0.00039057483,0.00013556136,0.00009385887,0.0002043196,0.00018409149,0.00022186124],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00077362417,0.00003485812,0.9523436,0.000039157294,0.0000879726,0.00017820866,0.00005207424,0.00032107154,0.036851775,0.000063088,0.00016618274,0.00908833],"study_design_scores_gemma":[0.0000045969527,0.000084787855,0.9951125,0.000003828548,0.000039918097,0.0006220223,0.000043461587,0.0005864917,0.0031302194,0.00012147153,0.00024604404,0.0000048187967],"about_ca_topic_score_codex":0.00044687456,"about_ca_topic_score_gemma":0.0007312953,"teacher_disagreement_score":0.0019017599,"about_ca_system_score_codex":0.00011500036,"about_ca_system_score_gemma":0.00009671137,"threshold_uncertainty_score":0.0063619614},"labels":[],"label_agreement":null},{"id":"W4324366844","doi":"10.1016/j.jhepr.2023.100727","title":"MELD 3.0 adequately predicts mortality and renal replacement therapy requirements in patients with alcohol-associated hepatitis","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; University of Alberta; Western University","funders":"Fondo Nacional de Desarrollo Científico y Tecnológico; National Center for Advancing Translational Sciences; National Institute on Alcohol Abuse and Alcoholism; National Institute of Diabetes and Digestive and Kidney Diseases; Agencia Nacional de Investigación y Desarrollo","keywords":"Renal replacement therapy; Medicine; Intensive care medicine; Alcohol; Internal medicine; Biology","score_opus":0.12744590396310973,"score_gpt":0.3778664451752489,"score_spread":0.2504205412121392,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324366844","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99898225,0.00019394216,0.00019761556,0.000050433864,0.000010261203,0.000006820855,0.00019417683,0.000007847298,0.00035666133],"genre_scores_gemma":[0.99957985,0.0000333587,0.000082866485,0.000015005903,0.0000062079725,0.0000024645003,0.00022324632,0.0000019041167,0.000055057237],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99937445,0.00023405373,0.00008808266,0.00010852244,0.00007947709,0.00011549917],"domain_scores_gemma":[0.99762696,0.00071220956,0.000913647,0.00016990607,0.00016780445,0.00040958863],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016699845,0.0004216396,0.0005022551,0.0005631297,0.00031011694,0.0010816859,0.00027927535,0.00041699864,0.0011157612],"category_scores_gemma":[0.0044144304,0.00024024396,0.00086824194,0.0006119722,0.00031815784,0.00086017494,0.00089463097,0.0005945768,0.00028839437],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022272806,0.000017115997,0.99820244,0.000005858619,0.000025919497,0.000038046725,0.000021849772,0.000124019,0.00011528727,0.000008057669,0.00005580354,0.0011629071],"study_design_scores_gemma":[0.000018245128,0.00029423152,0.9968646,0.00001359741,0.0000472239,0.00032249745,0.00012545477,0.0019762798,0.00010658799,0.00005920494,0.00016446318,0.000007482996],"about_ca_topic_score_codex":0.001618079,"about_ca_topic_score_gemma":0.0027776249,"teacher_disagreement_score":0.0016699845,"about_ca_system_score_codex":0.00030904557,"about_ca_system_score_gemma":0.0004133492,"threshold_uncertainty_score":0.008831859},"labels":[],"label_agreement":null},{"id":"W4353096527","doi":"10.1016/j.jhepr.2023.100742","title":"Endogenous sex steroid hormones and risk of liver cancer among US men: Results from the Liver Cancer Pooling Project","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hormonal and reproductive studies","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Public Health Ontario; University of Toronto; Ontario Institute for Cancer Research; Université Laval; Centre hospitalier universitaire de Québec","funders":"National Cancer Institute; Harvard T.H. Chan School of Public Health; National Institutes of Health; Brigham and Women's Hospital","keywords":"Testosterone (patch); Sex hormone-binding globulin; Internal medicine; Endocrinology; Hormone; Dihydrotestosterone; Dehydroepiandrosterone; Medicine; Odds ratio; Cancer; Androgen","score_opus":0.049954615401715446,"score_gpt":0.2848972761417054,"score_spread":0.23494266073998996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4353096527","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98729914,0.0005445822,0.000598919,0.00009538015,0.000008160939,0.00006971163,0.010846259,0.000035833516,0.000502101],"genre_scores_gemma":[0.9836044,0.00031251006,0.00045700461,0.00007114432,0.00002437502,0.0000907621,0.014917925,0.000018338147,0.0005035525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983101,0.0008090333,0.0001801139,0.00028834265,0.00027659096,0.00013594661],"domain_scores_gemma":[0.9978447,0.00042792453,0.00073226227,0.00043611956,0.0003043676,0.00025459548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0038113224,0.0004881993,0.0006605743,0.0013727674,0.00031881646,0.00060741557,0.00046799672,0.00025060668,0.0012722022],"category_scores_gemma":[0.0047529303,0.00031124044,0.0016272569,0.0020452829,0.00020431221,0.0002696087,0.0012389966,0.00022201274,0.00032424385],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00061228534,0.000051426145,0.99302506,0.00004037347,0.0012786376,0.000038902323,0.00010502085,0.00010432866,0.00022764971,0.000020976264,0.0008823391,0.003612958],"study_design_scores_gemma":[0.00005440178,0.00009112521,0.9983211,0.0000070481437,0.0006063091,0.00005313604,0.000083975705,0.00014454442,0.00008985304,0.00001670745,0.0005260889,0.000005593803],"about_ca_topic_score_codex":0.019542692,"about_ca_topic_score_gemma":0.014205027,"teacher_disagreement_score":0.019542692,"about_ca_system_score_codex":0.00038049562,"about_ca_system_score_gemma":0.00052658294,"threshold_uncertainty_score":0.038857877},"labels":[],"label_agreement":null},{"id":"W4361222909","doi":"10.1016/j.jhepr.2023.100745","title":"An international multicentre evaluation of treatment strategies for combined hepatocellular-cholangiocarcinoma✰","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"European Cooperation in Science and Technology; Roche","keywords":"Hepatocellular carcinoma; Medicine; Internal medicine; Hepatocellular cancer; Oncology; Gastroenterology","score_opus":0.08080938559773793,"score_gpt":0.3681195761049801,"score_spread":0.28731019050724216,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361222909","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9793993,0.0032188029,0.0012990426,0.0009439328,0.00012820234,0.0062874146,0.0050569093,0.000044199405,0.0036221445],"genre_scores_gemma":[0.98425335,0.001447191,0.0030992927,0.000566438,0.00008966633,0.0059436685,0.004111691,0.0000146156435,0.00047411217],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.98598456,0.0100664105,0.0017668911,0.00066166674,0.00095491495,0.0005656584],"domain_scores_gemma":[0.97429454,0.008720619,0.01009086,0.0016528345,0.0030370632,0.0022039567],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.018521667,0.0008221967,0.000629888,0.0018760837,0.00047881433,0.001007058,0.00086703454,0.0009139982,0.0030759838],"category_scores_gemma":[0.032210954,0.00041117493,0.0027981303,0.0024243018,0.00054804,0.0014971502,0.0014908031,0.00059016736,0.0006015469],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.045619614,0.01582594,0.7159806,0.006810557,0.0050834017,0.00021198246,0.0037326925,0.0034695154,0.0008003971,0.0010436581,0.01338017,0.18804158],"study_design_scores_gemma":[0.013417894,0.04587504,0.9193196,0.0011036311,0.002084038,0.00035575315,0.0032665846,0.0026364878,0.00058240857,0.00035381038,0.01086509,0.00013967132],"about_ca_topic_score_codex":0.003641728,"about_ca_topic_score_gemma":0.0032811535,"teacher_disagreement_score":0.018521667,"about_ca_system_score_codex":0.0027109976,"about_ca_system_score_gemma":0.0031280303,"threshold_uncertainty_score":0.09795308},"labels":[],"label_agreement":null},{"id":"W4361306822","doi":"10.1016/j.jhepr.2023.100743","title":"PRO-C3 is a predictor of clinical outcomes in distinct cohorts of patients with advanced liver disease","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver physiology and pathology","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"National Institute for Health and Care Research","keywords":"Disease; Medicine; Internal medicine; Oncology","score_opus":0.027491653280472213,"score_gpt":0.33543944693860267,"score_spread":0.30794779365813046,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4361306822","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99956256,0.00012162834,0.000056685716,0.00002177866,0.0000028886327,0.000004183437,0.000119124416,0.0000018036169,0.00010941379],"genre_scores_gemma":[0.9995479,0.000034449586,0.0000676542,0.000013032251,0.000009191932,0.0000053214244,0.00027580242,0.0000012665591,0.000045340297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9994393,0.0001554484,0.00004333628,0.00016267224,0.000105395324,0.00009373035],"domain_scores_gemma":[0.9975073,0.0005403113,0.0010881122,0.00022736425,0.0001568081,0.00048003692],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011241549,0.00042721175,0.00043952672,0.00056603,0.00048495148,0.0007065968,0.0003395712,0.0007020587,0.001288507],"category_scores_gemma":[0.0027895628,0.0002497218,0.00054845127,0.00052421325,0.0004348481,0.00040172203,0.00065943296,0.0009240729,0.00020190504],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0008696825,0.00002280642,0.9977239,0.000004757309,0.00005833451,0.000057524074,0.000027757489,0.000066507746,0.0005027625,0.0000114479335,0.000039028335,0.0006155106],"study_design_scores_gemma":[0.000029162276,0.0001907952,0.99898213,0.000003205947,0.000029382816,0.00024921336,0.00004763247,0.00026963075,0.00010010094,0.000034206812,0.000060271057,0.000004296516],"about_ca_topic_score_codex":0.0013851039,"about_ca_topic_score_gemma":0.0016726514,"teacher_disagreement_score":0.0013851039,"about_ca_system_score_codex":0.00024982207,"about_ca_system_score_gemma":0.0002990379,"threshold_uncertainty_score":0.0059452057},"labels":[],"label_agreement":null},{"id":"W4362640874","doi":"10.1016/j.jhepr.2023.100749","title":"Innovative approaches to the management of ascites in cirrhosis","year":2023,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Ascites; Medicine; Cirrhosis; Paracentesis; Hepatic encephalopathy; Rifaximin; Transjugular intrahepatic portosystemic shunt; Intensive care medicine; Internal medicine; Portal hypertension; Gastroenterology; Surgery; Antibiotics","score_opus":0.2959458255951879,"score_gpt":0.365538782188307,"score_spread":0.06959295659311909,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362640874","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.016441157,0.761367,0.05311334,0.108349554,0.00945702,0.00043036125,0.00028573174,0.0006757548,0.04987995],"genre_scores_gemma":[0.14626345,0.67773765,0.09590933,0.040832773,0.015163896,0.0008154577,0.0007337828,0.00016118269,0.022382569],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993616,0.00023848697,0.000043459797,0.000066492,0.00020929512,0.0000805977],"domain_scores_gemma":[0.99945194,0.00015353899,0.00008145479,0.00003623698,0.00015334232,0.00012346808],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014782491,0.0005754714,0.0006563169,0.0010341869,0.0004766781,0.0016072516,0.00094458123,0.001304178,0.0051202253],"category_scores_gemma":[0.0017383213,0.00014045494,0.00096173096,0.0005327117,0.00096484396,0.00133673,0.0019587686,0.0035045291,0.0019219045],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00039259734,0.000507277,0.0015834238,0.003672436,0.00022656399,0.0012442371,0.00041188602,0.0011169353,0.0069273533,0.027055841,0.04222173,0.9146397],"study_design_scores_gemma":[0.00041931518,0.0016932078,0.004959773,0.004629946,0.00030210923,0.0053395145,0.0006821844,0.0024092223,0.0041371584,0.08035166,0.894968,0.000108052605],"about_ca_topic_score_codex":0.00076399563,"about_ca_topic_score_gemma":0.0012133913,"teacher_disagreement_score":0.0051202253,"about_ca_system_score_codex":0.00086677604,"about_ca_system_score_gemma":0.0015408626,"threshold_uncertainty_score":0.017128825},"labels":[],"label_agreement":null},{"id":"W4362699996","doi":"10.1016/j.jhepr.2023.100753","title":"Prevalence, risk factors and diagnostic accuracy of non-invasive tests for NAFLD in people with type 1 diabetes","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Bijzonder Onderzoeksfonds UGent; Universiteit Antwerpen; Fonds Wetenschappelijk Onderzoek; Canadian Association for the Study of the Liver","keywords":"Medicine; Transient elastography; Fatty liver; Internal medicine; Gastroenterology; Diabetes mellitus; Metabolic syndrome; Cohort; Type 2 diabetes; Nonalcoholic fatty liver disease; Prospective cohort study; Magnetic resonance elastography; Epidemiology; Disease; Liver fibrosis; Elastography; Fibrosis; Ultrasound; Radiology; Obesity; Endocrinology","score_opus":0.014253847980743476,"score_gpt":0.27791890511913186,"score_spread":0.2636650571383884,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362699996","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9973023,0.0015568141,0.00023537496,0.0000959204,0.00002206093,0.000009894292,0.00021950284,0.000007838077,0.00055022916],"genre_scores_gemma":[0.9993104,0.00024633168,0.00017841239,0.000023616501,0.000025717745,0.0000064317182,0.0001567091,0.0000016924606,0.00005072939],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99687827,0.0012719859,0.00044759133,0.00046029588,0.0007033858,0.00023853092],"domain_scores_gemma":[0.98720413,0.005500768,0.004908809,0.0009856963,0.00087139267,0.0005291979],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0039415783,0.00053687807,0.00047472215,0.0014749055,0.00035973752,0.0010800101,0.0006090849,0.000889901,0.0011226245],"category_scores_gemma":[0.018367032,0.00038358348,0.00086099864,0.0010070081,0.0004706889,0.00065881136,0.0006564426,0.00076546805,0.00018958197],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008131003,0.000018115783,0.9988248,0.000006864817,0.000038285372,0.000018507275,0.000024054598,0.00002556146,0.000027390144,0.0000066975813,0.000023926268,0.00090454484],"study_design_scores_gemma":[0.0000070857423,0.00009229348,0.99855417,0.000019031837,0.0000778649,0.00033056104,0.00012020876,0.0005496687,0.000100210564,0.000050028862,0.000093437964,0.000005431682],"about_ca_topic_score_codex":0.0028323466,"about_ca_topic_score_gemma":0.0028112705,"teacher_disagreement_score":0.0039415783,"about_ca_system_score_codex":0.00031044177,"about_ca_system_score_gemma":0.00024961372,"threshold_uncertainty_score":0.020845294},"labels":[],"label_agreement":null},{"id":"W4366754899","doi":"10.1016/j.jhepr.2023.100778","title":"Treatment responses and outcomes in patients with autoimmune hepatitis and concomitant features of non-alcoholic fatty liver disease","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Autoimmune hepatitis; Internal medicine; Gastroenterology; Fatty liver; Liver biopsy; Cirrhosis; Steatohepatitis; Metabolic syndrome; Diabetes mellitus; Hepatitis; Disease; Obesity; Biopsy; Endocrinology","score_opus":0.010239327133959907,"score_gpt":0.2627745757340412,"score_spread":0.2525352486000813,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4366754899","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9987062,0.00066948484,0.000024049037,0.00006281351,0.0000068819686,0.0000059235936,0.0001791689,0.0000015764757,0.00034380372],"genre_scores_gemma":[0.999488,0.00013635814,0.000013331893,0.000032463788,0.000013481881,0.000006198345,0.00023937305,6.587331e-7,0.00007017984],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999388,0.0002150672,0.00006814388,0.00010014676,0.00009750944,0.00013117789],"domain_scores_gemma":[0.9982023,0.00031221568,0.0009759808,0.000068181005,0.00012023427,0.00032105797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00080908684,0.00015723673,0.0004916321,0.0005099953,0.0003645364,0.0005200846,0.00023496842,0.00046109356,0.0014467287],"category_scores_gemma":[0.0028077704,0.00014583906,0.0004852758,0.0009394,0.00019860831,0.0004442315,0.00037832616,0.00045973208,0.00018092923],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00046131038,0.000070212045,0.9969434,0.0000135497985,0.000075771575,0.00005395047,0.000039474056,0.000051041246,0.000054318105,0.000006444104,0.000098883305,0.0021316693],"study_design_scores_gemma":[0.00003107422,0.0001722781,0.9992902,0.0000066345333,0.00003128854,0.00015574631,0.00008508587,0.00010109372,0.000017259475,0.000012446266,0.00009393326,0.0000028667007],"about_ca_topic_score_codex":0.0021308954,"about_ca_topic_score_gemma":0.002493757,"teacher_disagreement_score":0.0021308954,"about_ca_system_score_codex":0.00050324085,"about_ca_system_score_gemma":0.00022949687,"threshold_uncertainty_score":0.004839778},"labels":[],"label_agreement":null},{"id":"W4367397117","doi":"10.1016/j.jhepr.2023.100782","title":"Interim results from an ongoing, open-label, single-arm trial of odevixibat in progressive familial intrahepatic cholestasis","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Drug Transport and Resistance Mechanisms","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"Biodel","keywords":"Medicine; Cohort; Internal medicine; Adverse effect; Placebo; Clinical endpoint; Cholestasis; Gastroenterology; Clinical trial; Pathology","score_opus":0.07938823805219147,"score_gpt":0.3582880309852884,"score_spread":0.2788997929330969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367397117","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97217065,0.005071536,0.0012535603,0.0009833112,0.0003714472,0.0025042507,0.011185863,0.0001973703,0.0062619555],"genre_scores_gemma":[0.97723776,0.0010263062,0.002060869,0.0012969751,0.00030446652,0.0030642725,0.012222036,0.00003807761,0.0027492149],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9988803,0.0004483194,0.00007416792,0.00016718078,0.00016698432,0.0002630434],"domain_scores_gemma":[0.9967602,0.00083084323,0.00076942774,0.00040732836,0.0003749523,0.0008572543],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0047537354,0.0010523275,0.0018806868,0.0002550215,0.0005445228,0.0014618824,0.0005029991,0.0012216654,0.0050658085],"category_scores_gemma":[0.003971713,0.00034941462,0.0017248514,0.00028129772,0.00043789443,0.0009288122,0.00044724785,0.0025356468,0.00077598676],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.8520076,0.0175616,0.015664168,0.0011045312,0.003557438,0.0004116683,0.00026304717,0.002082806,0.013870988,0.00035142543,0.014048046,0.07907669],"study_design_scores_gemma":[0.4814473,0.42188916,0.072484545,0.00017606307,0.0035548257,0.000709539,0.00014140943,0.0013413649,0.0058323382,0.0006744085,0.011682269,0.000066766384],"about_ca_topic_score_codex":0.00040387502,"about_ca_topic_score_gemma":0.0012084082,"teacher_disagreement_score":0.0050658085,"about_ca_system_score_codex":0.0005743242,"about_ca_system_score_gemma":0.0010752128,"threshold_uncertainty_score":0.025140464},"labels":[],"label_agreement":null},{"id":"W4368340905","doi":"10.1016/j.jhepr.2023.100785","title":"Use of albumin infusion for cirrhosis-related complications: An international position statement","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":46,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto","funders":"Shenyang Young and Middle-aged Science and Technology Innovation Talent Support Program","keywords":"Cirrhosis; Albumin; Position statement; Medicine; Statement (logic); Gastroenterology; Internal medicine; Intensive care medicine; Philosophy; Family medicine; Epistemology","score_opus":0.05821377306093508,"score_gpt":0.3460671124270163,"score_spread":0.28785333936608126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4368340905","genre_codex":"commentary","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.011398241,0.13821523,0.0064940667,0.75709355,0.06900855,0.0012859723,0.00034628247,0.00007608826,0.016082052],"genre_scores_gemma":[0.19072945,0.29272568,0.093071386,0.30221617,0.08992216,0.0059572705,0.0027550464,0.00027307248,0.022349775],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.97463393,0.009724047,0.006766267,0.0011235444,0.0061070444,0.0016451275],"domain_scores_gemma":[0.9331977,0.025080755,0.014058285,0.001740132,0.018345537,0.0075776265],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.049960334,0.0017520131,0.0012685125,0.001857561,0.002335277,0.0044138622,0.0030780698,0.013627583,0.0025552863],"category_scores_gemma":[0.051367708,0.00063549826,0.0019612145,0.0021282325,0.003482509,0.0032266225,0.004533613,0.0108251,0.0014486029],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00079450005,0.00079566025,0.013997499,0.0120199965,0.0002918061,0.0017761014,0.004860433,0.0023137045,0.005363022,0.033333566,0.45730108,0.4671526],"study_design_scores_gemma":[0.00040562698,0.0012051029,0.010872314,0.026294496,0.00047738868,0.0023053715,0.0037381796,0.0013601342,0.001957527,0.014090055,0.93712616,0.0001675343],"about_ca_topic_score_codex":0.0016195001,"about_ca_topic_score_gemma":0.0012654491,"teacher_disagreement_score":0.049960334,"about_ca_system_score_codex":0.0032759598,"about_ca_system_score_gemma":0.025359258,"threshold_uncertainty_score":0.26421863},"labels":[],"label_agreement":null},{"id":"W4379745482","doi":"10.1016/j.jhepr.2023.100809","title":"Oesophageal varices predict complications in compensated advanced non-alcoholic fatty liver disease","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Fonds de Recherche du Québec - Santé; Ministero dell’Istruzione, dell’Università e della Ricerca; Ministero della Salute","keywords":"Medicine; Decompensation; Internal medicine; Gastroenterology; Hazard ratio; Hepatocellular carcinoma; Esophageal varices; Fatty liver; Cirrhosis; Liver disease; Proportional hazards model; Portal vein thrombosis; Alcoholic liver disease; Varices; Portal hypertension; Confidence interval; Disease","score_opus":0.01942429766806594,"score_gpt":0.28729180521498704,"score_spread":0.2678675075469211,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379745482","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9988959,0.00051676936,0.00013996552,0.000040842602,0.000006852328,0.0000069024964,0.00012535999,0.0000028370234,0.00026443438],"genre_scores_gemma":[0.9996649,0.00007118661,0.000058736885,0.000005422427,0.000009614126,0.0000016023695,0.00011789875,6.8863244e-7,0.00006992281],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996939,0.00012999849,0.000033394717,0.000049839386,0.000044775286,0.000048110316],"domain_scores_gemma":[0.9977816,0.0007597083,0.00083691056,0.00014140304,0.00013257694,0.0003478649],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008611246,0.00038019012,0.00025493398,0.00047110612,0.00018960565,0.0004924926,0.00025602692,0.00037753838,0.0017506193],"category_scores_gemma":[0.0034450525,0.00022695657,0.000639334,0.00049649645,0.00022888432,0.00039404,0.0004768751,0.00062238146,0.00016811938],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014874389,0.000008828147,0.99902236,0.0000046569717,0.000024358611,0.000021230768,0.000006518457,0.00003567549,0.000055414705,0.0000046408472,0.000015870812,0.0006516673],"study_design_scores_gemma":[0.000006844837,0.00006404173,0.9991598,0.0000041163426,0.00003234554,0.00016004455,0.000025899462,0.00043639602,0.00004494019,0.000017160262,0.0000467374,0.0000018318859],"about_ca_topic_score_codex":0.0015425766,"about_ca_topic_score_gemma":0.0025440557,"teacher_disagreement_score":0.0017506193,"about_ca_system_score_codex":0.00013297623,"about_ca_system_score_gemma":0.00019236942,"threshold_uncertainty_score":0.005856395},"labels":[],"label_agreement":null},{"id":"W4381252706","doi":"10.1016/j.jhepr.2023.100817","title":"Efficacy of antiviral therapy and host–virus interactions visualised using serial liver sampling with fine-needle aspirates","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto General Hospital; University Health Network","funders":"Vir Biotechnology; Janssen Pharmaceuticals; Gilead Research Scholars; Gilead Sciences; GlaxoSmithKline","keywords":"Biology; Virology; RNA; Viral replication; Deep sequencing; Hepatitis B virus; Viral load; HBx; Virus; Transcription (linguistics); Gene; Genome; Genetics","score_opus":0.10564410419906027,"score_gpt":0.3653618667268447,"score_spread":0.2597177625277844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4381252706","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98565245,0.0024770978,0.009737093,0.0000501235,0.000029067716,0.00008129937,0.00026483386,0.00018203484,0.0015259341],"genre_scores_gemma":[0.9926139,0.0005621663,0.005743761,0.000050134295,0.00001930265,0.000053015283,0.0002304597,0.000017651186,0.00070966274],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99973184,0.00007577474,0.00001989117,0.000049282786,0.000096068914,0.000027172608],"domain_scores_gemma":[0.9994134,0.00027178423,0.00012478103,0.000042053496,0.000090227135,0.00005789027],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006324921,0.0002293912,0.00029676378,0.0004124044,0.00010370913,0.00033377833,0.00013389424,0.00029337843,0.0010881568],"category_scores_gemma":[0.0006719899,0.00013239903,0.0001798055,0.00016532204,0.00026134824,0.00023258191,0.00016418248,0.00034920362,0.00028725748],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019184889,0.00012459818,0.011668974,0.0000817562,0.000024121451,0.0000997649,0.00007971068,0.00031862233,0.97017205,0.000028839548,0.000050469996,0.015432542],"study_design_scores_gemma":[0.00004370993,0.004302809,0.13173436,0.000011900432,0.00007945142,0.0006114676,0.00010505526,0.006771231,0.8552932,0.00010092626,0.00092689507,0.000019053017],"about_ca_topic_score_codex":0.00045217664,"about_ca_topic_score_gemma":0.0004918651,"teacher_disagreement_score":0.0010881568,"about_ca_system_score_codex":0.00018450322,"about_ca_system_score_gemma":0.00009450983,"threshold_uncertainty_score":0.0036401749},"labels":[],"label_agreement":null},{"id":"W4384129505","doi":"10.1016/j.jhepr.2023.100847","title":"Tenofovir alafenamide and tenofovir disoproxil fumarate reduce incidence of hepatocellular carcinoma in patients with chronic hepatitis B","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Toronto Western Hospital","funders":"Gilead Sciences","keywords":"Tenofovir alafenamide; Hepatocellular carcinoma; Medicine; Internal medicine; Incidence (geometry); Gastroenterology; Hepatitis B; Hepatitis B virus; Tenofovir; Chronic hepatitis; Lower risk; Randomized controlled trial; Viral load; Immunology; Confidence interval; Human immunodeficiency virus (HIV); Virus","score_opus":0.011186443526818185,"score_gpt":0.23660211977195797,"score_spread":0.22541567624513978,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4384129505","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9945663,0.0030810677,0.0009829815,0.00014722135,0.000020844494,0.000103050595,0.00026472184,0.000039525734,0.0007942201],"genre_scores_gemma":[0.99900573,0.00027258118,0.00036335684,0.00003646296,0.0000075660546,0.000034672856,0.00016227867,0.000001811833,0.00011550986],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987224,0.0008509507,0.000074582436,0.00011430527,0.0001636698,0.0000740578],"domain_scores_gemma":[0.998626,0.0006495707,0.000406698,0.00009336042,0.00006149657,0.00016288186],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0029599736,0.00056720217,0.0008303757,0.00034081613,0.000101902035,0.0002998584,0.00017753443,0.00032402505,0.00080637407],"category_scores_gemma":[0.0044221366,0.00014659138,0.0018886233,0.00022087197,0.0001735415,0.00036931614,0.00043785915,0.00042101523,0.000084531515],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.1978726,0.004396711,0.5041819,0.001226428,0.011000764,0.00013948853,0.00029966928,0.030317597,0.0074264416,0.0006340687,0.0015765888,0.24092768],"study_design_scores_gemma":[0.016182257,0.1531675,0.76474303,0.00024724888,0.004640119,0.00041008642,0.00023453211,0.052230846,0.0040092403,0.0013930403,0.0026646839,0.00007739906],"about_ca_topic_score_codex":0.0009563417,"about_ca_topic_score_gemma":0.0017109303,"teacher_disagreement_score":0.0029599736,"about_ca_system_score_codex":0.00032402042,"about_ca_system_score_gemma":0.00048855774,"threshold_uncertainty_score":0.015653968},"labels":[],"label_agreement":null},{"id":"W4386572320","doi":"10.1016/j.jhepr.2023.100901","title":"Biliary disease progression in childhood onset autoimmune liver disease: A 30-year follow-up into adulthood","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre; University of Toronto","funders":"University of Birmingham; National Institute for Health and Care Research","keywords":"Medicine; Disease; Liver disease; Autoimmune disease; Autoimmune hepatitis; Clinical disease; Pediatrics; Immunology; Internal medicine","score_opus":0.011287669819765445,"score_gpt":0.2762524490524886,"score_spread":0.26496477923272316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386572320","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9980812,0.0007421014,0.00008308367,0.000055950866,0.0000062762147,0.000013640854,0.00055457064,0.0000064128253,0.00045672778],"genre_scores_gemma":[0.998271,0.0005141567,0.00012096807,0.000027600636,0.000011879606,0.000010578159,0.00091735215,0.0000024854314,0.00012402254],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995472,0.0000627045,0.00007469545,0.0000977505,0.00008116934,0.0001364406],"domain_scores_gemma":[0.9983895,0.0001503808,0.0007939725,0.000074725,0.0002776556,0.00031384794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007756914,0.00027423966,0.00035398637,0.0015253919,0.00063891587,0.00069759286,0.00028408697,0.00052593014,0.00083997444],"category_scores_gemma":[0.0019371695,0.0002035492,0.0004779691,0.0011075948,0.00029351944,0.0010671503,0.0007878803,0.00067743566,0.00034506942],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006990748,0.000020735008,0.99720734,0.000007800755,0.000012518883,0.0003564569,0.0002057662,0.000023155717,0.00007342384,0.0000059618833,0.000087562374,0.0019292807],"study_design_scores_gemma":[0.000002227479,0.00012149903,0.9983047,0.00001000792,0.000012919013,0.0009941969,0.00028365807,0.000043164033,0.000030125277,0.000007935163,0.00018626769,0.0000033005388],"about_ca_topic_score_codex":0.0114249615,"about_ca_topic_score_gemma":0.009654648,"teacher_disagreement_score":0.0114249615,"about_ca_system_score_codex":0.0006399494,"about_ca_system_score_gemma":0.0005363403,"threshold_uncertainty_score":0.02271694},"labels":[],"label_agreement":null},{"id":"W4386597720","doi":"10.1016/j.jhepr.2023.100904","title":"Multiple ammonia-induced episodes of hepatic encephalopathy provoke neuronal cell loss in bile-duct ligated rats","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal; Université de Montréal","funders":"Canadian Institutes of Health Research","keywords":"Hepatic encephalopathy; Oxidative stress; Internal medicine; Righting reflex; Endocrinology; Proinflammatory cytokine; Hippocampus; Hyperammonemia; Medicine; Encephalopathy; Pathology; Inflammation; Reflex","score_opus":0.01743909350003489,"score_gpt":0.2572460670616742,"score_spread":0.2398069735616393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386597720","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967282,0.00080872874,0.00083998375,0.000095176045,0.000085080035,0.00005761158,0.00036764515,0.00008272469,0.00093491876],"genre_scores_gemma":[0.99323165,0.0010232155,0.0014379479,0.00009348315,0.000029647195,0.00020688602,0.00047831426,0.00001547373,0.0034835427],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99968076,0.000031272208,0.00004376783,0.00005649849,0.00006766758,0.00012005162],"domain_scores_gemma":[0.9995347,0.000024586388,0.000150815,0.000042372143,0.00005221315,0.00019531825],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002695529,0.00077970437,0.00062684686,0.0008981075,0.00031120778,0.00030818436,0.00030070753,0.00056115934,0.002323543],"category_scores_gemma":[0.0001631528,0.0003581499,0.00059474545,0.00033655568,0.00069846364,0.00044798496,0.00038557127,0.0014096677,0.0003837949],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00600788,0.000930017,0.0032685485,0.00017407603,0.00004815383,0.00045248272,0.00016358825,0.00011069209,0.9857393,0.00009927212,0.00013672886,0.0028692337],"study_design_scores_gemma":[0.0002237535,0.01617107,0.044433814,0.000039829054,0.00010797756,0.00057050417,0.00057671044,0.0010922698,0.9353615,0.00017353019,0.001212463,0.00003662201],"about_ca_topic_score_codex":0.0015424187,"about_ca_topic_score_gemma":0.004683629,"teacher_disagreement_score":0.002323543,"about_ca_system_score_codex":0.00053677964,"about_ca_system_score_gemma":0.00046055103,"threshold_uncertainty_score":0.007772982},"labels":[],"label_agreement":null},{"id":"W4386989422","doi":"10.1016/j.jhepr.2023.100911","title":"Cardiomyopathy in cirrhosis: From pathophysiology to clinical care","year":2023,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Transjugular intrahepatic portosystemic shunt; Cirrhosis; Hepatorenal syndrome; Cardiology; Hyperdynamic circulation; Pathophysiology; Cardiomyopathy; Internal medicine; Heart failure; Liver disease; Ejection fraction; Portal hypertension; Intensive care medicine","score_opus":0.09798074427274693,"score_gpt":0.43468699937544253,"score_spread":0.3367062551026956,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386989422","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010962342,0.9880172,0.00046692055,0.00685582,0.00092638214,0.0000099670715,0.00003941012,0.000023069966,0.0025650037],"genre_scores_gemma":[0.013759524,0.97795326,0.0010182568,0.0029055085,0.003643341,0.000027854388,0.000115529445,0.000009370714,0.0005673244],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995555,0.00014038048,0.00009542364,0.000052525287,0.000108190725,0.000047905887],"domain_scores_gemma":[0.99926645,0.00031918506,0.000116951465,0.0000147308865,0.00018946291,0.00009320975],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008443861,0.0005495289,0.00077847834,0.0018653965,0.0003922012,0.0012000729,0.0006363322,0.0010472399,0.0015149724],"category_scores_gemma":[0.0021469442,0.00016226816,0.00030045104,0.0014516425,0.00089268875,0.0012435025,0.0009823336,0.0017810982,0.0006387743],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00011376767,0.000053765314,0.0055483757,0.01139477,0.00007828173,0.0037425298,0.000664608,0.0004262465,0.0010287677,0.009431325,0.0794721,0.8880455],"study_design_scores_gemma":[0.00007216676,0.00022510096,0.028890915,0.037270393,0.00021431815,0.049102657,0.0017858499,0.000653658,0.00058532035,0.019344004,0.8617075,0.00014809381],"about_ca_topic_score_codex":0.0017772805,"about_ca_topic_score_gemma":0.002062351,"teacher_disagreement_score":0.0018653965,"about_ca_system_score_codex":0.001026504,"about_ca_system_score_gemma":0.0016401082,"threshold_uncertainty_score":0.0074478984},"labels":[],"label_agreement":null},{"id":"W4387534095","doi":"10.1016/j.jhepr.2023.100928","title":"Marked difference in liver fat measured by histology vs. magnetic resonance-proton density fat fraction: A meta-analysis","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Novo Nordisk Fonden","keywords":"Steatosis; Histology; Nonalcoholic fatty liver disease; Fatty liver; Magnetic resonance imaging; Internal medicine; Pathology; Medicine; Chemistry; Gastroenterology; Radiology; Disease","score_opus":0.052701769997514546,"score_gpt":0.2842468748987557,"score_spread":0.23154510490124117,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387534095","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.060897898,0.9307411,0.003105763,0.0007932988,0.00041125354,0.00014458333,0.0029692175,0.00011108236,0.0008258984],"genre_scores_gemma":[0.88638353,0.105753854,0.002777858,0.0015248837,0.00040030593,0.00041806602,0.002095136,0.00013096374,0.00051547127],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9881902,0.005925336,0.0021355236,0.0024940076,0.0008144579,0.00044052216],"domain_scores_gemma":[0.96708596,0.026395172,0.002802801,0.0018827617,0.0014713363,0.00036191504],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.017371204,0.0020988411,0.009877612,0.0026908643,0.00079292664,0.0031988383,0.0018913903,0.002058478,0.0030402392],"category_scores_gemma":[0.032705627,0.0010703987,0.037525363,0.0043140016,0.00076418015,0.0012999579,0.0011935498,0.00214267,0.00039089852],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0051634433,0.000024639809,0.058303047,0.04673025,0.87813956,0.00029693107,0.00009208976,0.00092719187,0.00082987326,0.00017059824,0.0011772239,0.00814522],"study_design_scores_gemma":[0.00043423058,0.00017915311,0.025113013,0.0026094406,0.9695245,0.00015734426,0.000040015235,0.0004328435,0.00022315152,0.00026189393,0.0010009989,0.000023383613],"about_ca_topic_score_codex":0.005512972,"about_ca_topic_score_gemma":0.009202607,"teacher_disagreement_score":0.017371204,"about_ca_system_score_codex":0.001038544,"about_ca_system_score_gemma":0.0012881408,"threshold_uncertainty_score":0.09186882},"labels":[],"label_agreement":null},{"id":"W4388736488","doi":"10.1016/j.jhepr.2023.100965","title":"Transplant oncology – Current indications and strategies to advance the field","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Organ Transplantation Techniques and Outcomes","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Context (archaeology); Liver transplantation; Intensive care medicine; General surgery; Transplantation; Surgery; Oncology","score_opus":0.01750327538876078,"score_gpt":0.375293624284298,"score_spread":0.35779034889553724,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4388736488","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015357384,0.9327549,0.0035044432,0.03865587,0.003656603,0.000022264901,0.00004743589,0.00006430905,0.0197584],"genre_scores_gemma":[0.020581981,0.9521331,0.0047108363,0.011352353,0.0077985115,0.000054069347,0.00012188527,0.000036215693,0.0032110624],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991166,0.00032285322,0.00011287372,0.000076185184,0.000287064,0.000084408326],"domain_scores_gemma":[0.9978448,0.0010844229,0.00027394824,0.00009666987,0.0004310222,0.00026920644],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0031460344,0.0003881347,0.00037504671,0.0011887946,0.0004902801,0.002425498,0.0006036953,0.0013998456,0.0046231216],"category_scores_gemma":[0.0031327608,0.00011879636,0.00034173866,0.0007746724,0.0017463497,0.0028380947,0.0013212438,0.0030301274,0.0013740989],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008769052,0.000086632615,0.0013093585,0.0045055933,0.00003628117,0.0007886249,0.0004047353,0.0004773577,0.0017222499,0.07658017,0.065648936,0.84835243],"study_design_scores_gemma":[0.000009925745,0.00007675198,0.00076007843,0.0039443336,0.00002766589,0.0038462537,0.00033626254,0.00014081353,0.0005793878,0.021935452,0.96832186,0.00002123063],"about_ca_topic_score_codex":0.00028484905,"about_ca_topic_score_gemma":0.0006053344,"teacher_disagreement_score":0.0046231216,"about_ca_system_score_codex":0.0008691877,"about_ca_system_score_gemma":0.0024111518,"threshold_uncertainty_score":0.01663804},"labels":[],"label_agreement":null},{"id":"W4389166622","doi":"10.1016/j.jhepr.2023.100977","title":"Evolution of spontaneous portosystemic shunts over time and following aetiological intervention in patients with cirrhosis","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"European Social Fund; European Regional Development Fund; Instituto de Salud Carlos III; European Commission","keywords":"Cirrhosis; Medicine; Etiology; Intervention (counseling); Cardiology; Internal medicine; Psychiatry","score_opus":0.004369320110496301,"score_gpt":0.21893224146349796,"score_spread":0.21456292135300167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389166622","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995388,0.0002473693,0.000021844935,0.000014936342,0.000002763383,0.0000019648278,0.00004165918,0.000001064991,0.00012959674],"genre_scores_gemma":[0.99972826,0.000087070606,0.00002835725,0.000006016271,0.0000083223995,0.000002349929,0.000101768484,7.3173965e-7,0.00003708432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999671,0.00008254134,0.00004265225,0.000058895876,0.000051588904,0.000093312774],"domain_scores_gemma":[0.99850106,0.0002926423,0.0007666106,0.00007715418,0.0000856559,0.00027684416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0004635747,0.00019763979,0.00029239745,0.00067703746,0.00035833823,0.0006292489,0.00019323234,0.0003170064,0.0011354743],"category_scores_gemma":[0.0022530048,0.00016153624,0.00028285428,0.00073219073,0.0003081885,0.00043674678,0.0003953661,0.0003784746,0.00014949647],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023277554,0.000022219085,0.9981818,0.0000059395243,0.000013188261,0.0002009575,0.00004191868,0.000020680722,0.00006948205,0.000006010323,0.000019617159,0.0011854294],"study_design_scores_gemma":[0.000009036474,0.00015845514,0.998464,0.000004510369,0.000011665127,0.00095232204,0.00014574842,0.000097745185,0.00004579438,0.000022751492,0.00008483498,0.0000030924814],"about_ca_topic_score_codex":0.0011924267,"about_ca_topic_score_gemma":0.0014226333,"teacher_disagreement_score":0.0011924267,"about_ca_system_score_codex":0.00032093865,"about_ca_system_score_gemma":0.00025984558,"threshold_uncertainty_score":0.0037985444},"labels":[],"label_agreement":null},{"id":"W4389166630","doi":"10.1016/j.jhepr.2023.100975","title":"Safety, pharmacodynamics, and antiviral activity of selgantolimod in viremic patients with chronic hepatitis B virus infection","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre; University of Calgary; Toronto General Hospital; University of Toronto","funders":"Eisai; Gilead Sciences; Bristol-Myers Squibb","keywords":"Medicine; Internal medicine; HBeAg; Tenofovir alafenamide; Clinical endpoint; Pharmacodynamics; HBsAg; Adverse effect; Gastroenterology; Placebo; Hepatitis B virus; Viral load; Immunology; Clinical trial; Pharmacokinetics; Virus; Pathology","score_opus":0.008844287842600385,"score_gpt":0.2697018624479435,"score_spread":0.2608575746053431,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389166630","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99807906,0.0011312136,0.00009938123,0.0000689013,0.000011874061,0.00009671295,0.00008992648,0.000009869886,0.0004131432],"genre_scores_gemma":[0.998804,0.00028825374,0.00023648732,0.00014245934,0.000029975574,0.00010003643,0.00015722096,0.0000020567093,0.0002394055],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99955755,0.00024555583,0.00004267512,0.00004515475,0.00006355028,0.000045608052],"domain_scores_gemma":[0.9994368,0.00016345794,0.00019158417,0.000024566449,0.000037234193,0.0001462416],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013061819,0.00040105375,0.00066181825,0.00021632655,0.0002060968,0.00041618772,0.0001648583,0.00034129652,0.0012526606],"category_scores_gemma":[0.0010982706,0.00020841141,0.000489306,0.00015676412,0.00026808918,0.0003775778,0.00020879367,0.0005956449,0.00022213493],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.39190635,0.01874057,0.20745343,0.00083320483,0.0013699218,0.00038801387,0.00034243247,0.0026512763,0.08009871,0.00017193431,0.0015733697,0.29447076],"study_design_scores_gemma":[0.09716034,0.5628838,0.31922925,0.00009702227,0.0007777531,0.0009950309,0.00020637918,0.0031087243,0.011899878,0.00028435478,0.003306991,0.00005036292],"about_ca_topic_score_codex":0.00015543243,"about_ca_topic_score_gemma":0.00035689425,"teacher_disagreement_score":0.0013061819,"about_ca_system_score_codex":0.0002529484,"about_ca_system_score_gemma":0.00028837705,"threshold_uncertainty_score":0.0069078207},"labels":[],"label_agreement":null},{"id":"W4389978485","doi":"10.1016/j.jhepr.2023.100985","title":"Enhancing ACLF prediction by integrating sarcopenia assessment and frailty in liver transplant candidates on the waiting list","year":2023,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Sarcopenia; Medicine; Cirrhosis; Grip strength; Internal medicine; Malnutrition; Multivariate analysis; Physical therapy; Gerontology","score_opus":0.04033695668467189,"score_gpt":0.34255018510859553,"score_spread":0.3022132284239236,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4389978485","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9979662,0.00031060423,0.0009374947,0.00012560321,0.000007518519,0.000031976677,0.00012184602,0.000025587342,0.00047328486],"genre_scores_gemma":[0.9989095,0.000077031546,0.0007201265,0.000024145611,0.000014456968,0.000014814167,0.00014412182,0.000002074966,0.00009381307],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995629,0.00023466474,0.000038280028,0.00005199588,0.000047547714,0.00006464195],"domain_scores_gemma":[0.99837804,0.00062808,0.00046112714,0.00006271435,0.00017417516,0.00029597044],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001938108,0.00051198865,0.00047267711,0.00093327067,0.00025545026,0.0008995265,0.00022038205,0.00027926604,0.0019959433],"category_scores_gemma":[0.0041350243,0.0001809287,0.0005429467,0.00062731956,0.00016378048,0.0005311754,0.00074277463,0.00044801296,0.00029464206],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00018995104,0.000062278654,0.99054027,0.000015631853,0.000027637698,0.000023596709,0.000034859873,0.00030456795,0.00012064561,0.00001562397,0.00009767468,0.008567335],"study_design_scores_gemma":[0.00004704815,0.00082022423,0.9850181,0.00004232346,0.00009743195,0.00016627162,0.00016336072,0.012971312,0.00022479823,0.00014126074,0.00029361385,0.000014366594],"about_ca_topic_score_codex":0.002416028,"about_ca_topic_score_gemma":0.0050120484,"teacher_disagreement_score":0.002416028,"about_ca_system_score_codex":0.00021303273,"about_ca_system_score_gemma":0.00053875404,"threshold_uncertainty_score":0.0102497935},"labels":[],"label_agreement":null},{"id":"W4391037932","doi":"10.1016/j.jhepr.2024.101011","title":"Impact of age on NIS2+™ and other non-invasive blood tests for the evaluation of liver disease and detection of at-risk MASH","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; National Institute of Diabetes and Digestive and Kidney Diseases; Newcastle University; Shionogi; European Commission; Novo Nordisk; National Institute for Health and Care Research; Intercept Pharmaceuticals; Arrowhead Pharmaceuticals; Medpace; European Federation of Pharmaceutical Industries and Associations; Genentech; Valeant Pharmaceuticals International; LG Chem; CymaBay Therapeutics; Regeneron Pharmaceuticals; Alnylam Pharmaceuticals; Gilead Sciences; Amgen; National Heart, Lung, and Blood Institute; NGM Biopharmaceuticals; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Fibrosis; Internal medicine; Cohort; Confounding; Gastroenterology; Steatohepatitis; Liver biopsy; Liver disease; Fatty liver; Disease; Biopsy","score_opus":0.0335086251453721,"score_gpt":0.3358556132995721,"score_spread":0.30234698815419997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391037932","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99623173,0.0013242202,0.00068743975,0.000073150615,0.000036442736,0.000028246486,0.0003536855,0.00002229972,0.0012426764],"genre_scores_gemma":[0.99855274,0.00013359879,0.00047031036,0.000038342638,0.000035404646,0.000016526072,0.00036030865,0.0000044502276,0.00038830866],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981989,0.00084761967,0.00013248119,0.00035692638,0.00034442404,0.00011975038],"domain_scores_gemma":[0.9959643,0.0015990207,0.0013420214,0.00034570185,0.00039237348,0.00035655245],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004584077,0.0005519505,0.00057375635,0.0004292367,0.00018906622,0.0006747703,0.00025709148,0.00038323112,0.001343783],"category_scores_gemma":[0.004611463,0.00018310398,0.00087379676,0.00033963495,0.00020454297,0.0004379314,0.00047395958,0.0004645384,0.0003350935],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007626135,0.00012907882,0.9796902,0.000038283015,0.00042447087,0.000035082958,0.00002293298,0.0003488974,0.0012286087,0.000031083262,0.00016844076,0.010256875],"study_design_scores_gemma":[0.0001260442,0.0022727284,0.991903,0.000016467278,0.0005902519,0.00029416676,0.000032133863,0.0027785024,0.0013546564,0.000084393265,0.0005344348,0.00001316488],"about_ca_topic_score_codex":0.00045917192,"about_ca_topic_score_gemma":0.0012066925,"teacher_disagreement_score":0.004584077,"about_ca_system_score_codex":0.00022344364,"about_ca_system_score_gemma":0.00026831217,"threshold_uncertainty_score":0.024243176},"labels":[],"label_agreement":null},{"id":"W4391065196","doi":"10.1016/j.jhepr.2023.100999","title":"Long-term open-label vebicorvir for chronic HBV infection: Safety and off-treatment responses","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Society of Intestinal Research; Toronto Liver Centre; University of Toronto","funders":"Eisai; Celgene; Gilead Sciences; GlaxoSmithKline; Bristol-Myers Squibb","keywords":"Medicine; Clinical endpoint; Surrogate endpoint; Adverse effect; Internal medicine; Placebo; Pharmacodynamics; Gastroenterology; Clinical trial; Pharmacokinetics; Pathology","score_opus":0.0613409017301175,"score_gpt":0.3808454877862025,"score_spread":0.319504586056085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391065196","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9948396,0.0031083042,0.00032269862,0.00010000416,0.000026896048,0.00018444152,0.00026559024,0.000027353308,0.0011250384],"genre_scores_gemma":[0.9981036,0.0004347065,0.00018942301,0.0001342306,0.000058852005,0.000104490966,0.00044793598,0.000006580839,0.0005200417],"study_design_codex":"design_other","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.99920684,0.0003959261,0.000081123675,0.00007125769,0.00015001786,0.000094943905],"domain_scores_gemma":[0.9969728,0.0012034028,0.0009319294,0.00025623315,0.0002706256,0.00036507516],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002053209,0.00030337373,0.00068631757,0.00015027466,0.00017506069,0.00041681976,0.00027795805,0.0005728902,0.0025088394],"category_scores_gemma":[0.0022755144,0.000107942775,0.000543906,0.00012783753,0.0002648025,0.0004312743,0.00020522064,0.0013101383,0.00039084526],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.28599477,0.021504551,0.050744027,0.0013232912,0.0010716435,0.00039245997,0.00051603833,0.0013608033,0.0654476,0.00017542392,0.0020163162,0.569453],"study_design_scores_gemma":[0.0514824,0.6121464,0.2871444,0.00030990998,0.0008806163,0.00223884,0.00026423077,0.002790443,0.032253835,0.00033621266,0.010078788,0.00007401935],"about_ca_topic_score_codex":0.00016587437,"about_ca_topic_score_gemma":0.0002922924,"teacher_disagreement_score":0.0025088394,"about_ca_system_score_codex":0.00030815823,"about_ca_system_score_gemma":0.00029467102,"threshold_uncertainty_score":0.010858595},"labels":[],"label_agreement":null},{"id":"W4391066052","doi":"10.1016/j.jhepr.2024.101008","title":"Primary liver cancer classification from routine tumour biopsy using weakly supervised deep learning","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"AI in cancer detection","field":"Computer Science","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University","funders":"Assistance publique-Hôpitaux de Paris","keywords":"Artificial intelligence; Hepatocellular carcinoma; Liver cancer; Cluster analysis; Intrahepatic Cholangiocarcinoma; Computer science; Medicine; Cancer; Pathology; Biopsy; Convolutional neural network; Pattern recognition (psychology); Radiology; Internal medicine","score_opus":0.03249325826326052,"score_gpt":0.2709599125736169,"score_spread":0.23846665431035638,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391066052","genre_codex":"empirical","genre_gemma":"methods","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"methods","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8500809,0.0005960915,0.1450588,0.00013980885,0.00003610642,0.00017006356,0.0008780641,0.0012967852,0.0017432787],"genre_scores_gemma":[0.9742123,0.000087875014,0.023119438,0.00005016249,0.000018661289,0.00006927905,0.0017706986,0.000030293122,0.00064129505],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99926525,0.00016990649,0.00007587695,0.00022201781,0.00017153981,0.00009539419],"domain_scores_gemma":[0.9983342,0.0005088496,0.00027243485,0.00021349099,0.0005462097,0.00012481188],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014718847,0.00057254353,0.0005371353,0.0014592855,0.00026791517,0.0006846736,0.00078729674,0.0006597127,0.0009111293],"category_scores_gemma":[0.0025395197,0.00021235761,0.00064452074,0.000461623,0.00046180259,0.00043869912,0.00088505616,0.00041790179,0.00059755513],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027859244,0.0006554291,0.3688666,0.00060152466,0.00044146657,0.0009929219,0.000352244,0.10690321,0.07766456,0.00075733353,0.0046891533,0.43528956],"study_design_scores_gemma":[0.000032629407,0.00029764106,0.053090893,0.00004662737,0.000098686985,0.0005280316,0.000095002695,0.920624,0.022689154,0.001540261,0.0009296274,0.000027463173],"about_ca_topic_score_codex":0.0023900738,"about_ca_topic_score_gemma":0.004162687,"teacher_disagreement_score":0.0023900738,"about_ca_system_score_codex":0.0005559283,"about_ca_system_score_gemma":0.0006019997,"threshold_uncertainty_score":0.007784188},"labels":[],"label_agreement":null},{"id":"W4391255691","doi":"10.1016/j.jhepr.2024.101020","title":"Global and regional burden of alcohol-associated liver disease and alcohol use disorder in the elderly","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Alcohol Consumption and Health Effects","field":"Medicine","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"","keywords":"Alcohol use disorder; Medicine; Population; Alcoholic liver disease; Disease burden; Epidemiology; Burden of disease; Environmental health; Alcohol; Gerontology; Cirrhosis; Internal medicine","score_opus":0.07368375262630074,"score_gpt":0.3643857920519022,"score_spread":0.29070203942560147,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391255691","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.924504,0.03566908,0.0009467956,0.0036478231,0.00016311063,0.000057678833,0.026363181,0.000100594254,0.008547703],"genre_scores_gemma":[0.98380303,0.009665929,0.0006434188,0.0003372185,0.00010315712,0.000027467553,0.0048990124,0.0000063536622,0.0005143873],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99975866,0.00006770855,0.000038771588,0.000045038796,0.000041654675,0.000048146347],"domain_scores_gemma":[0.99928313,0.00003755561,0.0003623644,0.000032088996,0.00019766697,0.000087190434],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048946904,0.00022390214,0.0002504672,0.0010769833,0.00016780212,0.00046705548,0.00019052338,0.00019181134,0.0018438332],"category_scores_gemma":[0.00097224093,0.00008399997,0.00061809487,0.0014870699,0.00018741642,0.00038000717,0.0006824034,0.00025574077,0.00034601256],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000050828075,0.000011439486,0.97826743,0.00034986853,0.00033799355,0.00012250507,0.00018517923,0.00039328562,0.00028477143,0.0002737471,0.0037001302,0.016022855],"study_design_scores_gemma":[0.0000043362834,0.000029135525,0.99479866,0.00016141706,0.00016116619,0.00031332843,0.00043849263,0.0002318457,0.00005841062,0.00015485284,0.0036429674,0.000005310408],"about_ca_topic_score_codex":0.020798853,"about_ca_topic_score_gemma":0.02831147,"teacher_disagreement_score":0.020798853,"about_ca_system_score_codex":0.00056729076,"about_ca_system_score_gemma":0.0006489074,"threshold_uncertainty_score":0.04135561},"labels":[],"label_agreement":null},{"id":"W4391293858","doi":"10.1016/j.jhepr.2024.101021","title":"A phase Ib/II trial of capmatinib plus spartalizumab vs. spartalizumab alone in patients with pretreated hepatocellular carcinoma","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Novartis","keywords":"Hepatocellular carcinoma; Internal medicine; Medicine; Phase (matter); Gastroenterology; Oncology; Chemistry","score_opus":0.03161021835078301,"score_gpt":0.26121888789108116,"score_spread":0.22960866954029815,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391293858","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98934805,0.0031198189,0.00055298925,0.0011971355,0.00036775193,0.0019594275,0.0009965566,0.00015659288,0.0023017544],"genre_scores_gemma":[0.9927423,0.001056459,0.0009526612,0.0008329097,0.00021525472,0.0013132708,0.0011247455,0.000017943135,0.0017444356],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9995303,0.00024627076,0.000023028073,0.000082905535,0.00003512993,0.00008238235],"domain_scores_gemma":[0.9992273,0.00016520504,0.00015084786,0.00004962522,0.00004660511,0.0003605168],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018865723,0.0018398252,0.0019958587,0.00046333813,0.00029524267,0.0010452325,0.0007117474,0.0012167478,0.004813326],"category_scores_gemma":[0.0012793245,0.0005983396,0.0017590616,0.0003811202,0.00073576067,0.0009885771,0.00033721793,0.003305387,0.00081939076],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.92509615,0.018684208,0.0020522086,0.00055737566,0.001291588,0.000085410975,0.000077457145,0.002565246,0.0053433124,0.00016705712,0.0025500075,0.04153005],"study_design_scores_gemma":[0.82045406,0.17043503,0.0029412913,0.000028754343,0.00054707023,0.0000976676,0.000030225903,0.0032394775,0.0010538098,0.00020202625,0.0009508736,0.000019703666],"about_ca_topic_score_codex":0.0009984381,"about_ca_topic_score_gemma":0.0018558211,"teacher_disagreement_score":0.004813326,"about_ca_system_score_codex":0.0011854989,"about_ca_system_score_gemma":0.0014610181,"threshold_uncertainty_score":0.016102135},"labels":[],"label_agreement":null},{"id":"W4392723785","doi":"10.1016/j.jhepr.2024.101056","title":"Maternal obesity increases the risk of hepatocellular carcinoma through the transmission of an altered gut microbiome","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Stiftung Professor Dr. Max Cloëtta; Université de Genève; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Hepatocellular carcinoma; Microbiome; Gut microbiome; Transmission (telecommunications); Obesity; Medicine; Gut flora; Biology; Bioinformatics; Internal medicine; Immunology; Computer science","score_opus":0.00938645713190321,"score_gpt":0.24928992069549444,"score_spread":0.23990346356359124,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392723785","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967624,0.0007513917,0.0015524355,0.00016498165,0.000019501786,0.0000054013385,0.00020397827,0.000030395207,0.0005095189],"genre_scores_gemma":[0.99689996,0.00075546984,0.0013440677,0.00007354527,0.000012661787,0.000018094222,0.00014084051,0.000011580192,0.00074370485],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.9998111,0.000055461787,0.000010704775,0.00004559735,0.000042891283,0.000034201126],"domain_scores_gemma":[0.99962664,0.000036405298,0.00020934104,0.000035174584,0.000020523808,0.00007184497],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001804604,0.0002918385,0.00020823303,0.00026710896,0.00016272943,0.00029321932,0.00013985274,0.00025414428,0.0018656045],"category_scores_gemma":[0.00032928074,0.0001534488,0.00022483934,0.00015938416,0.00019814585,0.0001275711,0.00035426795,0.00045427092,0.00012603623],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020190114,0.0002487431,0.19333054,0.00017093874,0.00027231517,0.0008615689,0.00016919604,0.00019735796,0.7862445,0.0005679865,0.00041181842,0.015506064],"study_design_scores_gemma":[0.00004433511,0.0018099698,0.8907116,0.00008170908,0.0004604983,0.003228704,0.00038031169,0.0017677139,0.09663631,0.00065750047,0.0041922373,0.000029091398],"about_ca_topic_score_codex":0.0007020359,"about_ca_topic_score_gemma":0.0010982193,"teacher_disagreement_score":0.0018656045,"about_ca_system_score_codex":0.00024874657,"about_ca_system_score_gemma":0.0002446887,"threshold_uncertainty_score":0.0062410235},"labels":[],"label_agreement":null},{"id":"W4395085455","doi":"10.1016/j.jhepr.2024.101075","title":"Recurrence and tumor-related death after resection of hepatocellular carcinoma in patients with metabolic syndrome","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; McMaster University","funders":"National Cancer Institute","keywords":"Hepatocellular carcinoma; Metabolic syndrome; Medicine; Resection; Internal medicine; Oncology; Gastroenterology; Surgery; Obesity","score_opus":0.01739564781100721,"score_gpt":0.2195542655477571,"score_spread":0.20215861773674987,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4395085455","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994566,0.00020157464,0.0000761681,0.00004190087,0.0000028834854,0.0000020146967,0.00010176974,0.0000015093499,0.00011572355],"genre_scores_gemma":[0.9997497,0.000042661875,0.000039122162,0.000006375369,0.000004115883,0.000002132925,0.00012282794,3.870611e-7,0.000032563676],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996892,0.000117513104,0.00004029021,0.00004983706,0.000041109284,0.00006205653],"domain_scores_gemma":[0.9981774,0.00039579778,0.0010029718,0.00008096184,0.0001284607,0.00021429718],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006597498,0.00013544352,0.00018999747,0.0003707015,0.0002466598,0.00036278836,0.00020734881,0.000269013,0.001002585],"category_scores_gemma":[0.0027319256,0.0000968631,0.00053374446,0.0005019435,0.00012904145,0.00029379997,0.00035215766,0.00041585197,0.00008539836],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019819758,0.000013369366,0.9984097,0.000007318294,0.000029402972,0.00008108146,0.000024327195,0.00006976425,0.00004858111,0.000015351869,0.00003067229,0.001072386],"study_design_scores_gemma":[0.000009649029,0.00015938515,0.99803025,0.0000072371067,0.00004850558,0.0006683793,0.00013010138,0.0007101117,0.000072490686,0.00005924715,0.00009889062,0.000005713651],"about_ca_topic_score_codex":0.0022507687,"about_ca_topic_score_gemma":0.0029145014,"teacher_disagreement_score":0.0022507687,"about_ca_system_score_codex":0.00032170757,"about_ca_system_score_gemma":0.00032376844,"threshold_uncertainty_score":0.004475355},"labels":[],"label_agreement":null},{"id":"W4396900414","doi":"10.1016/j.jhepr.2024.101071","title":"Corrigendum to ‘Transplant oncology – Current indications and strategies to advance the field’ [JHEP Reports 6 (2024) 100965]","year":2024,"lang":"en","type":"erratum","venue":"JHEP Reports","topic":"Transplantation: Methods and Outcomes","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Current (fluid); Internal medicine; Medical physics; Oncology; Engineering","score_opus":0.02904277933730917,"score_gpt":0.3921160128786347,"score_spread":0.3630732335413255,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396900414","genre_codex":"editorial","genre_gemma":"other","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"other","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00014767208,0.0028543274,0.0008505736,0.13311812,0.8034982,0.00010422757,0.0030011975,0.0011750342,0.055250693],"genre_scores_gemma":[0.0043446487,0.010409599,0.0022436678,0.1794143,0.32273445,0.00028427405,0.0064253267,0.0022200886,0.4719237],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99562484,0.00065794465,0.0007149241,0.00037311952,0.0022150127,0.00041413386],"domain_scores_gemma":[0.9752263,0.0067809345,0.0018348893,0.0010871919,0.013368041,0.0017026982],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003490919,0.0010442303,0.0010015472,0.0028103536,0.0018482212,0.0050639925,0.0017485206,0.0038628369,0.259488],"category_scores_gemma":[0.045364946,0.0007011122,0.0011425818,0.00193741,0.0014447372,0.002319208,0.0019779566,0.0073288847,0.20068955],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005474967,0.0000025847587,0.000021090544,0.000034028693,0.0000010272767,0.000034536228,0.0000037451575,0.0000061924943,0.0000073482097,0.00022081453,0.99625885,0.0034041416],"study_design_scores_gemma":[0.000011809339,0.0000084394005,0.00025070316,0.0002406039,0.0000061063874,0.00021312117,0.000019459507,0.000024077272,0.00007229256,0.0005983242,0.9985447,0.000010446115],"about_ca_topic_score_codex":0.009205847,"about_ca_topic_score_gemma":0.009866328,"teacher_disagreement_score":0.259488,"about_ca_system_score_codex":0.002610695,"about_ca_system_score_gemma":0.004283631,"threshold_uncertainty_score":0.8680738},"labels":[],"label_agreement":null},{"id":"W4399366014","doi":"10.1016/j.jhepr.2024.101129","title":"Reply to: Correspondence on “Cardiomyopathy in cirrhosis: From pathophysiology to clinical care”","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Cirrhosis; Cardiology; Cardiomyopathy; Internal medicine; Heart failure","score_opus":0.019974811309292514,"score_gpt":0.3429103905674008,"score_spread":0.3229355792581083,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399366014","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019641957,0.0018852539,0.00011467809,0.94423985,0.052244738,0.000019720233,0.00011969274,0.00004590066,0.0011336512],"genre_scores_gemma":[0.0018081215,0.0015867471,0.00017096174,0.9406777,0.05108191,0.00003655406,0.00006918251,0.0000272941,0.004541624],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9981369,0.0005445148,0.00029901852,0.00029150012,0.00047901057,0.00024905286],"domain_scores_gemma":[0.9907693,0.004615665,0.0006041524,0.00022718242,0.0027491578,0.001034642],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024957305,0.0010005425,0.0012198478,0.00094734324,0.0017865883,0.0019095277,0.001750061,0.020328535,0.019290596],"category_scores_gemma":[0.027451629,0.0006399866,0.0013153407,0.0006086189,0.0019991458,0.00385313,0.0018809196,0.023144506,0.014885968],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003143604,0.0000065410354,0.00020716646,0.00005406729,0.000006006199,0.00023791584,0.00005199878,0.000017255632,0.000049106213,0.00046501833,0.9960188,0.0028546485],"study_design_scores_gemma":[0.00007339776,0.000054136224,0.00096301903,0.00045515096,0.000027004207,0.0023699033,0.00045058335,0.00016278446,0.00031455848,0.0026000447,0.9924584,0.00007108265],"about_ca_topic_score_codex":0.0030003237,"about_ca_topic_score_gemma":0.0026317602,"teacher_disagreement_score":0.020328535,"about_ca_system_score_codex":0.0018058746,"about_ca_system_score_gemma":0.0025540555,"threshold_uncertainty_score":0.06453347},"labels":[],"label_agreement":null},{"id":"W4399389397","doi":"10.1016/j.jhepr.2024.101132","title":"Incidence and prevalence of primary biliary cholangitis in the Netherlands – A nationwide cohort study","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre","funders":"Grifols; Ipsen; ZonMw; Vir Biotechnology; Amsterdam University Medical Centers; Intercept Pharmaceuticals; Gilead Sciences; GlaxoSmithKline","keywords":"Incidence (geometry); Medicine; Cohort; Population; Cohort study; Internal medicine; Pediatrics; Environmental health","score_opus":0.011974765544751612,"score_gpt":0.2785950898333813,"score_spread":0.2666203242886297,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399389397","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9950841,0.0005751919,0.00014329153,0.00009214455,0.000010014811,0.000035421508,0.0033901015,0.00000386204,0.0006658517],"genre_scores_gemma":[0.99507844,0.00060247787,0.00032255295,0.00005474165,0.000012199879,0.000062870335,0.003589419,0.0000059207987,0.00027145937],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991573,0.00019893877,0.00014217173,0.00026268812,0.00012936257,0.00010950386],"domain_scores_gemma":[0.9987533,0.00012945698,0.0005876272,0.0000954911,0.0002745656,0.00015947643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000987528,0.0001809154,0.00040064735,0.00096212036,0.00030178364,0.0008004405,0.00038465916,0.000333862,0.0007802102],"category_scores_gemma":[0.002006136,0.00049100595,0.00058885117,0.0016922777,0.0002272346,0.00062897697,0.0005890496,0.00031144582,0.00018843327],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000030564235,0.000014673973,0.99845195,0.000014990916,0.00008346594,0.00009444465,0.00008789468,0.000038834485,0.00006859831,0.000017294207,0.00030674014,0.0007906614],"study_design_scores_gemma":[0.000009891282,0.000023202954,0.9985985,0.000016746459,0.000035021185,0.0002974119,0.00024525216,0.00016608716,0.000019257528,0.000017806566,0.00056624215,0.000004536577],"about_ca_topic_score_codex":0.07399503,"about_ca_topic_score_gemma":0.07685253,"teacher_disagreement_score":0.07399503,"about_ca_system_score_codex":0.0011273227,"about_ca_system_score_gemma":0.00090429635,"threshold_uncertainty_score":0.14712864},"labels":[],"label_agreement":null},{"id":"W4400408647","doi":"10.1016/j.jhepr.2024.101168","title":"Loss of biochemical response at any time worsens outcomes in UDCA-treated patients with primary biliary cholangitis","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Alberta; Dalhousie University; University of British Columbia; University of Calgary; University of Ottawa; Western University; University of Toronto; Université de Sherbrooke; Queen's University; Toronto General Hospital; University Health Network; Université de Montréal; University of Saskatchewan; St. Michael's Hospital","funders":"Allergan; Grifols; Ipsen; Novo Nordisk; Swedish Orphan Biovitrum; European Association for the Study of the Liver; Vir Biotechnology; Intercept Pharmaceuticals; Pfizer; Incyte; Bristol-Myers Squibb; Dr. Falk Pharma; CSL Behring; Ultragenyx Pharmaceutical; Canadian Liver Foundation; Celgene; PSC Partners Seeking a Cure; Gilead Sciences; American Association for the Study of Liver Diseases; Kowa Company; Sanofi; Genesis Pharma; LifeArc; Falk Foundation","keywords":"Ursodeoxycholic acid; Medicine; Internal medicine; Liver transplantation; Primary biliary cirrhosis; Gastroenterology; Alkaline phosphatase; Liver disease; Cohort; Bilirubin; Transplantation; Biology","score_opus":0.00515738763793972,"score_gpt":0.23015237871998198,"score_spread":0.22499499108204227,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400408647","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9994524,0.0001837713,0.00005056681,0.00005689409,0.0000027823178,0.000003544241,0.00006720417,0.0000022765144,0.00018060258],"genre_scores_gemma":[0.9997701,0.000052678744,0.00003182246,0.000013644625,0.0000027015392,0.0000017314569,0.00009695195,6.234035e-7,0.000029737728],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995926,0.00013990946,0.000041639814,0.00007356599,0.000067729525,0.00008468913],"domain_scores_gemma":[0.9977646,0.0005219485,0.0011079062,0.00010553015,0.00014325132,0.0003567544],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009212032,0.00014740266,0.0002740891,0.0002885022,0.00037976867,0.0005703897,0.00026988616,0.00032509537,0.001176858],"category_scores_gemma":[0.0036629774,0.00017687901,0.0004656614,0.0004560791,0.00027777976,0.00025348435,0.000419297,0.000568002,0.00010031948],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015623972,0.000022582582,0.9985536,0.0000061825895,0.000023973555,0.000029010936,0.000027171349,0.00014075912,0.00004502335,0.00000921872,0.000047518006,0.00093884923],"study_design_scores_gemma":[0.000012587932,0.000116609415,0.9984308,0.0000114343575,0.000041496372,0.00018898123,0.00007932885,0.0009422866,0.00004797435,0.000052387884,0.00007244034,0.0000035627768],"about_ca_topic_score_codex":0.016245896,"about_ca_topic_score_gemma":0.022693083,"teacher_disagreement_score":0.016245896,"about_ca_system_score_codex":0.0008391496,"about_ca_system_score_gemma":0.0009796564,"threshold_uncertainty_score":0.032302678},"labels":[],"label_agreement":null},{"id":"W4401502546","doi":"10.1016/j.jhepr.2024.101183","title":"A novel multisite model to facilitate hepatitis C virus elimination in people experiencing homelessness","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Homelessness and Social Issues","field":"Health Professions","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Gilead Sciences; National Health Service Corps; Sussex Area Community Foundation","keywords":"Virology; Hepatitis C virus; Medicine; Psychology; Virus","score_opus":0.08672675441603818,"score_gpt":0.3989720492196257,"score_spread":0.31224529480358754,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401502546","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89705086,0.00039322127,0.07383169,0.004243492,0.00021831253,0.0045787995,0.0005171165,0.0013737145,0.017792776],"genre_scores_gemma":[0.9359317,0.00023191894,0.052214243,0.00063513336,0.00009425779,0.0018482582,0.00045442654,0.000040932566,0.00854906],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.99892175,0.00060612103,0.000038202863,0.000154589,0.00010441986,0.0001749544],"domain_scores_gemma":[0.9986325,0.00023319288,0.00016376967,0.00021642061,0.00015607201,0.0005980377],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0023341419,0.00037416338,0.00028719177,0.00042582472,0.0008817561,0.0011248057,0.0017565064,0.0007318154,0.013735097],"category_scores_gemma":[0.002901466,0.00022650886,0.00062328373,0.00035157785,0.0005668466,0.0013379514,0.0031112805,0.0007037487,0.001696445],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0070409547,0.044894658,0.12893158,0.0011128356,0.00033130316,0.0016171741,0.0057617035,0.03172478,0.012690313,0.01123106,0.026385037,0.72827864],"study_design_scores_gemma":[0.022144474,0.11910275,0.22684631,0.001136244,0.0013784191,0.0049641905,0.013114666,0.39182076,0.0097766565,0.03205656,0.17713939,0.00051960925],"about_ca_topic_score_codex":0.006141799,"about_ca_topic_score_gemma":0.010406708,"teacher_disagreement_score":0.013735097,"about_ca_system_score_codex":0.0011956568,"about_ca_system_score_gemma":0.003089432,"threshold_uncertainty_score":0.045948446},"labels":[],"label_agreement":null},{"id":"W4401821832","doi":"10.1016/j.jhepr.2024.101193","title":"Differential prevalence and prognostic value of metabolic syndrome components among patients with MASLD","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"Stichting voor Lever- en Maag-Darm Onderzoek","keywords":"Medicine; Internal medicine; National Health and Nutrition Examination Survey; Metabolic syndrome; Hypertriglyceridemia; Population; Diabetes mellitus; Obesity; Fatty liver; Disease; Endocrinology; Triglyceride; Cholesterol; Environmental health","score_opus":0.0066326780088731,"score_gpt":0.21899860921976935,"score_spread":0.21236593121089625,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401821832","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9993369,0.00019581405,0.00004635175,0.00003607066,0.000004978969,0.0000025518882,0.00012482182,0.0000022906192,0.0002501323],"genre_scores_gemma":[0.9996706,0.000048651327,0.00003950311,0.000009974967,0.000009510378,0.0000025583067,0.00016708742,8.453345e-7,0.00005116067],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997322,0.00006803297,0.000038544204,0.000070113296,0.000046204546,0.000044920544],"domain_scores_gemma":[0.9990625,0.00021734607,0.0003770587,0.000052555682,0.00009222772,0.00019835272],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000484241,0.00037020288,0.00033018328,0.000806033,0.0003223228,0.0006751357,0.00026674196,0.00044001927,0.0015779193],"category_scores_gemma":[0.0020487283,0.0001934779,0.00031305186,0.0007654852,0.0002581538,0.00049649854,0.00045345037,0.000572867,0.00021656904],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000079572776,0.000007443951,0.9993789,0.0000017844468,0.000011555901,0.000034254124,0.000015431391,0.0000125971355,0.00006436555,0.000005549047,0.000015905558,0.0003725502],"study_design_scores_gemma":[0.0000050799076,0.00005497645,0.999318,0.000003668634,0.000016215741,0.00025508425,0.00009508622,0.00015244781,0.000027898865,0.000026287558,0.000042886768,0.0000023916643],"about_ca_topic_score_codex":0.0013744358,"about_ca_topic_score_gemma":0.0019875944,"teacher_disagreement_score":0.0015779193,"about_ca_system_score_codex":0.00019543622,"about_ca_system_score_gemma":0.00019346314,"threshold_uncertainty_score":0.005278647},"labels":[],"label_agreement":null},{"id":"W4401823402","doi":"10.1016/j.jhepr.2024.101188","title":"Fecal deoxycholic acid associates with diet, intestinal microbes, and total bilirubin in primary sclerosing cholangitis","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Nutrition Society; Université Laval","funders":"Canadian Institutes of Health Research","keywords":"Deoxycholic acid; Primary sclerosing cholangitis; Feces; Gastroenterology; Internal medicine; Primary (astronomy); Microbiology; Bilirubin; Bile acid; Medicine; Chemistry; Food science; Biology; Disease","score_opus":0.009069113485443007,"score_gpt":0.23338089201275775,"score_spread":0.22431177852731474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401823402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9989502,0.0007546952,0.00004826494,0.000030697032,0.0000026256575,0.0000021065262,0.00005391306,0.0000034741743,0.00015404786],"genre_scores_gemma":[0.9996804,0.00013549105,0.000068941,0.000008923905,0.000004779247,0.0000017694905,0.00004526391,8.9826796e-7,0.00005358874],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99977964,0.00006937181,0.000035758825,0.000041822255,0.000039453655,0.000033977845],"domain_scores_gemma":[0.99904686,0.00018145223,0.0004907365,0.000039560284,0.00007921159,0.00016207623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00029318075,0.0002837689,0.0003996068,0.00074165955,0.00030862747,0.0004692115,0.00011920792,0.00027120503,0.0013023533],"category_scores_gemma":[0.0009770814,0.00017640993,0.00034257304,0.0009738801,0.0003542055,0.00019075151,0.00030589759,0.00031012288,0.0001503403],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030798733,0.000016551103,0.9974324,0.000012954069,0.00003542994,0.000079837126,0.000024244237,0.000023049293,0.00074816874,0.0000035821383,0.000017203185,0.0012986278],"study_design_scores_gemma":[0.0000040654845,0.00009515781,0.9991666,0.0000035310768,0.00003435257,0.0003550307,0.000046747526,0.00008646718,0.00014789667,0.000012784597,0.000046084173,0.000001385436],"about_ca_topic_score_codex":0.001893224,"about_ca_topic_score_gemma":0.002194166,"teacher_disagreement_score":0.001893224,"about_ca_system_score_codex":0.00023940661,"about_ca_system_score_gemma":0.00020636698,"threshold_uncertainty_score":0.004356861},"labels":[],"label_agreement":null},{"id":"W4402469356","doi":"10.1016/j.jhepr.2024.101216","title":"Tumor burden with AFP improves survival prediction for TACE-treated patients with HCC: An international observational study☆","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"National Key Research and Development Program of China","keywords":"Observational study; Internal medicine; Hepatocellular carcinoma; Medicine; Oncology; Overall survival","score_opus":0.0739277514550694,"score_gpt":0.28716219601485354,"score_spread":0.21323444455978413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402469356","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9986607,0.00017163857,0.00045042936,0.000086452244,0.000009656809,0.000011917974,0.00034586672,0.0000037249463,0.00025959223],"genre_scores_gemma":[0.9991736,0.00005994763,0.00015398255,0.000021620388,0.000014052149,0.000009013079,0.00048884243,0.0000020543944,0.00007679698],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99897385,0.0004944507,0.00007839643,0.00023452083,0.000110689616,0.00010825374],"domain_scores_gemma":[0.9965603,0.0010435855,0.0012497049,0.00049443496,0.00034189847,0.0003101025],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00323658,0.00045007508,0.00029612193,0.0004926658,0.00030777504,0.00063402817,0.00048074033,0.00041830094,0.0010678398],"category_scores_gemma":[0.006294511,0.0002583269,0.0009238067,0.0007249439,0.0003672834,0.0004851579,0.00061618176,0.0011285552,0.00020765945],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003749201,0.00009282831,0.9972474,0.000007127082,0.00013147542,0.00002880317,0.000054879547,0.00026134693,0.00006230183,0.000022804183,0.00018227528,0.0015337472],"study_design_scores_gemma":[0.000068860965,0.0004888502,0.9925224,0.000013421263,0.00033600925,0.00021742034,0.00019218007,0.005256693,0.00018822048,0.00013488843,0.0005674467,0.000013547443],"about_ca_topic_score_codex":0.004752515,"about_ca_topic_score_gemma":0.0046910774,"teacher_disagreement_score":0.004752515,"about_ca_system_score_codex":0.0004019446,"about_ca_system_score_gemma":0.0006322487,"threshold_uncertainty_score":0.017116845},"labels":[],"label_agreement":null},{"id":"W4403154199","doi":"10.1016/j.jhepr.2024.101231","title":"Progressive systemic inflammation precedes decompensation in compensated cirrhosis","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Instituto de Salud Carlos III; European Regional Development Fund; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas; Ministerio de Ciencia e Innovación","keywords":"Decompensation; Systemic inflammation; Cirrhosis; Inflammation; Medicine; Systemic circulation; Immunology; Intensive care medicine; Cardiology; Internal medicine","score_opus":0.010649512540929277,"score_gpt":0.28283360698341603,"score_spread":0.27218409444248676,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403154199","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99935263,0.00034969175,0.000070062146,0.000021537966,0.0000033905712,0.0000064756273,0.000043061125,0.0000023161676,0.00015083901],"genre_scores_gemma":[0.99980885,0.000033460823,0.00004558151,0.000007012813,0.0000070044175,0.0000025342397,0.000056782526,4.7456834e-7,0.000038221147],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9997267,0.000100696896,0.000023101034,0.00006037267,0.00003577484,0.00005334845],"domain_scores_gemma":[0.9979195,0.00033160372,0.0010097931,0.00008638776,0.00012391339,0.0005288613],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053443,0.00023264735,0.00034658733,0.00032971738,0.00028346526,0.0003470077,0.0001263379,0.0002535593,0.0017045594],"category_scores_gemma":[0.0013994911,0.00015138654,0.00027209078,0.00026423708,0.00027849947,0.00024879092,0.0003529662,0.00046758604,0.0001124757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0029071819,0.00006269054,0.9910693,0.000040383897,0.00004093294,0.0002288399,0.00006448296,0.000086832566,0.0026294675,0.000029405168,0.00005022197,0.002790232],"study_design_scores_gemma":[0.000028103817,0.00053668185,0.9985683,0.0000050401113,0.00002564596,0.0003370839,0.000035059726,0.000114793285,0.0002682254,0.000022857568,0.000055785516,0.000002294015],"about_ca_topic_score_codex":0.0006768642,"about_ca_topic_score_gemma":0.0011527884,"teacher_disagreement_score":0.0017045594,"about_ca_system_score_codex":0.00028955453,"about_ca_system_score_gemma":0.00037251832,"threshold_uncertainty_score":0.0057023764},"labels":[],"label_agreement":null},{"id":"W4403312140","doi":"10.1016/j.jhepr.2024.101232","title":"Second-line treatment patterns and outcomes in advanced HCC after progression on atezolizumab/bevacizumab","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital","funders":"European Association for the Study of the Liver; National Institute for Health and Care Research; NIHR Imperial Biomedical Research Centre; Cancer Research UK","keywords":"Atezolizumab; Bevacizumab; Oncology; Medicine; Internal medicine; Cancer; Nivolumab; Chemotherapy; Immunotherapy","score_opus":0.030543782792304238,"score_gpt":0.3042937490793094,"score_spread":0.27374996628700515,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403312140","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99958616,0.0001260634,0.000040674964,0.000020520316,0.0000016190165,0.000004217385,0.000088763365,0.000001577606,0.00013035566],"genre_scores_gemma":[0.9997396,0.000027103948,0.000020146574,0.0000081454955,0.0000033828842,0.0000034554068,0.00016783377,7.763267e-7,0.000029674298],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956757,0.00012139243,0.000060506452,0.00009531119,0.000067610374,0.000087667475],"domain_scores_gemma":[0.99712294,0.00032528225,0.0018703392,0.000115143055,0.00016149099,0.0004047068],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00071618595,0.00012877666,0.0002398359,0.00048679797,0.00019939481,0.0005265102,0.00022625957,0.00025967715,0.00093560596],"category_scores_gemma":[0.0022145123,0.00007726346,0.0003599337,0.0005790485,0.0002080211,0.00040730645,0.00036498182,0.0004358075,0.00011306012],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00035605775,0.00005368718,0.99684566,0.000008165784,0.000028974078,0.000079238416,0.000054587315,0.00008287975,0.00019189647,0.00001430597,0.000054631066,0.0022299318],"study_design_scores_gemma":[0.000020753558,0.00050567545,0.9980501,0.000007808955,0.000021757509,0.000516596,0.00016911066,0.00034974757,0.00017060566,0.000038521506,0.00014431911,0.0000050999197],"about_ca_topic_score_codex":0.0010791308,"about_ca_topic_score_gemma":0.001278671,"teacher_disagreement_score":0.0010791308,"about_ca_system_score_codex":0.0004032318,"about_ca_system_score_gemma":0.00030505972,"threshold_uncertainty_score":0.0037875772},"labels":[],"label_agreement":null},{"id":"W4404185764","doi":"10.1016/j.jhepr.2024.101263","title":"Comparative evaluation of multimarker algorithms for early-stage HCC detection in multicenter prospective studies","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Radiomics and Machine Learning in Medical Imaging","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital","funders":"Ipsen; Eisai; Bayer HealthCare; FibroGen; EA Pharma Co., Ltd.; Gilead Sciences; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Stage (stratigraphy); Algorithm; Oncology; Internal medicine; Medicine; Computer science; Biology","score_opus":0.0700108056272081,"score_gpt":0.43591009182488194,"score_spread":0.36589928619767387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404185764","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97878385,0.005830911,0.011517288,0.00036646484,0.00017071006,0.00066657487,0.0013127797,0.00019240896,0.0011590717],"genre_scores_gemma":[0.98557913,0.00045022485,0.011109785,0.00011162759,0.00009576539,0.00058878015,0.0018784532,0.000048564685,0.00013771198],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.90516454,0.076415695,0.005783907,0.007273911,0.004463913,0.0008980848],"domain_scores_gemma":[0.7473507,0.1938287,0.024766041,0.01820496,0.0125448285,0.0033048368],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.14029616,0.0013977634,0.002156327,0.0038595377,0.00065334555,0.0031834247,0.0019868293,0.0018896743,0.0014141721],"category_scores_gemma":[0.15653543,0.0008422883,0.002761734,0.0024575687,0.0007500155,0.002722124,0.0020584646,0.0008621156,0.0003118615],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.038051266,0.00058209384,0.9171878,0.0004457124,0.00781463,0.000054071512,0.0003503752,0.0041577904,0.00055910513,0.00056189264,0.00070475653,0.02953042],"study_design_scores_gemma":[0.008277259,0.021760046,0.87240356,0.0003492127,0.008336111,0.00080299505,0.0007755414,0.08015521,0.002330455,0.0016405362,0.0029535398,0.00021547369],"about_ca_topic_score_codex":0.00055083627,"about_ca_topic_score_gemma":0.0005922006,"teacher_disagreement_score":0.14029616,"about_ca_system_score_codex":0.00076781603,"about_ca_system_score_gemma":0.00090694893,"threshold_uncertainty_score":0.7419659},"labels":[],"label_agreement":null},{"id":"W4404289263","doi":"10.1016/j.jhepr.2024.101265","title":"Quo vadis autoimmune hepatitis? - Summary of the 5th international autoimmune hepatitis group research workshop 2024","year":2024,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"RWTH Aachen University; Deutsche Krebshilfe; Universitat de Barcelona; Medizinischen Hochschule Hannover; Università degli Studi di Milano-Bicocca; Deutsche Forschungsgemeinschaft; Yale University; National Institute for Health and Care Research; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas; Dipartimenti di Eccellenza; Falk Foundation","keywords":"Autoimmune hepatitis; Medicine; Hepatitis; Status quo; Group (periodic table); Virology; Immunology; Political science; Chemistry","score_opus":0.0830393063897963,"score_gpt":0.40301383828835297,"score_spread":0.3199745318985567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404289263","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00017867672,0.9675322,0.00021983273,0.010735828,0.016277542,0.000081999904,0.0003599785,0.000033199052,0.0045807115],"genre_scores_gemma":[0.0011303317,0.96837336,0.00060191716,0.011893259,0.0066985837,0.000114502844,0.0008573426,0.000018016755,0.010312703],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9996877,0.00006202786,0.000049369093,0.000042047912,0.00010652096,0.000052420928],"domain_scores_gemma":[0.9989742,0.00036563416,0.00013115532,0.000021580729,0.00035163082,0.0001558752],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0020567314,0.0008941111,0.0013419535,0.0020643852,0.00034468083,0.00160177,0.0010153537,0.002107688,0.019681906],"category_scores_gemma":[0.0020732682,0.00028163558,0.0012739107,0.0014865715,0.00026962796,0.0017934813,0.0012560873,0.002893612,0.007844461],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026748393,0.00007031524,0.00016432362,0.019909108,0.00013319534,0.00016088749,0.00005208911,0.00014150985,0.00082929264,0.002751592,0.47916868,0.49635148],"study_design_scores_gemma":[0.00004808732,0.00008562148,0.00058968744,0.010835163,0.0001882937,0.00029108208,0.000054007745,0.00003703507,0.00020321753,0.0009907995,0.9866616,0.00001535955],"about_ca_topic_score_codex":0.0013027274,"about_ca_topic_score_gemma":0.003539872,"teacher_disagreement_score":0.019681906,"about_ca_system_score_codex":0.0010630611,"about_ca_system_score_gemma":0.0023609013,"threshold_uncertainty_score":0.06584251},"labels":[],"label_agreement":null},{"id":"W4404353474","doi":"10.1016/j.jhepr.2024.101271","title":"Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":94,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Royal Victoria Hospital; University of Alberta Hospital; University of Alberta; McGill University Health Centre; Royal Victoria Regional Health Centre","funders":"Natural Science Basic Research Program of Shaanxi Province; Scientific Research Plan Projects of Shaanxi Education Department; College of Medicine, Seoul National University; Alnylam Pharmaceuticals; AstraZeneca; Genentech; LG Chem; Ipsen; National Key Research and Development Program of China; Sun Pharma; Key Science and Technology Program of Shaanxi Province; Siemens Healthineers; Yakult Bio-Science Foundation; Intercept Pharmaceuticals; Assistance publique-Hôpitaux de Paris; Education Department of Shaanxi Province; Universidade de Lisboa; Universidad Nacional Autónoma de México; Faculty of Medicine, Chulalongkorn University; National and Kapodistrian University of Athens; Daewoong Pharmaceutical Company; Universiti Malaya; Novo Nordisk; Helwan University; Yonsei University; Eisai; National Natural Science Foundation of China; Pfizer; Consejo Nacional de Investigaciones Científicas y Técnicas; Institut National de la Santé et de la Recherche Médicale; Royal College of Surgeons in Ireland; Universidad de Sevilla; Chulalongkorn University; McGill University Health Centre; Regeneron Pharmaceuticals; Bristol-Myers Squibb; Chinese University of Hong Kong; Eli Lilly and Company; CSL Behring; Yonsei University College of Medicine; McGill University; Universitas Indonesia; Amsterdam University Medical Centers; Gilead Sciences; Seoul National University; Inventiva Pharma; Kowa Company; Sanofi","keywords":"Burden of disease; Medicine; Disease; Liver dysfunction; Intensive care medicine; Environmental health; Internal medicine","score_opus":0.011524808326253818,"score_gpt":0.2642028400749321,"score_spread":0.2526780317486783,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404353474","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.49882835,0.09691823,0.0058569,0.018868783,0.0021471714,0.00036330006,0.3490119,0.0007141444,0.027291164],"genre_scores_gemma":[0.8337317,0.027497955,0.0050019436,0.0031883616,0.0006079506,0.0003622995,0.1264926,0.00005150642,0.0030657556],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.999516,0.00011787793,0.00006155524,0.00008163616,0.00010760221,0.00011527332],"domain_scores_gemma":[0.9991722,0.00006174199,0.00029404176,0.000027875272,0.00033391605,0.00011020721],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018886917,0.0007886551,0.00046139382,0.0014732154,0.0002175075,0.0010408334,0.00047569125,0.0006614784,0.0025426974],"category_scores_gemma":[0.0022548812,0.00018361607,0.0013890271,0.0020201297,0.00022163415,0.0010087875,0.00085772004,0.00079885975,0.0009826757],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00051971816,0.00007713437,0.84528315,0.002242533,0.00126984,0.00040227573,0.0003147775,0.0049197082,0.0006817306,0.0018458135,0.05954443,0.082898915],"study_design_scores_gemma":[0.00006036841,0.00020367694,0.9390579,0.0015667113,0.0007211904,0.0009008238,0.0007662681,0.0034850936,0.0003317,0.0009325936,0.05193081,0.00004282456],"about_ca_topic_score_codex":0.030568177,"about_ca_topic_score_gemma":0.034033604,"teacher_disagreement_score":0.030568177,"about_ca_system_score_codex":0.0016728226,"about_ca_system_score_gemma":0.0024015354,"threshold_uncertainty_score":0.060780525},"labels":[],"label_agreement":null},{"id":"W4404844276","doi":"10.1016/j.jhepr.2024.101290","title":"Recent advances in systemic therapy for advanced biliary tract cancer: A systematic review and meta-analysis using reconstructed RCT survival data","year":2024,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Biliary tract cancer; Meta-analysis; Randomized controlled trial; Medicine; Systemic therapy; Oncology; Internal medicine; Biliary tract; Overall survival; Cancer; Gemcitabine; Breast cancer","score_opus":0.2097868775859035,"score_gpt":0.44038850796007784,"score_spread":0.23060163037417433,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404844276","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.008869884,0.9870473,0.0015424847,0.0003007582,0.00016015749,0.00033594872,0.0013280753,0.000039495535,0.00037585382],"genre_scores_gemma":[0.39748558,0.590237,0.005424015,0.001491853,0.00027484883,0.0020706642,0.0024019026,0.00008418516,0.0005299561],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9832667,0.009685899,0.0042263037,0.001409222,0.0010481767,0.00036379008],"domain_scores_gemma":[0.96771485,0.0253534,0.004120372,0.0010556217,0.0014616355,0.00029414904],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.020162212,0.0024724198,0.0144031085,0.007107781,0.0004738085,0.0029417595,0.0019042885,0.0016660675,0.0038621984],"category_scores_gemma":[0.042574525,0.0014115322,0.037679985,0.008351824,0.0006764135,0.0018209057,0.0016030113,0.0019411368,0.00042481069],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013995833,0.000016743119,0.0034618224,0.22154701,0.7661552,0.00009875243,0.00006790347,0.00065451796,0.00013482111,0.00017228299,0.00039956538,0.0058917576],"study_design_scores_gemma":[0.0005270066,0.00012975065,0.002391062,0.014823142,0.9800514,0.0000643503,0.00003852718,0.00024761184,0.000068487934,0.00024098718,0.0014002412,0.000017412707],"about_ca_topic_score_codex":0.007038629,"about_ca_topic_score_gemma":0.013645805,"teacher_disagreement_score":0.020162212,"about_ca_system_score_codex":0.0021823603,"about_ca_system_score_gemma":0.0031482694,"threshold_uncertainty_score":0.10662925},"labels":[],"label_agreement":null},{"id":"W4404885936","doi":"10.1016/j.jhepr.2024.101272","title":"Primary sclerosing cholangitis–inflammatory bowel disease: Epidemiology, mortality, and impact of diagnostic sequence","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; SickKids Foundation; University of Toronto; Toronto General Hospital; Queen's University; Women's College Hospital; Public Health Ontario","funders":"University Health Network Foundation; Canadian Institutes of Health Research; PSC Partners Seeking a Cure","keywords":"Primary sclerosing cholangitis; Inflammatory bowel disease; Epidemiology; Medicine; Sequence (biology); Disease; Internal medicine; Gastroenterology; Biology","score_opus":0.07122271235830462,"score_gpt":0.36948930689861803,"score_spread":0.2982665945403134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404885936","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9875613,0.00790592,0.0003559435,0.00057018106,0.000020428415,0.000023913957,0.0020304718,0.000013016955,0.0015188204],"genre_scores_gemma":[0.99748635,0.0012707618,0.00016643766,0.00004668458,0.000025736499,0.000006338228,0.0009052516,0.0000019903837,0.00009047428],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986981,0.00043704777,0.00013474729,0.00019657942,0.00035452662,0.00017891303],"domain_scores_gemma":[0.99670947,0.00050198345,0.0018571722,0.00014217106,0.0005294601,0.00025973466],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013117965,0.00023801555,0.00025005368,0.00092983135,0.00023588423,0.00056726515,0.00027599788,0.00022543053,0.0011119022],"category_scores_gemma":[0.00396603,0.000112522896,0.00039295305,0.0020651587,0.0003666184,0.0002961976,0.00044646725,0.0003280578,0.00014768573],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005828408,0.0000065240997,0.9962768,0.00004846027,0.00007713091,0.00004538532,0.000032157364,0.00006960798,0.00007061634,0.00003340401,0.00016005921,0.0031215046],"study_design_scores_gemma":[0.000002575228,0.00002541509,0.99922717,0.00002391795,0.000027479711,0.00021809767,0.00005120635,0.00010702651,0.000026182941,0.000031273346,0.00025785805,0.0000018196466],"about_ca_topic_score_codex":0.06665928,"about_ca_topic_score_gemma":0.079180345,"teacher_disagreement_score":0.06665928,"about_ca_system_score_codex":0.001068939,"about_ca_system_score_gemma":0.0015331892,"threshold_uncertainty_score":0.13254255},"labels":[],"label_agreement":null},{"id":"W4405259999","doi":"10.1016/j.jhepr.2024.101300","title":"Non-invasive assessment of portal hypertension: Liver stiffness and beyond","year":2024,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Ludwig Boltzmann Gesellschaft; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Portal hypertension; Medicine; Internal medicine; Cardiology; Cirrhosis","score_opus":0.03439928864060379,"score_gpt":0.3336309422470708,"score_spread":0.299231653606467,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405259999","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00006330198,0.9989298,0.00005277581,0.00026666667,0.00015970325,0.000004655155,0.000018625931,0.0000031837872,0.0005012729],"genre_scores_gemma":[0.0006551315,0.9984345,0.00013385268,0.00024932582,0.0002604148,0.0000067036403,0.00003938652,0.0000013765153,0.00021935775],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995047,0.00012044397,0.00012842426,0.0000586012,0.00015531038,0.000032603886],"domain_scores_gemma":[0.9981224,0.0012326962,0.00022337792,0.000039107457,0.00032535254,0.000057103458],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0011088564,0.00072284427,0.0020200277,0.0035812927,0.00021518154,0.0013847656,0.0007679485,0.0010858197,0.0044141747],"category_scores_gemma":[0.0031531113,0.00026544888,0.0010287719,0.0023413172,0.00053471857,0.0013661225,0.0006721613,0.001465782,0.0015816551],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010478882,0.0000413182,0.0004908991,0.041317515,0.00028132595,0.00023532852,0.00007387419,0.00016187193,0.00044046526,0.0017218504,0.025680209,0.9294505],"study_design_scores_gemma":[0.000055844415,0.0001338089,0.00378049,0.046041433,0.0006809747,0.0051883273,0.0001476822,0.00014742906,0.00039760888,0.002587711,0.94079214,0.000046479625],"about_ca_topic_score_codex":0.0013370488,"about_ca_topic_score_gemma":0.0022536842,"teacher_disagreement_score":0.0044141747,"about_ca_system_score_codex":0.0004682667,"about_ca_system_score_gemma":0.0013745787,"threshold_uncertainty_score":0.014766872},"labels":[],"label_agreement":null},{"id":"W4405741174","doi":"10.1016/j.jhepr.2024.101311","title":"Modeling of hepatitis B virus kinetics and accumulation of cccDNA in primary human hepatocytes","year":2024,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Université du Québec à Montréal","funders":"National Institute of Allergy and Infectious Diseases; Japan Society for the Promotion of Science; National Institutes of Health; United States-Israel Binational Science Foundation; Japan Agency for Medical Research and Development","keywords":"cccDNA; Virology; Hepatitis B virus; Primary (astronomy); Kinetics; Virus; Biology; Chemistry; Physics; HBsAg","score_opus":0.06270405028205692,"score_gpt":0.3445699201040431,"score_spread":0.28186586982198614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4405741174","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.708941,0.0014922253,0.27437133,0.00047425038,0.00007128207,0.00014847735,0.0013133549,0.00048967794,0.012698379],"genre_scores_gemma":[0.9760657,0.0007476057,0.016595513,0.00005183805,0.000017458417,0.00020466051,0.0004237852,0.000054624114,0.0058388375],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998865,0.000024619965,0.000006172172,0.00002697198,0.000029636432,0.00002597095],"domain_scores_gemma":[0.99968266,0.00015623614,0.000057134228,0.000016906348,0.000067304274,0.0000197441],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00021676632,0.0005608986,0.0005080732,0.00028369477,0.00025944083,0.0005709009,0.00057081546,0.000941913,0.00095033064],"category_scores_gemma":[0.00066194375,0.00036145683,0.0009937572,0.00023903257,0.00027997812,0.00034216244,0.00033644354,0.00036430467,0.00028444527],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000039705243,0.000020857706,0.0011224009,0.000049619437,0.000014026871,0.00010333839,0.000025747282,0.9859605,0.010519854,0.0008460016,0.00008547687,0.0012125437],"study_design_scores_gemma":[0.000005021163,0.000021017702,0.00022552478,0.000002181105,0.0000063041325,0.000024927476,0.000005845931,0.9979955,0.001325685,0.00020222178,0.0001823736,0.0000034067093],"about_ca_topic_score_codex":0.015598569,"about_ca_topic_score_gemma":0.00518295,"teacher_disagreement_score":0.015598569,"about_ca_system_score_codex":0.00090544607,"about_ca_system_score_gemma":0.00079958816,"threshold_uncertainty_score":0.031015515},"labels":[],"label_agreement":null},{"id":"W4406283509","doi":"10.1016/j.jhepr.2024.101325","title":"Hemodynamic profile of terlipressin and octreotide in patients with cirrhosis and portal hypertension: a randomized, single-blind clinical trial","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Instituto de Salud Carlos III; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas; Agència de Gestió d'Ajuts Universitaris i de Recerca; Boston Scientific Corporation; Generalitat de Catalunya; European Commission; Mallinckrodt Pharmaceuticals","keywords":"Terlipressin; Octreotide; Portal hypertension; Medicine; Cirrhosis; Hemodynamics; Internal medicine; Portal venous pressure; Randomized controlled trial; Cardiology; Gastroenterology; Somatostatin; Hepatorenal syndrome","score_opus":0.015727796399592046,"score_gpt":0.2790695597728927,"score_spread":0.2633417633733007,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406283509","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9908404,0.0024992719,0.0006373231,0.00043147954,0.00036550514,0.0039250446,0.00039588276,0.00006197315,0.0008432409],"genre_scores_gemma":[0.98681265,0.0016976562,0.0018514931,0.0008312731,0.0007080111,0.0063164425,0.00047926168,0.000014451361,0.001288733],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99889344,0.00062301586,0.0000961651,0.00017342897,0.000081043174,0.00013281078],"domain_scores_gemma":[0.9984799,0.00039584676,0.0003594131,0.00013583481,0.00010380863,0.00052513945],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0024601698,0.0012615379,0.0038248068,0.00040870789,0.00041946353,0.0009975657,0.00064023427,0.0019028491,0.0046478226],"category_scores_gemma":[0.0022517124,0.0006785942,0.0013190027,0.00043880328,0.0013284297,0.0010673251,0.00039656536,0.0019305603,0.0007781701],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9856253,0.005609406,0.00036880784,0.00020482898,0.00023275353,0.000017834476,0.00001906246,0.000078458004,0.002150705,0.000027655315,0.00011690108,0.005548249],"study_design_scores_gemma":[0.9286276,0.069951564,0.00069447357,0.000010328252,0.00015669505,0.000014602471,0.000008781295,0.00014894846,0.00022012548,0.000029881598,0.00013042227,0.000006657421],"about_ca_topic_score_codex":0.00033335088,"about_ca_topic_score_gemma":0.0006356745,"teacher_disagreement_score":0.0046478226,"about_ca_system_score_codex":0.0004914899,"about_ca_system_score_gemma":0.001402278,"threshold_uncertainty_score":0.015548527},"labels":[],"label_agreement":null},{"id":"W4406980504","doi":"10.1016/j.jhepr.2025.101338","title":"Serum proteomics of adults with acute liver failure provides mechanistic insights and attractive prognostic biomarkers","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Deutsche Forschungsgemeinschaft","keywords":"Proteomics; Computational biology; Medicine; Liver failure; Bioinformatics; Intensive care medicine; Biology; Internal medicine; Genetics","score_opus":0.004320680443534701,"score_gpt":0.21839591755306287,"score_spread":0.21407523710952817,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406980504","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99645543,0.0018363071,0.0007852792,0.00014474825,0.000009806787,0.000011310236,0.00040335814,0.000023204442,0.0003305808],"genre_scores_gemma":[0.99787664,0.0004788761,0.0009099873,0.0000841988,0.00002598587,0.000008748666,0.0005194855,0.0000032121286,0.00009284738],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99982005,0.000035738656,0.00002557456,0.00005247409,0.000038951723,0.000027131242],"domain_scores_gemma":[0.9996532,0.00006349952,0.0001662556,0.000024949151,0.000050935694,0.000041200623],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00053671794,0.0005279872,0.0003671987,0.00072301825,0.00019792153,0.00044707372,0.0001451295,0.0003458401,0.0005522004],"category_scores_gemma":[0.000787586,0.00009344361,0.00026977298,0.00054581405,0.00020706154,0.0002811615,0.00040294457,0.00028483605,0.00018511592],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001169451,0.000080952144,0.92004687,0.00015191792,0.0001574458,0.00056282186,0.0001288153,0.0006280848,0.050077707,0.00010888824,0.000604676,0.026282465],"study_design_scores_gemma":[0.000034930927,0.00042593438,0.9845909,0.00003261443,0.000109481676,0.0016889722,0.0001420428,0.0021143549,0.0093818195,0.00035561484,0.0011138115,0.000009618592],"about_ca_topic_score_codex":0.00038264648,"about_ca_topic_score_gemma":0.00048377414,"teacher_disagreement_score":0.00072301825,"about_ca_system_score_codex":0.00021607813,"about_ca_system_score_gemma":0.00014765926,"threshold_uncertainty_score":0.0028384924},"labels":[],"label_agreement":null},{"id":"W4407588098","doi":"10.1016/j.jhepr.2025.101354","title":"Salsalate improves the anti-tumor efficacy of lenvatinib in MASH-driven hepatocellular carcinoma","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Cancer, Lipids, and Metabolism","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University; McMaster University Medical Centre","funders":"McMaster University; Canadian Institutes of Health Research; Hamilton Health Sciences","keywords":"Lenvatinib; Hepatocellular carcinoma; Medicine; Oncology; Internal medicine; Carcinoma; Sorafenib","score_opus":0.007376531883041114,"score_gpt":0.24222326125277627,"score_spread":0.23484672936973516,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407588098","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99443674,0.0028823232,0.0004922205,0.00024603624,0.00010386451,0.000053780135,0.00034123502,0.00016201677,0.00128174],"genre_scores_gemma":[0.99654466,0.0012803013,0.0004613669,0.00013785245,0.000023011393,0.00003336459,0.000548397,0.000018165738,0.00095282705],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99991393,0.000018173003,0.000008491657,0.000010154929,0.000023598313,0.00002565751],"domain_scores_gemma":[0.9999217,0.000009799656,0.000017434008,0.000007425532,0.000009046232,0.00003468268],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017151004,0.00036958573,0.00065075175,0.0003509441,0.00014495026,0.00033947296,0.00025447574,0.00022655487,0.0022669274],"category_scores_gemma":[0.00013061278,0.000111185815,0.0004369296,0.00021123663,0.00021491827,0.00021072326,0.00018125022,0.0009343802,0.00034701647],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012463692,0.0025491691,0.0014351888,0.00039664187,0.00018827106,0.00018337753,0.000045547484,0.0011180311,0.9265566,0.00014273696,0.0010812354,0.05383944],"study_design_scores_gemma":[0.0040595946,0.05129052,0.01662401,0.00004241188,0.0004134205,0.0006677453,0.00013897808,0.0045267544,0.9124313,0.00019666155,0.009574337,0.000034253517],"about_ca_topic_score_codex":0.00054822344,"about_ca_topic_score_gemma":0.0015543419,"teacher_disagreement_score":0.0022669274,"about_ca_system_score_codex":0.0003017825,"about_ca_system_score_gemma":0.00032262685,"threshold_uncertainty_score":0.0075835586},"labels":[],"label_agreement":null},{"id":"W4408303709","doi":"10.1016/j.jhepr.2025.101332","title":"Recurrence of autoimmune hepatitis cholestatic variant syndromes after liver transplantation affects graft and patient survival","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; University of Alberta","funders":"National Institute of Diabetes and Digestive and Kidney Diseases; Sir Jules Thorn Charitable Trust; European Association for the Study of the Liver; Canadian Institutes of Health Research; Canadian Liver Foundation; Medical Research Foundation; Medical Research Council; Soy Nutrition Institute; Queen Elizabeth Hospital Birmingham Charity","keywords":"Medicine; Cholestatic hepatitis; Liver transplantation; Autoimmune hepatitis; Transplantation; Hepatitis; Gastroenterology; Immunology; Internal medicine","score_opus":0.0076581597323133995,"score_gpt":0.24070584910694526,"score_spread":0.23304768937463186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4408303709","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991825,0.00045737874,0.00012407199,0.000040823124,0.000003943635,0.0000014240369,0.00003255892,0.000004161461,0.00015305527],"genre_scores_gemma":[0.9998061,0.00008768455,0.00002661283,0.000007838916,0.000010086026,8.38453e-7,0.000038186576,9.770067e-7,0.000021549527],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9995815,0.00016146347,0.000041235602,0.00006457266,0.000055529857,0.0000956653],"domain_scores_gemma":[0.9961259,0.0013167626,0.0017149157,0.00019693724,0.00014950338,0.00049593917],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010757718,0.00019916148,0.00034468606,0.00042824703,0.00022475728,0.00046765976,0.00022864484,0.0004080614,0.0013990033],"category_scores_gemma":[0.003628261,0.00013873266,0.0005928769,0.00042333096,0.00033046448,0.0003709099,0.00035673537,0.00043804038,0.00013878413],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026112783,0.000017979559,0.99636203,0.000007215563,0.000055893124,0.00014943162,0.000025302536,0.00023040408,0.00015904076,0.000021207012,0.000044702985,0.0026656804],"study_design_scores_gemma":[0.000011264487,0.00019565523,0.99663687,0.000010477859,0.00007313912,0.0015455582,0.000064504864,0.0011455895,0.00012114772,0.00010365972,0.000085101616,0.0000070527867],"about_ca_topic_score_codex":0.00080436026,"about_ca_topic_score_gemma":0.00072320015,"teacher_disagreement_score":0.0013990033,"about_ca_system_score_codex":0.00021571729,"about_ca_system_score_gemma":0.00020952159,"threshold_uncertainty_score":0.005689323},"labels":[],"label_agreement":null},{"id":"W4409670273","doi":"10.1016/j.jhepr.2025.101431","title":"Efficacy of atezolizumab plus bevacizumab for unresectable HCC: Systematic review and meta-analysis of real-world evidence","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Imperial Experimental Cancer Medicine Centre; European Association for the Study of the Liver; Associazione Italiana per la Ricerca sul Cancro; Foundation for Liver Research; National Institute for Health and Care Research; NIHR Imperial Biomedical Research Centre; Cancer Treatment and Research Trust; Cancer Research UK; Wellcome Trust; F. Hoffmann-La Roche; Roche","keywords":"Atezolizumab; Bevacizumab; Medicine; Internal medicine; Oncology; Nivolumab; Cancer; Chemotherapy","score_opus":0.15455715574314444,"score_gpt":0.3669817862430308,"score_spread":0.21242463049988636,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409670273","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0042135543,0.9939633,0.00052499876,0.00021796845,0.000119443466,0.00023334945,0.00047233552,0.000022694603,0.00023239538],"genre_scores_gemma":[0.1849499,0.80901676,0.0025126257,0.0009840503,0.00026615424,0.000976356,0.0009877731,0.0000354648,0.0002708958],"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99049044,0.004756546,0.0027171054,0.00087321305,0.0009109556,0.00025170404],"domain_scores_gemma":[0.98090935,0.013970126,0.0032202473,0.00047280453,0.0011874306,0.00024004573],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01387653,0.0025976507,0.017763818,0.006883279,0.00047961276,0.0031912876,0.0020398332,0.0019153293,0.0030908627],"category_scores_gemma":[0.03434138,0.0015308901,0.035005838,0.006400509,0.0007001184,0.0018547077,0.0014530101,0.0019471063,0.00029594978],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017144777,0.000024568235,0.0021388433,0.3216451,0.6629327,0.000073374205,0.000052998806,0.00057227083,0.00015698686,0.0001113625,0.00041800606,0.010159349],"study_design_scores_gemma":[0.0005022624,0.00015060027,0.0021185377,0.020617608,0.975022,0.00006384892,0.00002706198,0.0001678767,0.00007719901,0.00016586328,0.0010698986,0.000017234548],"about_ca_topic_score_codex":0.0062618232,"about_ca_topic_score_gemma":0.013812885,"teacher_disagreement_score":0.017763818,"about_ca_system_score_codex":0.0026597248,"about_ca_system_score_gemma":0.0034144402,"threshold_uncertainty_score":0.07338697},"labels":[],"label_agreement":null},{"id":"W4410221646","doi":"10.1016/j.jhepr.2025.101451","title":"SBRT for bridging and downstaging HCC before transplant","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Bridging (networking); Medicine; Oncology; Computer science","score_opus":0.025146067120193957,"score_gpt":0.26103194842607785,"score_spread":0.2358858813058839,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410221646","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94294834,0.048102077,0.0035748864,0.00071755727,0.00006912837,0.00010494757,0.00037403867,0.000051419283,0.0040576183],"genre_scores_gemma":[0.9910897,0.0071314904,0.00085385493,0.00018815091,0.000104319945,0.000026951744,0.00033815202,0.000008777782,0.0002586219],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.99975485,0.00009187923,0.000039599687,0.000023815199,0.00006156285,0.000028301376],"domain_scores_gemma":[0.99802643,0.000642973,0.0010037433,0.00009370636,0.00012880264,0.00010417772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009131025,0.000089881556,0.00025662177,0.00047882274,0.00012752597,0.00034270977,0.00014544897,0.00011227456,0.0012161065],"category_scores_gemma":[0.0015503826,0.0000416843,0.0004908686,0.00042993552,0.0001787612,0.00020482714,0.00019268406,0.00024071103,0.00018346347],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0024657785,0.00018364812,0.5553869,0.0019470836,0.00034961075,0.0024871584,0.00033493104,0.0012658411,0.009247949,0.0008328462,0.0024800054,0.4230182],"study_design_scores_gemma":[0.0003810419,0.00608282,0.8932189,0.0017775578,0.000974537,0.030751085,0.00061370793,0.003546912,0.02453396,0.0019414707,0.036145627,0.000032382308],"about_ca_topic_score_codex":0.00046092103,"about_ca_topic_score_gemma":0.0007886288,"teacher_disagreement_score":0.0012161065,"about_ca_system_score_codex":0.00037083123,"about_ca_system_score_gemma":0.00049485127,"threshold_uncertainty_score":0.0048289895},"labels":[],"label_agreement":null},{"id":"W4410708099","doi":"10.1016/j.jhepr.2025.101455","title":"Type II fibre atrophy and nuclear disruption in decompensated cirrhosis","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta Hospital; Alberta Hospital Edmonton; University of Alberta","funders":"Institute of Nutrition, Metabolism and Diabetes; Faculty of Medicine and Dentistry, University of Alberta; University Hospital Foundation; Canada Foundation for Innovation; Canadian Institutes of Health Research; Canadian Liver Foundation; University of Alberta; Canadian Association for the Study of the Liver; Canadian Donation and Transplantation Research Program","keywords":"Atrophy; Cirrhosis; Medicine; Internal medicine","score_opus":0.01631844964273129,"score_gpt":0.33084914662329834,"score_spread":0.31453069698056707,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410708099","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9991887,0.00041255186,0.00009001848,0.000036539823,0.000003451972,0.00000319395,0.000029202713,0.0000032288883,0.00023315907],"genre_scores_gemma":[0.9996649,0.00010432209,0.000089373636,0.000010780493,0.000007325629,0.0000016792625,0.000043005704,8.40375e-7,0.000077793105],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99990237,0.000027861399,0.0000116218935,0.000018437348,0.000020069347,0.000019673062],"domain_scores_gemma":[0.998946,0.0001722981,0.00059490063,0.000032882792,0.00007400816,0.0001799631],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00027508338,0.00023239195,0.0001554548,0.0006354789,0.00021160777,0.00023396712,0.00013592702,0.00023559427,0.0026025146],"category_scores_gemma":[0.000972765,0.00010308256,0.00012978284,0.00037785742,0.0003113054,0.00020721817,0.00027006946,0.00027228126,0.00021867282],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00020065373,0.000014497264,0.9953754,0.000016854352,0.000012649418,0.0003902412,0.00003325344,0.000044998294,0.0017507114,0.000010875857,0.000039983363,0.0021098708],"study_design_scores_gemma":[0.0000035229632,0.00009406712,0.9977477,0.0000066790626,0.000008185231,0.0016842603,0.00006105393,0.00009347886,0.00021259859,0.000026350608,0.000060932765,0.0000011717297],"about_ca_topic_score_codex":0.0010260268,"about_ca_topic_score_gemma":0.0017101811,"teacher_disagreement_score":0.0026025146,"about_ca_system_score_codex":0.0001730669,"about_ca_system_score_gemma":0.00018020025,"threshold_uncertainty_score":0.008706272},"labels":[],"label_agreement":null},{"id":"W4410893913","doi":"10.1016/j.jhepr.2025.101465","title":"Modelling the liver’s regenerative capacity across different clinical conditions","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver physiology and pathology","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Lunenfeld-Tanenbaum Research Institute; University of British Columbia; University Health Network","funders":"University Health Network; Scheme for Promotion of Academic and Research Collaboration; Hospital for Sick Children; Stem Cell Network; Natural Sciences and Engineering Research Council of Canada; University Health Network Foundation","keywords":"Regeneration (biology); Liver regeneration; Biology; Transcriptome; Fibrosis; Computational biology; Bioinformatics; Medicine; Pathology; Cell biology; Gene; Gene expression; Genetics","score_opus":0.10681498027195654,"score_gpt":0.3974263234288321,"score_spread":0.29061134315687553,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410893913","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89806956,0.000680781,0.09873525,0.00031541561,0.00001870976,0.00006970426,0.0007350202,0.00020382414,0.0011717832],"genre_scores_gemma":[0.98777395,0.00022363427,0.011001368,0.000045668596,0.0000051037914,0.00007082012,0.00031776383,0.000012950842,0.0005488464],"study_design_codex":"simulation_or_modeling","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.9998847,0.000036306505,0.000005596445,0.000033817636,0.000019807601,0.00001976763],"domain_scores_gemma":[0.9997423,0.0001341413,0.000064395965,0.00001693548,0.000020156162,0.000022085127],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005109822,0.00053312443,0.000234218,0.00035739425,0.000098667646,0.0005295486,0.0003370543,0.0005234852,0.0007418805],"category_scores_gemma":[0.0008617805,0.0001606184,0.0005581915,0.00018689799,0.0004073129,0.00032119884,0.00033737227,0.0004627476,0.0001357233],"study_design_candidate":"simulation_or_modeling","study_design_consensus":"simulation_or_modeling","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00044082708,0.00018128345,0.017632067,0.00015485307,0.000085825515,0.00018533343,0.00003816425,0.9199713,0.044961788,0.0013022568,0.0002915999,0.014754766],"study_design_scores_gemma":[0.000016092148,0.00025248833,0.005543802,0.000011867653,0.000029660067,0.000099066136,0.000024342415,0.98283964,0.009399653,0.0014257464,0.0003476227,0.00001002715],"about_ca_topic_score_codex":0.0024704824,"about_ca_topic_score_gemma":0.0021107432,"teacher_disagreement_score":0.0024704824,"about_ca_system_score_codex":0.000577989,"about_ca_system_score_gemma":0.0005850047,"threshold_uncertainty_score":0.0049121976},"labels":[],"label_agreement":null},{"id":"W4411103641","doi":"10.1016/j.jhepr.2025.101472","title":"Consistent improvements in liver histology across subgroups in a post hoc analysis of the SYNERGY-NASH trial with tirzepatide","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Genentech; Novartis Pharma; Bausch Health; Novo Nordisk; Intercept Pharmaceuticals; Jazz Pharmaceuticals; Regeneron Pharmaceuticals; Gilead Foundation; Alnylam Pharmaceuticals; Janssen Pharmaceuticals; Gilead Sciences; Medpace; Arrowhead Pharmaceuticals; GlaxoSmithKline; Amgen; NGM Biopharmaceuticals; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Post-hoc analysis; Post hoc; Histology; Medicine; Computer science; Internal medicine","score_opus":0.008694000275621356,"score_gpt":0.27642456383699926,"score_spread":0.2677305635613779,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411103641","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9960336,0.0020139348,0.0005691786,0.00014065544,0.000068414345,0.00023037009,0.00038283132,0.000022773647,0.0005382518],"genre_scores_gemma":[0.99843985,0.00019090416,0.00039766767,0.00010120208,0.00005220328,0.0001648829,0.0003884307,0.000008655385,0.000256154],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9915172,0.006077266,0.00056995125,0.0009319931,0.00047043388,0.0004331737],"domain_scores_gemma":[0.993789,0.0029118643,0.001375726,0.0010604028,0.00037121648,0.00049179065],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.012255796,0.0011704196,0.0028855954,0.00036464274,0.0002840986,0.0009266656,0.0004937377,0.0007531881,0.001500735],"category_scores_gemma":[0.0075413287,0.00047573596,0.0040731966,0.000334299,0.00064346084,0.00080929307,0.0005094711,0.0013323196,0.00022748367],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9085644,0.0010483772,0.04713563,0.00040229014,0.017158905,0.00016772858,0.00012710274,0.0008596528,0.009275123,0.0001051409,0.00068597135,0.014469537],"study_design_scores_gemma":[0.17457075,0.1955344,0.5722236,0.00014896574,0.03872565,0.0005650803,0.00035717,0.0058350516,0.008214518,0.00093716435,0.0026981635,0.00018961054],"about_ca_topic_score_codex":0.00030622352,"about_ca_topic_score_gemma":0.00093018176,"teacher_disagreement_score":0.012255796,"about_ca_system_score_codex":0.0003399137,"about_ca_system_score_gemma":0.0008636741,"threshold_uncertainty_score":0.06481564},"labels":[],"label_agreement":null},{"id":"W4411964743","doi":"10.1016/j.jhepr.2025.101508","title":"Genetic risk score correlates with immune profile and risk of HCC and cirrhosis development in Hispanics with MASLD","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Horizon 2020 Framework Programme; National Cancer Institute; Erasmus Universitair Medisch Centrum Rotterdam; Universidad San Francisco de Quito; Pontificia Universidad Católica de Chile; Fondo Nacional de Desarrollo Científico y Tecnológico; Universidad de Navarra; University of Toronto; Euskal Herriko Unibertsitatea; Stichting voor Lever- en Maag-Darm Onderzoek; University of Minnesota","keywords":"Cirrhosis; Internal medicine; Immune system; Medicine; Oncology; Hepatocellular carcinoma; Framingham Risk Score; Immunology; Disease","score_opus":0.004282798868604924,"score_gpt":0.20263247802064335,"score_spread":0.19834967915203844,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411964743","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9995241,0.00007554853,0.00004779085,0.000026826754,0.0000028856912,0.0000021861963,0.00006971243,0.0000017617787,0.00024927582],"genre_scores_gemma":[0.9996966,0.000033556636,0.000044883833,0.000012530986,0.000004500803,0.0000030664721,0.00008276875,0.0000015524126,0.00012065635],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998915,0.000031064945,0.000011040941,0.000030387344,0.00001585819,0.000020088659],"domain_scores_gemma":[0.99964595,0.000058716956,0.00015542672,0.000028667602,0.00004258477,0.000068727255],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022711697,0.00020188924,0.00019161793,0.0005069893,0.0002768956,0.0003811347,0.00010935091,0.00020773032,0.0024439192],"category_scores_gemma":[0.00088210654,0.00011638264,0.0002494044,0.0005463439,0.00019562861,0.00012456448,0.00022330371,0.00024126109,0.00016776788],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015800487,0.000021009553,0.99825376,0.0000039280912,0.00003584403,0.00008677023,0.000044519405,0.00002447016,0.0004933882,0.000019440577,0.000047831363,0.0008109941],"study_design_scores_gemma":[0.0000113025035,0.000067403336,0.9985329,0.00000716882,0.000046130725,0.00041306918,0.00025995928,0.00032041967,0.00011228903,0.000071320006,0.0001554823,0.0000025647018],"about_ca_topic_score_codex":0.002627622,"about_ca_topic_score_gemma":0.0021814217,"teacher_disagreement_score":0.002627622,"about_ca_system_score_codex":0.00013154745,"about_ca_system_score_gemma":0.00015847731,"threshold_uncertainty_score":0.008175671},"labels":[],"label_agreement":null},{"id":"W4412049501","doi":"10.1016/j.jhepr.2025.101510","title":"Improving risk stratification and detection of early HCC using ultrasound-based deep learning models","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; McGill University Health Centre","funders":"Centre Hospitalier Régional Universitaire de Montpellier; Centre National de la Recherche Scientifique; Eisai; Université de Strasbourg; Assistance publique-Hôpitaux de Paris; AstraZeneca; Agence Nationale de la Recherche; Institut National de la Santé et de la Recherche Médicale; European Commission; Bristol-Myers Squibb","keywords":"Risk stratification; Ultrasound; Artificial intelligence; Deep learning; Medicine; Computer science; Radiology; Internal medicine","score_opus":0.03914402113417043,"score_gpt":0.24861898286194228,"score_spread":0.20947496172777186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412049501","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9215081,0.0004781648,0.07614958,0.00045803285,0.000026037873,0.000082090926,0.00026296242,0.00027978647,0.00075526215],"genre_scores_gemma":[0.9849598,0.00010185017,0.014135325,0.00009888617,0.00001737029,0.00004296376,0.00030556027,0.000008164741,0.00033003232],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99956316,0.00021056792,0.0000262726,0.000092283524,0.000045402347,0.000062369436],"domain_scores_gemma":[0.99888223,0.00063614146,0.00016105533,0.000067252244,0.0001738042,0.00007935927],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0018650513,0.0006956769,0.00056093663,0.0005738728,0.0001495532,0.00048079604,0.0004604845,0.0005154467,0.000682077],"category_scores_gemma":[0.003432216,0.00022510083,0.00059099816,0.00023437147,0.00022205486,0.0004548058,0.00062459975,0.0006031107,0.00021429642],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0017501495,0.0015513512,0.46660557,0.00013588017,0.00059298787,0.0001281857,0.000104205,0.28349593,0.0092622405,0.00062188914,0.0018641644,0.23388745],"study_design_scores_gemma":[0.0000717295,0.00069839595,0.026307119,0.000020933243,0.000119794364,0.00008005728,0.000025349065,0.96912956,0.0024488396,0.0008507474,0.00023087864,0.000016611977],"about_ca_topic_score_codex":0.0029096345,"about_ca_topic_score_gemma":0.0035206538,"teacher_disagreement_score":0.0029096345,"about_ca_system_score_codex":0.0005543113,"about_ca_system_score_gemma":0.00076566066,"threshold_uncertainty_score":0.009863436},"labels":[],"label_agreement":null},{"id":"W4413384329","doi":"10.1016/j.jhepr.2025.101560","title":"Persistent risk of hepatocellular carcinoma despite improvement of liver stiffness in patients with chronic HBV with advanced fibrosis","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital","funders":"Stichting voor Lever- en Maag-Darm Onderzoek; Vlaamse regering; Faculty of Medicine, Prince of Songkla University; Ipsen; National and Kapodistrian University of Athens; Prince of Songkla University; Norgine; Fonds Wetenschappelijk Onderzoek; Chinese University of Hong Kong; Maastricht Universitair Medisch Centrum; Rijksuniversiteit Groningen; Janssen Pharmaceuticals; Amsterdam University Medical Centers; Gilead Sciences; University of Toronto; Amgen; Universiteit Maastricht; GlaxoSmithKline; Universitair Medisch Centrum Groningen; Bristol-Myers Squibb; Novo Nordisk; Abbott Laboratories","keywords":"Hepatocellular carcinoma; Medicine; Chronic hepatitis; Fibrosis; Liver fibrosis; Gastroenterology; Internal medicine; Carcinoma; Oncology; Immunology; Virus","score_opus":0.004282488972549752,"score_gpt":0.1985558713954053,"score_spread":0.19427338242285552,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413384329","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99924564,0.00029687415,0.000060859773,0.00006568435,0.0000066432153,0.0000027812143,0.000098182376,0.0000023925406,0.00022093943],"genre_scores_gemma":[0.99969983,0.00006461714,0.0000342246,0.00001723179,0.000017423445,0.0000021797018,0.000109933506,9.0798864e-7,0.000053580432],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99960226,0.0001142578,0.000038445585,0.00008849618,0.000056138193,0.00010044105],"domain_scores_gemma":[0.99760276,0.0003449551,0.0014332669,0.00017352447,0.00011110831,0.00033447015],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006647998,0.00024771562,0.0003611489,0.00038598743,0.0005455267,0.0006583447,0.000318935,0.00042129267,0.0014244547],"category_scores_gemma":[0.0021251088,0.00028578128,0.00043032382,0.0007385398,0.00032048736,0.0004720519,0.00039313253,0.0007912706,0.00015329802],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001375277,0.000012889534,0.9992035,0.0000031205916,0.0000151345785,0.00004219896,0.000016693952,0.000015235906,0.000069155976,0.000007504824,0.000025149704,0.00045196066],"study_design_scores_gemma":[0.000009339834,0.00009330713,0.9991159,0.000004213938,0.00002356226,0.00034147408,0.0000762563,0.0001906883,0.00003551287,0.000036205623,0.000071017705,0.0000026290024],"about_ca_topic_score_codex":0.002762837,"about_ca_topic_score_gemma":0.0029787759,"teacher_disagreement_score":0.002762837,"about_ca_system_score_codex":0.00024750954,"about_ca_system_score_gemma":0.00037452398,"threshold_uncertainty_score":0.0054935217},"labels":[],"label_agreement":null},{"id":"W4413788159","doi":"10.1016/j.jhepr.2025.101566","title":"Liver transplantation for HCC with macrovascular invasion: A systematic review and meta-analysis of observational studies","year":2025,"lang":"en","type":"review","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre; Toronto General Hospital; University Health Network","funders":"Incyte; Roche; AstraZeneca; Servier; MSD","keywords":"Liver transplantation; Observational study; Meta-analysis; Medicine; Internal medicine; Transplantation; Oncology","score_opus":0.3662705535403707,"score_gpt":0.38299568102747755,"score_spread":0.01672512748710686,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413788159","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0031322394,0.99542564,0.00034977793,0.00018401469,0.00008981092,0.00019126161,0.00046270198,0.000011417394,0.00015308357],"genre_scores_gemma":[0.08941633,0.9063664,0.001558757,0.00068720774,0.00018963071,0.00083406566,0.0007737726,0.000015424963,0.0001584043],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99281126,0.002925662,0.0025929422,0.00065152097,0.0007627934,0.0002558183],"domain_scores_gemma":[0.9803709,0.014287795,0.0032394254,0.00046105555,0.0014444783,0.00019645193],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01136883,0.0022292358,0.014603046,0.006408352,0.00062957464,0.0027059922,0.0017688762,0.0015697791,0.003046721],"category_scores_gemma":[0.028215077,0.0011192844,0.030058483,0.00807826,0.00057999964,0.0015843095,0.0014195978,0.0016505874,0.00022532565],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00095183915,0.000025538735,0.0047044586,0.62681633,0.35225818,0.00016092195,0.0001096548,0.00040644212,0.0001990808,0.00012920493,0.00076205656,0.013476252],"study_design_scores_gemma":[0.00030254817,0.00014136021,0.005523614,0.058018524,0.9330591,0.00014120057,0.000084616055,0.00016860166,0.00010700736,0.00021750451,0.002208205,0.000027746928],"about_ca_topic_score_codex":0.006850519,"about_ca_topic_score_gemma":0.016302655,"teacher_disagreement_score":0.014603046,"about_ca_system_score_codex":0.0023901488,"about_ca_system_score_gemma":0.0043914984,"threshold_uncertainty_score":0},"labels":[{"model":"gpt","categories":[],"domain":null,"study_design":"meta_analysis","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"grok","categories":["metaepi_broad"],"domain":null,"study_design":"meta_analysis","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"},{"model":"opus","categories":[],"domain":null,"study_design":"meta_analysis","genre":"review","about_ca_system":false,"about_ca_topic":false,"confidence":"high"}],"label_agreement":"split"},{"id":"W4413847639","doi":"10.1016/j.jhepr.2025.101570","title":"Time for a globally unified chronic HBV terminology?","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Liver Centre","funders":"Gilead Sciences; Grifols; GlaxoSmithKline","keywords":"Terminology; Virology; Medicine; Computer science; Linguistics; Philosophy","score_opus":0.015833899807558924,"score_gpt":0.305834603299202,"score_spread":0.29000070349164303,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413847639","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0028743793,0.02719797,0.026009725,0.9043356,0.030761512,0.00012280571,0.00032121091,0.00031452294,0.008062222],"genre_scores_gemma":[0.1248998,0.03407301,0.1301485,0.6730072,0.021687951,0.0013935211,0.0021477924,0.0023219807,0.0103202],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.91532993,0.04987158,0.012271804,0.006144554,0.012590791,0.0037913506],"domain_scores_gemma":[0.8890278,0.04558006,0.008114154,0.013320633,0.034705576,0.009251768],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.1106735,0.0016687964,0.003165204,0.004157598,0.0066765393,0.020071113,0.0061178384,0.011975459,0.007126056],"category_scores_gemma":[0.1511655,0.0012260922,0.0027091752,0.004762348,0.028767327,0.041658707,0.018782988,0.032906976,0.0051852614],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015719006,0.00007433918,0.0018400204,0.0021062628,0.00009026269,0.00047742817,0.034565974,0.00034844154,0.00094062346,0.5132901,0.3156006,0.13050868],"study_design_scores_gemma":[0.000049504248,0.0000963976,0.00095205195,0.0042046243,0.000056991103,0.0005796928,0.019056136,0.00034340058,0.00037397913,0.16284426,0.81130904,0.00013387324],"about_ca_topic_score_codex":0.0110485125,"about_ca_topic_score_gemma":0.0059602917,"teacher_disagreement_score":0.1106735,"about_ca_system_score_codex":0.013221535,"about_ca_system_score_gemma":0.034782164,"threshold_uncertainty_score":0.5853044},"labels":[],"label_agreement":null},{"id":"W4414440271","doi":"10.1016/j.jhepr.2025.101596","title":"Development of a CRE/CREB-driven HBx responsive HBV cell culture reporter system for antiviral drug evaluation","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"Gilead Sciences; GlaxoSmithKline","keywords":"HBx; cccDNA; Hepatitis B virus; Antiviral drug; Drug development; Cell culture; DNA; Chronic hepatitis","score_opus":0.023942647351603355,"score_gpt":0.3257353504875284,"score_spread":0.30179270313592504,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414440271","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.5118441,0.0051934887,0.4575518,0.0009943484,0.0007043902,0.002477805,0.008371341,0.0028416882,0.010021054],"genre_scores_gemma":[0.6434566,0.00460765,0.3153285,0.0004414121,0.000109042936,0.0034561807,0.012080707,0.00033763747,0.020182189],"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99933666,0.00010354537,0.000067213055,0.00013079228,0.0002848781,0.000076918004],"domain_scores_gemma":[0.99973565,0.000055561468,0.000051702573,0.000039466966,0.00008034034,0.000037308535],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007336029,0.0005854621,0.00070961966,0.0005298268,0.00028743583,0.000553664,0.0007471553,0.00074495975,0.0024827514],"category_scores_gemma":[0.00036686487,0.00039387547,0.0005857931,0.0003622696,0.0003532323,0.00041324933,0.0003041368,0.0013179303,0.0014614146],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006983319,0.000044529697,0.00006121327,0.0000844206,0.0000064120045,0.000024945022,0.000017339047,0.00012595006,0.9966009,0.00019813763,0.0001465903,0.0026197664],"study_design_scores_gemma":[0.00002436326,0.0001978049,0.00023780363,0.000008792447,0.000015149568,0.00010324286,0.000010149253,0.0014365506,0.9938975,0.000032723063,0.0040269145,0.000008994691],"about_ca_topic_score_codex":0.00074887037,"about_ca_topic_score_gemma":0.0011331367,"teacher_disagreement_score":0.0024827514,"about_ca_system_score_codex":0.00049120863,"about_ca_system_score_gemma":0.0004926975,"threshold_uncertainty_score":0.008305609},"labels":[],"label_agreement":null},{"id":"W4414979676","doi":"10.1016/j.jhepr.2025.101619","title":"From model to man: Understanding Tregs' dual role in MASLD","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University Health Network","funders":"Horizon 2020 Framework Programme; Bundesministerium für Bildung und Forschung; Deutsche Forschungsgemeinschaft","keywords":"Immune system; Complement (music); Steatohepatitis; Acquired immune system; Translation (biology); Dual (grammatical number); Constraint (computer-aided design); Complement system","score_opus":0.03497788461030359,"score_gpt":0.30180014939867816,"score_spread":0.26682226478837456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414979676","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.18847555,0.59153444,0.08598485,0.101538315,0.0054564252,0.00016531303,0.00074331963,0.00088848145,0.025213392],"genre_scores_gemma":[0.72160685,0.22171718,0.024792988,0.02055828,0.0029940403,0.00021812903,0.00030513387,0.00007958283,0.0077279196],"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","domain_scores_codex":[0.99974316,0.000103640945,0.000013897692,0.00005474525,0.000039609273,0.000044906472],"domain_scores_gemma":[0.9997496,0.00007681737,0.000035760004,0.000032198936,0.00003162974,0.00007405816],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012033193,0.0005644003,0.0006003481,0.0005389577,0.00038793293,0.0013504925,0.0006708177,0.0012258833,0.0019338634],"category_scores_gemma":[0.0005767013,0.0002142521,0.00037843364,0.00015830454,0.0016805601,0.0022291637,0.0008927436,0.003483532,0.00060984754],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022534053,0.0008380229,0.027714916,0.004106428,0.00029321425,0.0039577223,0.001902508,0.0026487617,0.41253796,0.14862327,0.034100942,0.3610228],"study_design_scores_gemma":[0.0003087423,0.0044713933,0.031295005,0.0035245188,0.00065071724,0.013524073,0.004399389,0.011102724,0.08976466,0.2795152,0.56120116,0.00024240058],"about_ca_topic_score_codex":0.00038100834,"about_ca_topic_score_gemma":0.0007251726,"teacher_disagreement_score":0.0019338634,"about_ca_system_score_codex":0.0007279595,"about_ca_system_score_gemma":0.0008793632,"threshold_uncertainty_score":0.0064694285},"labels":[],"label_agreement":null},{"id":"W4415069879","doi":"10.1016/j.jhepr.2025.101630","title":"Navigating second-line therapy after immunotherapy in advanced HCC☆","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital","funders":"","keywords":"Immunotherapy; Hepatocellular carcinoma; Clinical trial; Sorafenib; Disease; Systemic therapy; Tyrosine kinase; Therapeutic approach","score_opus":0.009116866115393253,"score_gpt":0.31641623419048914,"score_spread":0.3072993680750959,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415069879","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.021855036,0.9499396,0.009319511,0.008200978,0.0009820572,0.00018543086,0.00010221984,0.00007090873,0.009344359],"genre_scores_gemma":[0.24852918,0.719528,0.017082065,0.008405534,0.0019941449,0.000507513,0.0005521475,0.000052514126,0.0033488597],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99910575,0.00046874117,0.000112324844,0.00008922898,0.0001376439,0.00008626671],"domain_scores_gemma":[0.9981006,0.0012896237,0.0002858478,0.00006241201,0.00017883413,0.00008277574],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0036749633,0.00023804416,0.00087961834,0.00044553407,0.00021610041,0.0013771784,0.00047624612,0.0005380674,0.0022774509],"category_scores_gemma":[0.0032508639,0.000108875625,0.000745761,0.00030725027,0.00040253202,0.0014000601,0.0006534215,0.0014962151,0.00063299935],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012573692,0.00023537841,0.0023414525,0.006307454,0.00023244921,0.00036616577,0.00021141946,0.0016442118,0.0033607332,0.0061834096,0.006611759,0.97124827],"study_design_scores_gemma":[0.001246738,0.007970989,0.012530329,0.017799705,0.0015247468,0.005390618,0.00081308343,0.0034747035,0.01584362,0.036798976,0.8964752,0.00013134233],"about_ca_topic_score_codex":0.0004472773,"about_ca_topic_score_gemma":0.0014327146,"teacher_disagreement_score":0.0036749633,"about_ca_system_score_codex":0.0006336216,"about_ca_system_score_gemma":0.0012489972,"threshold_uncertainty_score":0.019435346},"labels":[],"label_agreement":null},{"id":"W4415304935","doi":"10.1016/j.jhepr.2025.101640","title":"MELD 3.i and the case for continuous updating in liver allocation","year":2025,"lang":"en","type":"letter","venue":"JHEP Reports","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Gilead Sciences","keywords":"Liver transplantation; Liver disease; Liver failure; Waiting list; Disease; Transplantation","score_opus":0.011349507147428668,"score_gpt":0.2575242420283196,"score_spread":0.24617473488089092,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415304935","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0006181685,0.00076687324,0.00018212413,0.98759556,0.0070017907,0.000007832437,0.000014396195,0.000017738046,0.0037954706],"genre_scores_gemma":[0.009732433,0.001409114,0.0008866967,0.93874276,0.04355513,0.00003243471,0.00002737274,0.00002448067,0.005589522],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970476,0.0011174423,0.00045522585,0.00027707304,0.00075375615,0.00034894206],"domain_scores_gemma":[0.9913043,0.0050568804,0.0005396184,0.0004282693,0.0012512933,0.0014196289],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004174082,0.0004591956,0.0006757788,0.0004814126,0.0021018083,0.0027613004,0.0013322909,0.030793108,0.004920766],"category_scores_gemma":[0.025940305,0.0003892883,0.0009883285,0.00058963295,0.0029919127,0.004138961,0.001116622,0.028649773,0.0031627708],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007399231,0.000053597683,0.0022000642,0.00006083436,0.00001159611,0.012940636,0.00024155386,0.00019893284,0.00028915642,0.011021207,0.9476787,0.025229877],"study_design_scores_gemma":[0.00015610715,0.00010757621,0.0026508179,0.0006908111,0.000024645808,0.031243956,0.000648979,0.0012499404,0.00034120554,0.035679486,0.9271246,0.00008178583],"about_ca_topic_score_codex":0.003993215,"about_ca_topic_score_gemma":0.007246287,"teacher_disagreement_score":0.030793108,"about_ca_system_score_codex":0.0034019188,"about_ca_system_score_gemma":0.003815808,"threshold_uncertainty_score":0.02468276},"labels":[],"label_agreement":null},{"id":"W4415756350","doi":"10.1016/j.jhepr.2025.101658","title":"Pembrolizumab and stereotactic body radiotherapy combined in advanced hepatocellular carcinoma post sorafenib – A phase II trial (PEMRAD)","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University Health Network; Princess Margaret Cancer Centre","funders":"Merck Canada; Princess Margaret Cancer Foundation; Merck","keywords":"Pembrolizumab; Sorafenib; Hepatocellular carcinoma; Clinical trial; Radiation therapy; Hepatocellular cancer; Stereotactic radiotherapy","score_opus":0.02267633328266469,"score_gpt":0.28418463771258057,"score_spread":0.2615083044299159,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415756350","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9823516,0.011524344,0.0005203353,0.0005733684,0.00014684754,0.0014105131,0.000673739,0.0000921729,0.0027070486],"genre_scores_gemma":[0.98769104,0.004129388,0.0013322941,0.0005620562,0.00023009528,0.0016213158,0.0014813504,0.00001401092,0.0029384778],"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","domain_scores_codex":[0.9997713,0.00011453756,0.000014260867,0.000033473574,0.000021795928,0.000044543307],"domain_scores_gemma":[0.9997774,0.00003775814,0.000055115037,0.000016723543,0.000017034012,0.000096004514],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010189508,0.0006004182,0.0011829569,0.00024133748,0.00019427095,0.0005638242,0.0003367776,0.00046922578,0.0027771296],"category_scores_gemma":[0.0004263174,0.00018934136,0.0006684128,0.00021246597,0.0003074416,0.0003084739,0.00020612706,0.0012128997,0.0004903271],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.71495306,0.014873581,0.0059549813,0.0018564401,0.0023507494,0.00035153245,0.00012781835,0.0028408365,0.02346083,0.0005388049,0.005450382,0.22724088],"study_design_scores_gemma":[0.6829626,0.2821129,0.017828627,0.00014494597,0.00093838194,0.00064402644,0.000056167602,0.001981443,0.0048039583,0.0003104736,0.008190975,0.000025635676],"about_ca_topic_score_codex":0.00037685555,"about_ca_topic_score_gemma":0.0010066729,"teacher_disagreement_score":0.0027771296,"about_ca_system_score_codex":0.00040339556,"about_ca_system_score_gemma":0.00059564546,"threshold_uncertainty_score":0.009290397},"labels":[],"label_agreement":null},{"id":"W4415901190","doi":"10.1016/j.jhepr.2025.101635","title":"Clinical practice and implications of biomarker testing in biliary tract cancer: An observational study","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Toronto General Hospital","funders":"Cilag; Horizon 2020 Framework Programme; Ipsen; Servier; Deutsche Krebshilfe; Eisai; LEO Pharma; European Cooperation in Science and Technology; Incyte; Deutsche Bahn; Les Laboratories Pierre Fabre; Eli Lilly and Company; AstraZeneca; Celgene; Daiichi Sankyo Europe; Sanofi; Deutsche Forschungsgemeinschaft; Wilhelm Sander-Stiftung; Amgen","keywords":"Observational study; Clinical Practice; Clinical trial; Profiling (computer programming); Biliary tract; Precision medicine; Randomized controlled trial; Biomarker","score_opus":0.24815108010042666,"score_gpt":0.4805192816871646,"score_spread":0.23236820158673796,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415901190","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9975611,0.0011017263,0.0003091492,0.00014420108,0.000009969602,0.000023866369,0.0004860618,0.0000035067558,0.00036038915],"genre_scores_gemma":[0.99929583,0.00015695451,0.00012684552,0.00005385518,0.000010832794,0.000017261858,0.00031494067,0.0000024968253,0.00002079689],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9927451,0.0033366259,0.0012998022,0.0013898015,0.0007465182,0.00048216747],"domain_scores_gemma":[0.9764855,0.0073505724,0.011785651,0.0016857622,0.0014597698,0.001232772],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0054247896,0.00025364393,0.0005832454,0.001248962,0.00056983513,0.001218831,0.0005094182,0.0005307695,0.0012196946],"category_scores_gemma":[0.016699262,0.00030634704,0.0005165312,0.0030234666,0.0007162498,0.0008593402,0.0010760403,0.00052871316,0.00023797809],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000091699185,0.00001786693,0.99849916,0.00001762899,0.00003398926,0.00005629314,0.000081625,0.000033538632,0.000044861034,0.00002920547,0.000092282055,0.0010019001],"study_design_scores_gemma":[0.000024141782,0.00019467472,0.99675566,0.0000406881,0.000096818956,0.0008841112,0.0006725431,0.0004047951,0.000085032734,0.0001144723,0.0007132531,0.000013696457],"about_ca_topic_score_codex":0.0025715015,"about_ca_topic_score_gemma":0.0023626564,"teacher_disagreement_score":0.0054247896,"about_ca_system_score_codex":0.0008264258,"about_ca_system_score_gemma":0.0010710383,"threshold_uncertainty_score":0.028689325},"labels":[],"label_agreement":null},{"id":"W4416023742","doi":"10.1016/j.jhepr.2025.101671","title":"Circulating HBV RNA and hepatitis B core-related antigen as determinants of HBsAg loss in persons with HIV in Europe","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute of Infection and Immunity","funders":"European AIDS Treatment Network; Swiss HIV Cohort Research Foundation; Schweizerische Akademie der Medizinischen Wissenschaften; Gottfried und Julia Bangerter-Rhyner-Stiftung; Danmarks Grundforskningsfond; MSD Sharp and Dohme; Agence Nationale de la Recherche; FP7 Coordination of Research Activities; Inselspital, Universitätsspital Bern; Janssen Scientific Affairs; Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung; Gilead Sciences; Sidaction; Bristol-Myers Squibb","keywords":"HBsAg; Hepatitis B virus; Human immunodeficiency virus (HIV); Hepatitis B; Antigen; RNA; Antibody; Transmission (telecommunications)","score_opus":0.01569297630744075,"score_gpt":0.28605223645782385,"score_spread":0.2703592601503831,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416023742","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99920964,0.0004917214,0.000030947926,0.000022352177,0.0000026194907,0.0000022434538,0.000067331406,0.0000010464955,0.00017214136],"genre_scores_gemma":[0.99966514,0.00015637263,0.00002672242,0.000017521781,0.0000042920833,0.0000017591124,0.00008297565,6.142913e-7,0.00004456934],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9996524,0.00014568857,0.000043164055,0.000059939648,0.000042658696,0.00005615439],"domain_scores_gemma":[0.9990526,0.00021348614,0.0004143999,0.000048534755,0.000092346854,0.00017858797],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013252009,0.00019397073,0.00024203984,0.00072747265,0.00030164156,0.0008056356,0.00025557503,0.00040192483,0.00095822604],"category_scores_gemma":[0.0021821256,0.00015802568,0.0003992932,0.0008117186,0.00020952178,0.00038314055,0.00047898438,0.00029196014,0.00009859936],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012749751,0.000017944323,0.99838316,0.0000068537965,0.000035779714,0.00004877605,0.000044598655,0.000039908762,0.000051150117,0.000011998563,0.00003356417,0.0011987064],"study_design_scores_gemma":[0.00000858095,0.00006971757,0.999005,0.000020597747,0.000038280632,0.00026955054,0.00021341673,0.00018340582,0.000039135284,0.000025695574,0.00012453701,0.00000201366],"about_ca_topic_score_codex":0.0045562023,"about_ca_topic_score_gemma":0.0030054557,"teacher_disagreement_score":0.0045562023,"about_ca_system_score_codex":0.00019724143,"about_ca_system_score_gemma":0.00025333214,"threshold_uncertainty_score":0.00905937},"labels":[],"label_agreement":null},{"id":"W4416713291","doi":"10.1016/j.jhepr.2025.101683","title":"External beam radiation for HCC: Ready for incorporation into guidelines?","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"External beam radiation; Radiation therapy; Beam (structure); External beam radiotherapy; Clinical trial; Clinical Practice","score_opus":0.11159624147511966,"score_gpt":0.361849546685738,"score_spread":0.25025330521061834,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416713291","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00087453914,0.28278515,0.0059737754,0.67724746,0.022554591,0.00018165608,0.00056399533,0.0004689802,0.009349882],"genre_scores_gemma":[0.01643146,0.6211862,0.07670892,0.23715721,0.0367688,0.0005730157,0.0029724303,0.0004183993,0.007783577],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9905302,0.0038434407,0.0026231494,0.00034211978,0.0023009295,0.00036019957],"domain_scores_gemma":[0.94721746,0.017892718,0.0055615436,0.002724967,0.023348235,0.003255181],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.014163621,0.0006666925,0.0019141757,0.0021836492,0.0008458034,0.003934766,0.002198237,0.0060005034,0.0074083805],"category_scores_gemma":[0.056393456,0.00060555775,0.0014482051,0.0026818935,0.0016434259,0.008337993,0.0024164729,0.009460295,0.0060336078],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009404821,0.00013150377,0.00086022593,0.006271158,0.0001103167,0.0003180189,0.00038843555,0.0003344461,0.0005566513,0.009888782,0.5187639,0.46228257],"study_design_scores_gemma":[0.0000577995,0.00009219385,0.0011775899,0.020027563,0.00012678008,0.00043099697,0.00060441473,0.00016524472,0.0001487741,0.010940969,0.9661806,0.00004713253],"about_ca_topic_score_codex":0.0057203285,"about_ca_topic_score_gemma":0.014357286,"teacher_disagreement_score":0.014163621,"about_ca_system_score_codex":0.0018806672,"about_ca_system_score_gemma":0.012679482,"threshold_uncertainty_score":0.074905336},"labels":[],"label_agreement":null},{"id":"W4416910545","doi":"10.1016/j.jhepr.2025.101597","title":"PD-L1 and the risk of bacterial infection in patients with chronic liver diseases: An international multicohort study","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Faculty of Medicine and Health, University of Sydney; Klinisk Institut, Syddansk Universitet; School of Medicine, Stanford University; European Regional Development Fund; Norgine; Grifols; Syddansk Universitet; Università di Bologna; Instituto de Salud Carlos III; Universitat de Barcelona; Novo Nordisk Foundation Center for Basic Metabolic Research; Novo Nordisk; Aarhus Universitet; KU Leuven; Universidad Complutense de Madrid; Institut National de la Santé et de la Recherche Médicale; Università degli Studi di Torino; University College London; Amsterdam University Medical Centers; Novo Nordisk Fonden; Universiteit van Amsterdam; Instituto de Investigación Sanitaria Gregorio Marañón; Centres de Recerca de Catalunya; Mallinckrodt Pharmaceuticals; Hospital Clínic de Barcelona; Pfizer; Odense Universitetshospital; Universitat Autònoma de Barcelona; Boston Scientific Corporation; European Commission; Ministero della Salute","keywords":"Immune system; Biomarker; Chronic liver disease; Disease; Risk factor; Immune Dysfunction; Liver dysfunction","score_opus":0.0022983704790313967,"score_gpt":0.23725592358288544,"score_spread":0.23495755310385405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416910545","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99910635,0.00035841812,0.00007172277,0.000039007937,0.0000076040574,0.0000134666225,0.00021471009,0.0000019221943,0.00018678635],"genre_scores_gemma":[0.9994641,0.00010248413,0.000056671157,0.00003122235,0.000014921231,0.000013668225,0.00023337416,0.0000012242406,0.000082498285],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99924374,0.00030047615,0.000058391954,0.00019200805,0.00009151577,0.00011399732],"domain_scores_gemma":[0.9987846,0.0001820637,0.0004849983,0.00018222143,0.00011661059,0.0002496548],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001688642,0.0006382585,0.00053912215,0.00081015757,0.00058016856,0.00092575705,0.00043565134,0.0008629074,0.001403852],"category_scores_gemma":[0.0017451929,0.000626556,0.0009036814,0.0010330294,0.00039672456,0.0005257116,0.00064549205,0.0007428599,0.00022362266],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043197573,0.00004054988,0.99872893,0.000008252227,0.00014720892,0.00003902624,0.000046842877,0.00002635696,0.00008834047,0.000012255207,0.000057682268,0.00037270863],"study_design_scores_gemma":[0.00006232498,0.00025680746,0.9986755,0.000008588737,0.00012906994,0.00028375204,0.00014596808,0.0002277504,0.000035291778,0.000027493812,0.00014120979,0.000006174323],"about_ca_topic_score_codex":0.0024339303,"about_ca_topic_score_gemma":0.0016665244,"teacher_disagreement_score":0.0024339303,"about_ca_system_score_codex":0.00033660798,"about_ca_system_score_gemma":0.00027262128,"threshold_uncertainty_score":0.008930504},"labels":[],"label_agreement":null},{"id":"W4417515877","doi":"10.1016/j.jhepr.2025.101714","title":"A liver gene signature links liver cancer risk in chronic viral hepatitis to intrahepatic IgA plasma cells","year":2025,"lang":"en","type":"article","venue":"JHEP Reports","topic":"Hepatitis C virus research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Toronto General Hospital; University Health Network","funders":"Cilag; Fondation contre le Cancer; Vlaamse regering; Stichting Tegen Kanker; Fonds Wetenschappelijk Onderzoek; Universiteit Antwerpen; Vlaams Supercomputer Centrum; Gilead Sciences","keywords":"Hepatocellular carcinoma; Liver cancer; Viral hepatitis; Gene signature; Liver biopsy; Transcriptome; Hepatitis C; Cancer; Antibody","score_opus":0.011786665702950389,"score_gpt":0.2993961855991077,"score_spread":0.2876095198961573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4417515877","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99966884,0.00004789035,0.00012846554,0.000008372206,7.877371e-7,0.000002464569,0.00007256781,0.0000039725846,0.00006664807],"genre_scores_gemma":[0.99964297,0.00001343417,0.00016826965,0.0000063352586,0.0000017585014,0.000002161948,0.00011101862,0.0000013927153,0.00005254757],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9998636,0.000027949203,0.000009772787,0.00004505543,0.000024834178,0.00002878069],"domain_scores_gemma":[0.9994784,0.000082351995,0.00023438678,0.0000525536,0.00006365157,0.00008869727],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00032448597,0.00019399644,0.0001772163,0.00048706512,0.00019724481,0.00036020318,0.0001582656,0.00022249865,0.001191965],"category_scores_gemma":[0.0005908118,0.000109348926,0.0002112036,0.0003819034,0.00026401246,0.00009367852,0.00023543664,0.00023052671,0.00014785636],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00056005234,0.000027915998,0.9585412,0.00001837356,0.00006234562,0.00008478325,0.000060115046,0.00013110139,0.03728709,0.000023985269,0.00005527062,0.003147826],"study_design_scores_gemma":[0.0000061593755,0.00008206934,0.99732345,0.0000020791888,0.000030167274,0.00035886932,0.000042347972,0.00047784785,0.0015649846,0.000032080236,0.00007836394,0.0000016723521],"about_ca_topic_score_codex":0.0020398952,"about_ca_topic_score_gemma":0.0023619663,"teacher_disagreement_score":0.0020398952,"about_ca_system_score_codex":0.00021952094,"about_ca_system_score_gemma":0.00023932492,"threshold_uncertainty_score":0.004056096},"labels":[],"label_agreement":null}]}